No.,Title,Link
1,Calcium-sensing stromal interaction molecule 2 upregulates nuclear factor of activated T cells 1 and transforming growth factor-β signaling to promote breast cancer metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1185-1
2,Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1182-4
3,Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1180-6
4,Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1168-2
5,Disease trajectories and mortality among women diagnosed with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1181-5
6,Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1177-1
7,Inequities in breast cancer treatment in sub-Saharan Africa: findings from a prospective multi-country observational study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1174-4
8,Development of a prediction model for breast cancer based on the national cancer registry in Taiwan,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1172-6
9,Investigating the feasibility of stratified breast cancer screening using a masking risk predictor,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1179-z
10,Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1176-2
11,Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1173-5
12,Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1167-3
13,Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1171-7
14,The prognostic value of JUNB-positive CTCs in metastatic breast cancer: from bioinformatics to phenotypic characterization,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1166-4
15,Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1170-8
16,Vitamin D receptor expression in invasive breast tumors and breast cancer survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1169-1
17,A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1165-5
18,Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1164-6
19,Relationship of circulating insulin-like growth factor-I and binding proteins 1–7 with mammographic density among women undergoing image-guided diagnostic breast biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1162-8
20,"Abrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1163-7
21,Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1160-x
22,"Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1154-8
23,A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1161-9
24,Gene expression signature of atypical breast hyperplasia and regulation by SFRP1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1157-5
25,Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1158-4
26,The p52 isoform of SHC1 is a key driver of breast cancer initiation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1155-7
27,On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1159-3
28,Reanalysis of the NCCN PD-L1 companion diagnostic assay study for lung cancer in the context of PD-L1 expression findings in triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1156-6
29,Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1149-5
30,Association between C-reactive protein and radiotherapy-related pain in a tri-racial/ethnic population of breast cancer patients: a prospective cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1151-y
31,"Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1152-x
32,Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1138-8
33,Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1153-9
34,Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1147-7
35,Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1148-6
36,Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1150-z
37,Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1146-8
38,Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1145-9
39,Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1141-0
40,Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1144-x
41,Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1140-1
42,"Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1143-y
43,Distant metastasis dynamics following subsequent surgeries after primary breast cancer removal,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1139-7
44,Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor DDR2,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1142-z
45,Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1137-9
46,The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1136-x
47,The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1131-2
48,Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1135-y
49,BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1132-1
50,Association between prediagnostic leukocyte telomere length and breast cancer risk: the Singapore Chinese Health Study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1133-0
51,Calcium-sensing stromal interaction molecule 2 upregulates nuclear factor of activated T cells 1 and transforming growth factor-β signaling to promote breast cancer metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1185-1
52,Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1182-4
53,Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1180-6
54,Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1168-2
55,Disease trajectories and mortality among women diagnosed with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1181-5
56,Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1177-1
57,Inequities in breast cancer treatment in sub-Saharan Africa: findings from a prospective multi-country observational study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1174-4
58,Development of a prediction model for breast cancer based on the national cancer registry in Taiwan,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1172-6
59,Investigating the feasibility of stratified breast cancer screening using a masking risk predictor,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1179-z
60,Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1176-2
61,Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1173-5
62,Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1167-3
63,Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1171-7
64,The prognostic value of JUNB-positive CTCs in metastatic breast cancer: from bioinformatics to phenotypic characterization,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1166-4
65,Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1170-8
66,Vitamin D receptor expression in invasive breast tumors and breast cancer survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1169-1
67,A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1165-5
68,Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1164-6
69,Relationship of circulating insulin-like growth factor-I and binding proteins 1–7 with mammographic density among women undergoing image-guided diagnostic breast biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1162-8
70,"Abrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1163-7
71,Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1160-x
72,"Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1154-8
73,A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1161-9
74,Gene expression signature of atypical breast hyperplasia and regulation by SFRP1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1157-5
75,Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1158-4
76,The p52 isoform of SHC1 is a key driver of breast cancer initiation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1155-7
77,On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1159-3
78,Reanalysis of the NCCN PD-L1 companion diagnostic assay study for lung cancer in the context of PD-L1 expression findings in triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1156-6
79,Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1149-5
80,Association between C-reactive protein and radiotherapy-related pain in a tri-racial/ethnic population of breast cancer patients: a prospective cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1151-y
81,"Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1152-x
82,Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1138-8
83,Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1153-9
84,Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1147-7
85,Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1148-6
86,Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1150-z
87,Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1146-8
88,Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1145-9
89,Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1141-0
90,Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1144-x
91,Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1140-1
92,"Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1143-y
93,Distant metastasis dynamics following subsequent surgeries after primary breast cancer removal,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1139-7
94,Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor DDR2,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1142-z
95,Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1137-9
96,The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1136-x
97,The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1131-2
98,Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1135-y
99,BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1132-1
100,Association between prediagnostic leukocyte telomere length and breast cancer risk: the Singapore Chinese Health Study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1133-0
101,"CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1134-z
102,"Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1129-9
103,The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1130-3
104,Genomic signature of parity in the breast of premenopausal women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1128-x
105,Correction to: ECM1 regulates cell proliferation and trastuzumab resistance through activation of EGF-signaling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1106-3
106,Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1122-3
107,Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1127-y
108,Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1126-z
109,Impact of obesity on breast cancer recurrence and minimal residual disease,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1087-7
110,"Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses’ Health Studies",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1119-y
111,"PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1115-2
112,Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1120-5
113,GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1125-0
114,Separation of breast cancer and organ microenvironment transcriptomes in metastases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1123-2
115,Updating the role of obesity and cholesterol in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1124-1
116,The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1121-4
117,The distribution and determinants of mammographic density measures in Western Australian aboriginal women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1113-4
118,Patterns of occurrence and implications of neratinib-associated diarrhea in patients with HER2-positive breast cancer: analyses from the randomized phase III ExteNET trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1112-5
119,Osteoblasts are “educated” by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1117-0
120,Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1118-z
121,AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1107-2
122,Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1108-1
123,"MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1116-1
124,Correction to: Targeted therapy against Bcl-2-related proteins in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1105-4
125,Imprint of parity and age at first pregnancy on the genomic landscape of subsequent breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1111-6
126,Airborne metals and polycyclic aromatic hydrocarbons in relation to mammographic breast density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1110-7
127,CXCL17-derived CD11b+Gr-1+ myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1114-3
128,Targeted mutation detection in breast cancer using MammaSeq™,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1102-7
129,Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1109-0
130,"MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1104-5
131,Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1091-y
132,"A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1098-z
133,"Serum erythropoietin levels, breast cancer and breast cancer-initiating cells",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1100-9
134,Associations between dietary patterns and the risk of breast cancer: a systematic review and meta-analysis of observational studies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1096-1
135,Letter to the Editor: A response to Hruska’s case study on molecular breast imaging and the need for true tissue quantification,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1103-6
136,Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1090-z
137,p53 controls the plasticity of mammary luminal progenitor cells downstream of Met signaling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1101-8
138,Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1079-7
139,"Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1095-7
140,HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1097-0
141,Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1092-x
142,Localized mammographic density is associated with interval cancer and large breast cancer: a nested case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1099-y
143,"Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP)",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1088-6
144,Hydrodynamic shear stress promotes epithelial-mesenchymal transition by downregulating ERK and GSK3β activities,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1071-2
145,Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1094-8
146,Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1093-9
147,Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1085-9
148,Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1089-5
149,A method of producing genetically manipulated mouse mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1086-8
150,Adjusting for BMI in analyses of volumetric mammographic density and breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1078-8
151,"Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1084-x
152,"CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1076-x
153,Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1082-z
154,Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1081-0
155,ErbB2-driven downregulation of the transcription factor Irf6 in breast epithelial cells is required for their 3D growth,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1080-1
156,The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1074-z
157,"CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1083-y
158,"Alterations in arginine and energy metabolism, structural and signalling lipids in metastatic breast cancer in mice detected in plasma by targeted metabolomics and lipidomics",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1075-y
159,Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1073-0
160,Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1077-9
161,"Induction of cell cycle arrest and inflammatory genes by combined treatment with epigenetic, differentiating, and chemotherapeutic agents in triple-negative breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1068-x
162,Statin drugs to reduce breast cancer recurrence and mortality,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1066-z
163,Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1070-3
164,No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1065-0
165,Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1067-y
166,Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1064-1
167,HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1072-1
168,Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1063-2
169,Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1060-5
170,Correction to: Consistent and reproducible cultures of large-scale 3D mammary epithelial structures using an accessible bioprinting platform,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1069-9
171,Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1062-3
172,Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1061-4
173,Sulfatide decreases the resistance to stress-induced apoptosis and increases P-selectin-mediated adhesion: a two-edged sword in breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1058-z
174,Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1056-1
175,British Society of Breast Radiology Annual Scientific Meeting 2018,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1052-5
176,Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1057-0
177,Monitoring Src status after dasatinib treatment in HER2+ breast cancer with 89Zr-trastuzumab PET imaging,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1055-2
178,Integrin-Rac signalling for mammary epithelial stem cell self-renewal,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1048-1
179,Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1059-y
180,Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1054-3
181,Disrupted circadian clocks and altered tissue mechanics in primary human breast tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1053-4
182,"Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1051-6
183,Ribociclib for the first-line treatment of advanced hormone receptor-positive breast cancer: a review of subgroup analyses from the MONALEESA-2 trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1050-7
184,NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1049-0
185,Consistent and reproducible cultures of large-scale 3D mammary epithelial structures using an accessible bioprinting platform,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1045-4
186,Serially transplantable mammary epithelial cells express the Thy-1 antigen,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1006-y
187,Long-term exposure to road traffic noise and incidence of breast cancer: a cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1047-2
188,Maternal breast cancer risk in relation to birthweight and gestation of her offspring,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1035-6
189,Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1043-6
190,BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1046-3
191,Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1030-y
192,Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1044-5
193,"Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1033-8
194,Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1042-7
195,Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1028-5
196,Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1036-5
197,"A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1015-x
198,Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1037-4
199,Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1038-3
200,European Network of Breast Development and Cancer turned 10 years: a growing family of mammary gland researchers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1032-9
201,Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1041-8
202,NOTCH3 expression is linked to breast cancer seeding and distant metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1020-0
203,Obesity promotes the expansion of metastasis-initiating cells in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1029-4
204,"Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1040-9
205,Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1039-2
206,Epigenomics of mammary gland development,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1031-x
207,Paternal malnutrition programs breast cancer risk and tumor metabolism in offspring,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1034-7
208,Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0999-6
209,TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1024-9
210,Clonal relatedness in tumour pairs of breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1022-y
211,Volumetric breast density and risk of advanced cancers after a negative screening episode: a cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1025-8
212,Thyroid hormones and breast cancer association according to menopausal status and body mass index,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1017-8
213,Long-term exposure to insulin and volumetric mammographic density: observational and genetic associations in the Karma study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1026-7
214,High mammographic density in women is associated with protumor inflammation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1010-2
215,Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1027-6
216,Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1023-x
217,Correction to: Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in luminal B breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0998-7
218,Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1007-x
219,"Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1011-1
220,Nitric oxide deficiency and endothelial–mesenchymal transition of pulmonary endothelium in the progression of 4T1 metastatic breast cancer in mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1013-z
221,Can novel technologies improve breast conserving surgery?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1016-9
222,The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1019-6
223,Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1018-7
224,"A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1014-y
225,Effect of exercise and/or reduced calorie dietary interventions on breast cancer-related endogenous sex hormones in healthy postmenopausal women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1009-8
226,Correction to: Association of invasion-promoting tenascin-C additional domains with breast cancers in young women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0997-8
227,The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1012-0
228,Intracellular hypoxia measured by 18F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0970-6
229,Retraction Note: Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1021-z
230,Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1008-9
231,Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1005-z
232,Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0996-9
233,ETV4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0992-0
234,Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1001-3
235,The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1004-0
236,"Vitamin D, DNA methylation, and breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0994-y
237,Intra-operative spectroscopic assessment of surgical margins during breast conserving surgery,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1002-2
238,Correction to: The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1000-4
239,"Evaluation of α-tubulin, detyrosinated α-tubulin, and vimentin in CTCs: identification of the interaction between CTCs and blood cells through cytoskeletal elements",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0993-z
240,Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0995-x
241,Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0977-z
242,Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0978-y
243,Correction to: Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0984-0
244,Immune characterization of breast cancer metastases: prognostic implications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-1003-1
245,Correction to: Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0987-x
246,SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0988-9
247,Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0990-2
248,Can diffusion-weighted imaging predict tumor grade and expression of Ki-67 in breast cancer? A multicenter analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0991-1
249,Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0986-y
250,Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0974-2
251,Identifying an early treatment window for predicting breast cancer response to neoadjuvant chemotherapy using immunohistopathology and hemoglobin parameters,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0975-1
252,NDRG1 regulates neutral lipid metabolism in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0980-4
253,Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0981-3
254,"OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0971-5
255,Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0989-8
256,Amide chemical exchange saturation transfer at 7 T: a possible biomarker for detecting early response to neoadjuvant chemotherapy in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0982-2
257,Exploring the prediction performance for breast cancer risk based on volumetric mammographic density at different thresholds,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0979-x
258,Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0976-0
259,"Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0983-1
260,Correction to: Identification of novel human RANK isoforms generated through alternative splicing. Implications in breast cancer cell survival and migration,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0985-z
261,Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0973-3
262,"A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0964-4
263,Proteolytic single hinge cleavage of pertuzumab impairs its Fc effector function and antitumor activity in vitro and in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0972-4
264,Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0969-z
265,Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0966-2
266,Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0968-0
267,"Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0967-1
268,Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0965-3
269,Real-world evidence analysis of palbociclib prescribing patterns for patients with advanced/metastatic breast cancer treated in community oncology practice in the USA one year post approval,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0958-2
270,The combined effect of mammographic texture and density on breast cancer risk: a cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0961-7
271,Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0963-5
272,MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0950-x
273,Comparison of methods to assess onset of breast development in the LEGACY Girls Study: methodological considerations for studies of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0943-9
274,IMP1 regulates UCA1-mediated cell invasion through facilitating UCA1 decay and decreasing the sponge effect of UCA1 for miR-122-5p,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0959-1
275,Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0962-6
276,Common genetic variation and novel loci associated with volumetric mammographic density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0954-6
277,"Mitochondrial DNA copy number variation, leukocyte telomere length, and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0955-5
278,Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0951-9
279,Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0945-7
280,Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0957-3
281,Isocitrate dehydrogenase 1–snail axis dysfunction significantly correlates with breast cancer prognosis and regulates cell invasion ability,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0953-7
282,A novel neuregulin – jagged1 paracrine loop in breast cancer transendothelial migration,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0960-8
283,The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0948-4
284,Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0949-3
285,The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0946-6
286,Murine breast cancer feed arteries are thin-walled with reduced α1A-adrenoceptor expression and attenuated sympathetic vasocontraction,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0952-8
287,Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0938-6
288,Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0947-5
289,The origins of breast cancer associated with mammographic density: a testable biological hypothesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0941-y
290,The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0944-8
291,Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0942-x
292,Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0940-z
293,Not all false positive diagnoses are equal: On the prognostic implications of false-positive diagnoses made in breast MRI versus in mammography / digital tomosynthesis screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0937-7
294,Frequency of breast cancer subtypes among African American women in the AMBER consortium,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0939-5
295,The significance of tumour microarchitectural features in breast cancer prognosis: a digital image analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0934-x
296,A comparison of five methods of measuring mammographic density: a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0932-z
297,Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0936-8
298,HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0933-y
299,"BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-018-0935-9
300,Inherited factors contribute to an inverse association between preeclampsia and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0930-6
301,Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0931-5
302,Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0928-0
303,Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0929-z
304,Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0927-1
305,SNPs related to vitamin D and breast cancer risk: a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0925-3
306,Use of prescription drugs and risk of postoperative red blood cell transfusion in breast cancer patients: a Danish population-based cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0926-2
307,Association between mammographic breast density and histologic features of benign breast disease,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0922-6
308,miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0918-2
309,Phosphoproteomics reveals network rewiring to a pro-adhesion state in annexin-1-deficient mammary epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0924-4
310,Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0914-6
311,Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0920-8
312,GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0923-5
313,Obesity reversibly depletes the basal cell population and enhances mammary epithelial cell estrogen receptor alpha expression and progenitor activity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0921-7
314,Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0919-1
315,Influence of breast compression pressure on the performance of population-based mammography screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0917-3
316,Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0916-4
317,Residential particulate matter and distance to roadways in relation to mammographic density: results from the Nurses’ Health Studies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0915-5
318,Smoking and risk of breast cancer in the Generations Study cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0908-4
319,Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0913-7
320,The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0912-8
321,Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0910-x
322,Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0911-9
323,Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0909-3
324,British Society of Breast Radiology Annual Scientific Meeting 2017,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0903-9
325,Addition of T2-guided optical tomography improves noncontrast breast magnetic resonance imaging diagnosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0902-x
326,Roles of BCCIP deficiency in mammary tumorigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0907-5
327,A novel and fully automated mammographic texture analysis for risk prediction: results from two case-control studies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0906-6
328,Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0881-y
329,Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0905-7
330,FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0904-8
331,Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0900-z
332,Erratum to: Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0898-2
333,Alcohol consumption and breast tumor gene expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0901-y
334,Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0896-4
335,Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0899-1
336,ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0893-7
337,"SPEN, a new player in primary cilia formation and cell migration in breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0897-3
338,Breast Tissue Organisation and its Association with Breast Cancer Risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0894-6
339,"Pathobiology of the 129:Stat1
−/− mouse model of human age-related ER-positive breast cancer with an immune infiltrate-excluded phenotype",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0892-8
340,Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0895-5
341,Tissue-based associations of mammographic breast density with breast stem cell markers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0889-3
342,The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0861-2
343,Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0888-4
344,Combining quantitative and qualitative breast density measures to assess breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0887-5
345,The ninth ENBDC Weggis meeting: growth and in-depth characterisation of normal and neoplastic breast cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0891-9
346,"Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0890-x
347,"White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0886-6
348,Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0878-6
349,Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0885-7
350,Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0884-8
351,Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0882-x
352,A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0879-5
353,AKT1low quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0877-7
354,Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0883-9
355,Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0880-z
356,"Consistency, now what?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0869-7
357,Body size in early life and risk of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0875-9
358,Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0874-x
359,Early pregnancy sex steroids during primiparous pregnancies and maternal breast cancer: a nested case–control study in the Northern Sweden Maternity Cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0876-8
360,Normal breast tissue DNA methylation differences at regulatory elements are associated with the cancer risk factor age,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0873-y
361,Erratum to: Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0862-1
362,Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0872-z
363,The footprint of the ageing stroma in older patients with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0871-0
364,Maternal intake of high n-6 polyunsaturated fatty acid diet during pregnancy causes transgenerational increase in mammary cancer risk in mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0866-x
365,Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0867-9
366,Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0870-1
367,Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0868-8
368,MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0858-x
369,miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0865-y
370,Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0864-z
371,Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0863-0
372,Pubertal development in girls by breast cancer family history: the LEGACY girls cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0849-y
373,Tightly controlled MRTF-A activity regulates epithelial differentiation during formation of mammary acini,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0860-3
374,The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0859-9
375,Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0857-y
376,Molecular characterization of breast cancer cell lines through multiple omic approaches,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0855-0
377,BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0856-z
378,A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer data,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0854-1
379,"LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0853-2
380,Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0850-5
381,Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0851-4
382,Rapid evaporative ionisation mass spectrometry of electrosurgical vapours for the identification of breast pathology: towards an intelligent knife for breast cancer surgery,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0845-2
383,An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0852-3
384,Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0846-1
385,Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situ,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0847-0
386,"An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0848-z
387,"A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0836-3
388,TIMELESS contributes to the progression of breast cancer through activation of MYC,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0838-1
389,"Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0840-7
390,Cooperation of neurotrophin receptor TrkB and Her2 in breast cancer cells facilitates brain metastases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0844-3
391,A 3D in vitro model of the human breast duct: a method to unravel myoepithelial-luminal interactions in the progression of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0843-4
392,Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0841-6
393,"Erratum to: Detecting gene signature activation in breast cancer in an absolute, single-patient manner",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0842-5
394,Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0839-0
395,"Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0827-4
396,Association between air pollution and mammographic breast density in the Breast Cancer Surveilance Consortium,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0828-3
397,"Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0837-2
398,Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0812-y
399,Erratum to: Ubiquitin-conjugating enzyme complex Uev1A-Ubc13 promotes breast cancer metastasis through nuclear factor-кB mediated matrix metalloproteinase-1 gene regulation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0833-6
400,Erratum to: Honokiol activates AMP-activated protein kinase in breast cancer cells via LKB1-dependent pathway and inhibits breast carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0829-2
401,Erratum to: Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0831-8
402,Erratum to: JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0830-9
403,Erratum to: A novel function for p21 Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0832-7
404,Erratum to: Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0834-5
405,"Erratum to: Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0835-4
406,Glucocorticoids induce production of reactive oxygen species/reactive nitrogen species and DNA damage through an iNOS mediated pathway in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0823-8
407,Decision making for breast cancer prevention among women at elevated risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0826-5
408,Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0822-9
409,"Detecting gene signature activation in breast cancer in an absolute, single-patient manner",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0824-7
410,Nighttime eating and breast cancer among Chinese women in Hong Kong,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0821-x
411,Increased genomic burden of germline copy number variants is associated with early onset breast cancer: Australian breast cancer family registry,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0825-6
412,A clinical model for identifying the short-term risk of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0820-y
413,Anthropometric measures and serum estrogen metabolism in postmenopausal women: the Women’s Health Initiative Observational Study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0810-0
414,Gossypol has anti-cancer effects by dual-targeting MDM2 and VEGF in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0818-5
415,The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0819-4
416,DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0814-9
417,Response to “Lack of association between bovine leukemia virus and breast cancer in Chinese patients”,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0808-7
418,Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0815-8
419,Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0816-7
420,EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses’ Health Studies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0817-6
421,Immune profiles of elderly breast cancer patients are altered by chemotherapy and relate to clinical frailty,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0813-x
422,Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0811-z
423,"Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2− breast cancer that had progressed during or after prior endocrine therapy",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0807-8
424,Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0809-6
425,"Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0806-9
426,Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0785-2
427,Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0802-0
428,Childhood body size and pubertal timing in relation to adult mammographic density phenotype,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0804-y
429,Non-invasive optical spectroscopic monitoring of breast development during puberty,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0805-x
430,"Prevalence of preterm, low birthweight, and small for gestational age delivery after breast cancer diagnosis: a population-based study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0803-z
431,"Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0798-x
432,"Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0801-1
433,Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0791-4
434,"PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0789-y
435,Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0799-9
436,Erratum to: Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0800-2
437,CCL2-driven inflammation increases mammary gland stromal density and cancer susceptibility in a transgenic mouse model,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0796-z
438,18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0793-2
439,Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0794-1
440,Erratum to: Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0797-y
441,Lifetime body size and estrogen-receptor-positive breast cancer risk in the California Teachers Study cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0790-5
442,The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0795-0
443,Mammographic density assessed on paired raw and processed digital images and on paired screen-film and digital images across three mammography systems,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0787-0
444,Circulating cell-free DNA-based epigenetic assay can detect early breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0788-z
445,Involution of breast tissue and mammographic density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0792-3
446,Imaging the mammary gland and mammary tumours in 3D: optical tissue clearing and immunofluorescence methods,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0754-9
447,Safety and efficacy of vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer: VELVET Cohort 1 final results,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0773-6
448,MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0781-6
449,Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0786-1
450,The AF-1-deficient estrogen receptor ERα46 isoform is frequently expressed in human breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0780-7
451,Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0778-1
452,An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0783-4
453,High mammographic breast density predicts locoregional recurrence after modified radical mastectomy for invasive breast cancer: a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0784-3
454,Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0782-5
455,Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0779-0
456,Erratum to: Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0775-4
457,The complexities and caveats of lineage tracing in the mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0774-5
458,"Complexity galore: 3D cultures, biomechanics and systems medicine at the eighth ENBDC workshop “Methods in Mammary Gland Development and Cancer”",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0777-2
459,Erratum to: JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0776-3
460,ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0770-9
461,"Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0768-3
462,The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0762-9
463,Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0771-8
464,British Society of Breast Radiology Annual Scientific Meeting 2016,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0766-5
465,Deep targeted sequencing of 12 breast cancer susceptibility regions in 4611 women across four different ethnicities,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0772-7
466,Evidence of two distinct functionally specialized fibroblast lineages in breast stroma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0769-2
467,Mammographically dense human breast tissue stimulates MCF10DCIS.com progression to invasive lesions and metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0767-4
468,The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0764-7
469,Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0765-6
470,Extending the Developmental Origins of Health and Disease theory: does paternal diet contribute to breast cancer risk in daughters?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0760-y
471,Pre-natal exposures and breast tissue composition: findings from a British pre-birth cohort of young women and a systematic review,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0751-z
472,Lack of association between bovine leukemia virus and breast cancer in Chinese patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0763-8
473,Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0761-x
474,The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0759-4
475,Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0758-5
476,Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0757-6
477,Impact of type of full-field digital image on mammographic density assessment and breast cancer risk estimation: a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0756-7
478,PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0749-6
479,Mammographic density and breast cancer risk: a mediation analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0750-0
480,Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0752-y
481,WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0748-7
482,Beyond breast density: a review on the advancing role of parenchymal texture analysis in breast cancer risk assessment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0755-8
483,Plasma exosome microRNAs are indicative of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0753-x
484,Circadian clocks and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0743-z
485,"Relationships between mammographic density, tissue microvessel density, and breast biopsy diagnosis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0746-9
486,Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0739-8
487,Predicted 25-hydroxyvitamin D in relation to incidence of breast cancer in a large cohort of African American women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0745-x
488,Adolescent fiber intake and mammographic breast density in premenopausal women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0747-8
489,Tumor-associated stromal cells as key contributors to the tumor microenvironment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0740-2
490,Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0744-y
491,Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0742-0
492,SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0738-9
493,CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0741-1
494,Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0736-y
495,Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0737-x
496,Paternal programming of breast cancer risk in daughters in a rat model: opposing effects of animal- and plant-based high-fat diets,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0729-x
497,"Comment on: Tan WJ, Cima I, Choudhury Y, Wei X, Lim JCT, Thicke AA, Tan MH, Tan PH. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions. Breast Cancer Research 2016;18:31",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0730-4
498,Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0734-0
499,MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0735-z
500,"Psychological stress, adverse life events and breast cancer incidence: a cohort investigation in 106,000 women in the United Kingdom",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0733-1
501,Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0726-0
502,Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0724-2
503,Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0720-6
504,"Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0731-3
505,Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0728-y
506,Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0732-2
507,Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0725-1
508,"Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0721-5
509,Clonal relationships between lobular carcinoma in situ and other breast malignancies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0727-z
510,Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0718-0
511,Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0722-4
512,Recreational physical activity and risk of triple negative breast cancer in the California Teachers Study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0723-3
513,Common genetic susceptibility to DCIS and invasive ductal carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0719-z
514,Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0713-5
515,SEARCHBreast: a new online resource to make surplus material from in vivo models of breast cancer visible and accessible to researchers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0716-2
516,Intermittent energy restriction induces changes in breast gene expression and systemic metabolism,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0714-4
517,Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0717-1
518,Breast cancer and social environment: getting by with a little help from our friends,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0700-x
519,Cancer stem cell metabolism,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0712-6
520,Case-control study of mammographic density and breast cancer risk using processed digital mammograms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0715-3
521,Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0709-1
522,CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0711-7
523,Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0708-2
524,Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0703-7
525,Determining breast cancer histological grade from RNA-sequencing data,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0710-8
526,The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0705-5
527,Tumor characterization and treatment monitoring of postsurgical human breast specimens using harmonic motion imaging (HMI),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0707-3
528,Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0706-4
529,Raised mammographic density: causative mechanisms and biological consequences,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0701-9
530,Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0702-8
531,Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0704-6
532,Association of infertility and fertility treatment with mammographic density in a large screening-based cohort of women: a cross-sectional study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0693-5
533,Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0697-1
534,miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0699-z
535,Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0696-2
536,Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0698-0
537,"The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0694-4
538,COX-2 modulates mammary tumor progression in response to collagen density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0695-3
539,"Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0691-7
540,Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0690-8
541,Selective isolation and characterization of primary cells from normal breast and tumors reveal plasticity of adipose derived stem cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0688-2
542,A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0692-6
543,In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0687-3
544,Lack of cortistatin or somatostatin differentially influences DMBA-induced mammary gland tumorigenesis in mice in an obesity-dependent mode,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0689-1
545,Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0684-6
546,Growth of human breast tissues from patient cells in 3D hydrogel scaffolds,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0677-5
547,An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0685-5
548,Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0686-4
549,Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0683-7
550,"Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0678-4
551,LIN7A is a major determinant of cell-polarity defects in breast carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0680-x
552,Genetic predisposition to ductal carcinoma in situ of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0675-7
553,Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0682-8
554,Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0679-3
555,High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0681-9
556,Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0661-5
557,Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0671-y
558,Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0676-6
559,The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0674-8
560,p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0673-9
561,Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0669-x
562,Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-016-0672-x
563,The cell surface mucin podocalyxin regulates collective breast tumor budding,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0670-4
564,Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0668-y
565,Breast cancer brain metastases: biology and new clinical perspectives,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0665-1
566,Breast primary epithelial cells that escape p16-dependent stasis enter a telomere-driven crisis state,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0667-z
567,Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0662-4
568,Increased peri-ductal collagen micro-organization may contribute to raised mammographic density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0664-2
569,ELF5 isoform expression is tissue-specific and significantly altered in cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0666-0
570,Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0663-3
571,SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0659-z
572,Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0660-6
573,“New” metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0657-1
574,HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0658-0
575,Dual inhibition of Type I and Type III PI3 kinases increases tumor cell apoptosis in HER2+ breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0656-2
576,Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0653-5
577,The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0652-6
578,β2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0655-3
579,Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0650-8
580,Erratum to: Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0651-7
581,Mammographic density defined by higher than conventional brightness threshold better predicts breast cancer risk for full-field digital mammograms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0654-4
582,Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0649-1
583,The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0648-2
584,The radiologist in the fast track breast clinic: the invisible man (woman),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3805
585,Breast cancer in women under 35 years,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3803
586,Prospective study looking at CT staging for metastases in early breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3801
587,Do bone scans add to CT in detecting skeletal metastases in breast cancer staging?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3798
588,Role of mammographic templates in managing ever increasing workloads,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3796
589,Outcome of ultrasound of the mammographically normal contralateral breast in patients recalled to the screening assessment clinic,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3785
590,A review of BRCA gene carrier demographics in Wales,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3783
591,A perceptual aid to delineating the extent of potential mammographic abnormalities,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3781
592,Comparative study of radiation dose between tomosynthesis and standard compression views in mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3777
593,Can public consultation effectively optimise the design of a patient information leaflet about breast magnetic resonance imaging?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3775
594,Comparison of MRI and digital breast tomosynthesis in the preoperative evaluation of multifocal breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3773
595,Use of MRI to predict response following neoadjuvant chemotherapy for breast cancer: how accurately can it guide surgical choice?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3771
596,Use of preoperative breast MRI to determine disease extent,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3769
597,Preoperative identification and biopsy of sentinel lymph nodes using contrast-enhanced ultrasound: the Tunbridge Wells experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3767
598,Evaluation of the use of microbubbles in the ultrasound assessment of the axilla in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3765
599,Breast density measurements with ultrasound tomography: a comparison with non-contrast MRI,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3759
600,Sensitivity of US and FNAC for staging of the axilla in patients presenting with symptomatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3763
601,Effect of physical activity on sex hormones in women: a systematic review and meta-analysis of randomized controlled trials,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0647-3
602,Follow-up imaging of breast symptomatic patients: a waste of radiologist time?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3806
603,'Peace of mind'? Demand for breast imaging investigation following normal clinical examination: establishing the patient benefits and service implications for a symptomatic service,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3804
604,Breast pain in the over 40s: impact on imaging,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3802
605,Comparison of prognostic indices in symptomatic and screen-detected invasive breast cancer in Asian and Caucasian women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3800
606,A comparative study of pathological and prognostic differences in DCIS between Asian and Caucasian women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3799
607,Local experience of referral for breast assessment resulting from incidental findings on CT and PET-CT studies over a 5-year period,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3797
608,Breast biopsy in patients on anti-coagulants: is new guidance needed?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3795
609,Use of WHO checklist in interventional breast radiological procedures,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3794
610,"Safety of vacuum-assisted biopsy/mammatome guided, non-operative management of B3 lesions with atypia: a 7-year follow-up study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3793
611,"Safety of vacuum-assisted biopsy/mammatome guided, non-operative management of B3 lesions without atypia: a 7-year follow-up study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3792
612,Quantitative study: should vacuum-assisted biopsy be the first biopsy approach in breast interventional techniques in stereotactic guided microcalcifications rather than 14 gauge core needle biopsy?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3791
613,The 3.5-year to 13.5-year follow up of 137 lesions of uncertain malignant potential (B3 lesions) diagnosed by vacuum-assisted biopsy alone,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3790
614,Handheld ultrasound-guided 20 mm basket Intact breast lesion excision system biopsy for excision of benign breast lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3789
615,An audit of marker placement in stereotactic guided biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3788
616,Does tomosynthesis increase confidence in grading the suspicious appearance of a lesion? An audit of cancers diagnosed in the assessment clinic using tomosynthesis: initial experience at Avon Breast Screening Unit,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3787
617,Impact of index of multiple deprivation and ethnicity on breast screening uptake in the North West of England,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3786
618,Audit of high prevalent breast screening recall rates: Torbay Hospital,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3784
619,Diagnostic implications of digital breast tomosynthesis in symptomatic patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3782
620,Initial outcome of contrast-enhanced spectral mammography in lesion characterisation in the mammographically dense breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3780
621,Positive predictive value of mammographic features on digital breast tomosynthesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3778
622,Contrast-enhanced spectral mammography: what is the 'added value' in a symptomatic setting? Initial findings from a UK centre,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3776
623,MRI guided breast biopsy: initial experience of service expansion in West Midlands,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3774
624,Is pretreatment assessment of the contralateral breast with MRI useful following a new diagnosis of invasive lobular cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3772
625,MRI evaluation of multifocality and contralateral disease in lobular breast cancer: what can we learn from one region's experience?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3770
626,Correlation of post-neoadjuvant chemotherapy response on MRI with final histology in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3768
627,Informed choice and consent among women attending for breast screening in the UK: data from a qualitative study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3762
628,Is surgical diagnostic excision always necessary for solid lesions with atypia?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3761
629,Use of sulphur hexafluoride microbubbles injection to identify the sentinel lymph node in breast cancer patients: initial experience in a UK breast unit,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3766
630,Breast tumour localisation using Iodine seeds in the UK: the first 100 patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3760
631,Accuracy of axillary nodal ultrasound and ultrasound fine needle aspiration/core biopsy in the preoperative staging of patients with invasive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3764
632,Breast screening interval and the characteristics of screen-detected cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3758
633,Accuracy of GE digital breast tomosynthesis versus supplementary mammographic views for diagnosis of screen-detected soft tissue breast lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3757
634,Puberty-specific promotion of mammary tumorigenesis by a high animal fat diet,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0646-4
635,Multipotent luminal mammary cancer stem cells model tumor heterogeneity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0615-y
636,Circulating DNA as biomarker in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0645-5
637,Tumor-induced inflammation alters neutrophil phenotype and disease progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0644-6
638,Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0642-8
639,The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0643-7
640,Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0641-9
641,An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0638-4
642,Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0640-x
643,"The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0639-3
644,Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0630-z
645,ALK alteration is a frequent event in aggressive breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0610-3
646,Erratum to: Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0612-1
647,"Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0637-5
648,Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0632-x
649,Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0636-6
650,A hypoxic ticket to the bone metastatic niche,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0635-7
651,Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0634-8
652,"Effect of weight loss, with or without exercise, on body composition and sex hormones in postmenopausal women: the SHAPE-2 trial",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0633-9
653,The seventh ENBDC workshop on methods in mammary gland development and cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0629-5
654,Breast bruises and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0631-y
655,Preliminary evaluation of the publicly available Laboratory for Breast Radiodensity Assessment (LIBRA) software tool: comparison of fully automated area and volumetric density measures in a case–control study with digital mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0626-8
656,Breast cancer tumour growth modelling for studying the association of body size with tumour growth rate and symptomatic detection using case-control data,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0614-z
657,Lack of epidermal growth factor receptor (EGFR)-activating mutations in triple-negative breast cancer in China,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0628-6
658,Assessing breast cancer cell lines as tumour models by comparison of mRNA expression profiles,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0613-0
659,Micro-anatomical quantitative optical imaging: toward automated assessment of breast tissues,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0617-9
660,Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0624-x
661,Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0622-z
662,Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0627-7
663,A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0625-9
664,Decoding breast cancer tissue–stroma interactions using species-specific sequencing,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0616-x
665,Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0623-y
666,Targeting lysyl oxidase for molecular imaging in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0609-9
667,Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0619-7
668,The molecular landscape of premenopausal breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0618-8
669,"Alcohol consumption, endogenous estrogen and mammographic density among premenopausal women",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0620-1
670,Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0608-x
671,Human breast cancer cells educate macrophages toward the M2 activation status,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0621-0
672,"Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0611-2
673,Lobular breast cancer - the most common special subtype or a most special common subtype?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0606-z
674,Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0607-y
675,Alternative signaling network activation through different insulin receptor family members caused by pro-mitogenic antidiabetic insulin analogues in human mammary epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0600-5
676,"Erratum to: Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0597-9
677,Body fatness during childhood and adolescence and breast density in young women: a prospective analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0601-4
678,Lobular breast cancer series: imaging,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0605-0
679,Mammographic density and breast cancer in women from high risk families,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0604-1
680,Tipping the balance between good and evil: aberrant 14-3-3ζ expression drives oncogenic TGF-β signaling in metastatic breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0603-2
681,Can the breast screening appointment be used to provide risk assessment and prevention advice?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0595-y
682,Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0590-3
683,Reduced proliferation in breast cancer cells contacting the neighboring adipocytes in human breast cancer tissues,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0602-3
684,Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0599-7
685,Metformin in breast cancer - an evolving mystery,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0598-8
686,Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0572-5
687,PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2+ breast cancer cells by inducing Bim,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0594-z
688,Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0585-0
689,Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0586-z
690,MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0593-0
691,Genetic risk variants associated with in situ breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0596-x
692,nab-Paclitaxel dose and schedule in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0587-y
693,High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0592-1
694,CD24+ cells fuel rapid tumor growth and display high metastatic capacity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0589-9
695,Adolescent endogenous sex hormones and breast density in early adulthood,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0581-4
696,Molecular drivers of lobular carcinoma in situ,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0580-5
697,Identification of two novel mammographic density loci at 6Q25.1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0591-2
698,The effect of weight change on changes in breast density measures over menopause in a breast cancer screening cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0583-2
699,Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0582-3
700,Macroscopic optical physiological parameters correlate with microscopic proliferation and vessel area breast cancer signatures,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0578-z
701,Anti-HER2 CD4+ T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0584-1
702,Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0588-x
703,Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0579-y
704,Anti-CCL2: building a reservoir or opening the floodgates to metastasis?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0573-4
705,Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0577-0
706,Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0576-1
707,Omega-3 fatty acids for breast cancer prevention and survivorship,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0571-6
708,Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0575-2
709,"Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0574-3
710,Benefits and harms of mammography screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0525-z
711,An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0567-2
712,Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0569-0
713,Molecular characterization and targeted therapeutic approaches in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0560-9
714,Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0564-5
715,Common germline polymorphisms associated with breast cancer-specific survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0570-7
716,Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0568-1
717,Long non-coding RNA expression profiles predict metastasis in lymph node-negative breast cancer independently of traditional prognostic markers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0557-4
718,The E2F4 prognostic signature is also predictive of the pathological response of breast cancer to chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0559-2
719,Quantification of HER family receptors in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0561-8
720,The clinical and functional significance of c-Met in breast cancer: a review,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0547-6
721,Targeting PTEN-defined breast cancers with a one-two punch,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0566-3
722,Background risk of breast cancer and the association between physical activity and mammographic density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0565-4
723,Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0563-6
724,"Enhanced anti-tumor immune responses and delay of tumor development in human epidermal growth factor receptor 2 mice immunized with an immunostimulatory peptide in poly(D,L-lactic-co-glycolic) acid nanoparticles",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0552-9
725,FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0551-x
726,Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0562-7
727,Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0558-3
728,"Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0548-5
729,Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0550-y
730,Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0549-4
731,Quantitative measurement of HER2 expression in breast cancers: comparison with ‘real-world’ routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0543-x
732,Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0542-y
733,Estimated dietary dioxin exposure and breast cancer risk among women from the French E3N prospective cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0536-9
734,Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0545-8
735,Lobular breast cancer: incidence and genetic and non-genetic risk factors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0546-7
736,Lectin RCA-I specifically binds to metastasis-associated cell surface glycans in triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0544-9
737,Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0532-0
738,"Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0541-z
739,"Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0534-y
740,Mouse mammary stem cells express prognostic markers for triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0539-6
741,Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0540-0
742,FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0531-1
743,Molecular subtyping for clinically defined breast cancer subgroups,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0520-4
744,Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0537-8
745,In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0529-8
746,"Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0533-z
747,Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0527-x
748,RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0538-7
749,Prognostic stromal gene signatures in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0530-2
750,A case–control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0535-x
751,Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0526-y
752,Mammary gland tumor promotion by chronic administration of IGF1 and the insulin analogue AspB10 in the p53R270H/+WAPCre mouse model,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0518-y
753,Perhexiline promotes HER3 ablation through receptor internalization and inhibits tumor growth,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0528-9
754,Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0524-0
755,Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0522-2
756,Patient-derived xenograft models of breast cancer and their predictive power,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0523-1
757,"Lobular breast cancer: molecular basis, mouse and cellular models",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0517-z
758,Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0521-3
759,MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0515-1
760,"Invasive lobular carcinoma of the breast: morphology, biomarkers and ’omics",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0519-x
761,"Multigene prognostic tests in breast cancer: past, present, future",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0514-2
762,Markers for the identification of late breast cancer recurrence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0516-0
763,Erratum to: “A novel role for ezrin in breast cancer angio/lymphangiogenesis”,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0511-x
764,Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0498-3
765,Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0513-8
766,Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0506-7
767,BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0512-9
768,A co-culture genome-wide RNAi screen with mammary epithelial cells reveals transmembrane signals required for growth and differentiation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0510-y
769,Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0508-5
770,Circulating tumor cells in newly diagnosed inflammatory breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0507-6
771,"The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0509-4
772,Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0497-4
773,Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0492-9
774,Standardized uptake value of 18F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0502-y
775,Role of bone-anabolic agents in the treatment of breast cancer bone metastases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0484-9
776,Toca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0503-x
777,Outcomes of children exposed in uteroto chemotherapy for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0500-0
778,"Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0474-y
779,Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0505-8
780,Humanization of the mouse mammary gland by replacement of the luminal layer with genetically-engineered preneoplastic human cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0504-9
781,"Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0499-2
782,Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0501-z
783,Mammary cancer initiation and progression studied with magnetic resonance imaging,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0495-6
784,Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0493-8
785,Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0476-9
786,DEAD-box protein p68 is regulated by β-catenin/transcription factor 4 to maintain a positive feedback loop in control of breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0496-5
787,Estrogen receptor mutations and their role in breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0494-7
788,Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0479-6
789,Hormone metabolism pathway genes and mammographic density change after quitting estrogen and progestin combined hormone therapy in the California Teachers Study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0477-8
790,"A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0482-y
791,Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0491-x
792,Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0489-4
793,Association of BRCA1/2defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0475-x
794,"The Triple-Negative Breast Cancer Database: an omics platform for reference, integration and analysis of triple-negative breast cancer data",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0490-y
795,"Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0481-z
796,Embryonic cells contribute directly to the quiescent stem cell population in the adult mouse mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0487-6
797,HER2 expression and efficacy of T-DM1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0478-7
798,E2F4 regulatory program predicts patient survival prognosis in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0486-7
799,Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0458-y
800,Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0485-8
801,Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0488-5
802,Bipotent mammary stem cells: now in amazing 3D,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0480-0
803,The small molecule C-6 is selectively cytotoxic against breast cancer cells and its biological action is characterized by mitochondrial defects and endoplasmic reticulum stress,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0472-0
804,The role of androgens in experimental rodent mammary carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0483-x
805,Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0466-y
806,"Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0464-0
807,A novel mechanism of regulation of the anti-metastatic miR-31 by EMSY in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0467-x
808,A migrant study of pubertal timing and tempo in British-Bangladeshi girls at varying risk for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0469-8
809,MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0473-z
810,Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0463-1
811,Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0470-2
812,Is immune checkpoint modulation a potential therapeutic option in triple negative breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0457-z
813,An unexpected alliance between stress responses to drive oncogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0471-1
814,Erratum to: Dual HER2 blockade: preclinical and clinical data,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0468-9
815,PB.38. Extent of agreement between radiological and pathological size and factors affecting completeness of excision in breast-conserving surgery for invasive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3744
816,PB.45. Correlation of perilesional tissue stiffness measured by ultrasound strain elastography with breast density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3742
817,PB.44. Do qualitative patterns of stiffness help differentiate benign from malignant breast masses of similar stiffness during shear wave elastography?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3740
818,PB.16. Breast screening mammograms: recall or not to recall. What is the golden ratio?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3738
819,PB.25. Implementation of two new digital mammography technologies for Breast Test Wales: more or less accurate?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3737
820,PB.17. Are patients who have had total body irradiation at similar risk of breast cancer to those having mantle radiotherapy? A review of the evidence and suggestions on breast imaging surveillance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3736
821,PB.40. What happens to the ductal carcinoma in situ in HER2-positive cancers treated with neoadjuvant chemotherapy and trastuzumab?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3735
822,PB.4. Ultrasound false negative preoperative axillary assessment in breast cancer patients undergoing sentinel node biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3734
823,PB.3. Detection of lymph node metastases in newly diagnosed breast cancer patients with axillary ultrasonography in combination with the Memorial Sloan Kettering Cancer Centre normogram as a prediction tool,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3733
824,PB.31. Occult breast carcinoma: an experience at a single unit,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3732
825,PB.11. Modern management of acute breast abscesses: radiological interventions replacing surgical incisions?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3731
826,PB.30. Apparent diffusion coefficient and fractional anisotropy values as biomarkers for treatment response in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3730
827,PB.24. How does volumetric breast density change with time?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3729
828,PB.21. Is the technical quality of screening mammograms lower in Asian women who cannot understand the English language?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3728
829,PB.43. A clinical audit of breast cancer staging,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3727
830,PB.29. Retrospective correlation between MRI and histopathology in preoperative assessment of invasive breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3726
831,PB.39. CT or not CT: a systematic review of the breast on CT of the chest and abdomen over 1 year - another screening tool?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3725
832,PB.20. Audit of 5 years of routine screening mammography of the reconstructed breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3724
833,PB.19. Distortion conspicuity and cancer detection: a comparison of cranio-caudal and mediolateral oblique mammographic projections,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3723
834,"PB.37. Does conventional imaging accurately predict the extent of disease in women with dense breasts? If so, does this have a significant impact on patient surgical outcome?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3721
835,PB.10. Stereotactic 20 mm basket Intact Breast Lesion Excision System biopsy for indeterminate breast microcalcification: pilot study within a UK breast unit,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3719
836,PB.23. Breast density in previous screening mammograms of women with and without breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3717
837,PB.7. Large-volume biopsy for B3 lesions without atypia: is once enough?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3715
838,PB.2. Axillary node ultrasound in breast cancer: which threshold for 'diffuse cortical thickening' predicts node metastasis?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3713
839,PB.1. Axillary lymph node ultrasound and needle sampling in preoperative staging of breast cancer: re-audit,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3711
840,PB.26. MRI-guided breast biopsy in Leeds: 12 years' experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3709
841,PB.41. What is the incidence of internal mammary node lymphadenopathy on CT in primary breast cancer patients within 1 year of a diagnosis?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3707
842,PB.13. Impact on film reading of moving from analogue to digital screening: a service evaluation - South East Scotland Breast Screening Programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3705
843,Digital breast tomosynthesis improves the accuracy of the diagnosis of circumscribed lesions because of increase of margin visibility,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3701
844,Are abnormalities missed in the PERFORMS self-assessment scheme due to visual or cognitive factors?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3700
845,Local breast density at lesion sites in diagnostic and previous screening mammograms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3699
846,PB.12. Audit and root-cause analysis of classification 2 and 3 interval cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3703
847,Efficacy of second-time vacuum-assisted breast excision in the management of screen-detected high-risk breast lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3698
848,Preoperative assessment of breast volume to aid surgical planning: comparison of software-based mammographic measurements with subsequent mastectomy volumes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3697
849,PB.34. Marker clip placement may not be needed in breast cancer patients undergoing neoadjuvant chemotherapy with a view to breast-conserving surgery whose tumours are associated with microcalcification,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3702
850,Multidetector CT Improving Surgical Outcomes in Breast Cancer (MISO BC),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3696
851,PB.32. Type of breast surgery in patients undergoing neoadjuvant chemotherapy: role of DCE-MRI,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3743
852,PB.9. Randomised controlled trial of stereotactic 11G vacuum-assisted core biopsy for diagnosis and management of malignant microcalcification,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3741
853,PB.5. Accuracy of axillary nodal staging on MRI of the breasts: correlation with ultrasound of the axilla and histopathology findings,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3739
854,PB.15. An audit of our benign surgical biopsy rate in the prevalent round for the reporting year 1 April 2012 to 31 March 2013,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3722
855,PB.28. Determination of recall rates for assessment in women undergoing annual surveillance breast MRI: is a rate <10% achievable?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3720
856,PB.36. Imaging in gynaecomastia: audit of referral and imaging practise to establish referral guidelines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3718
857,PB.8. Ultrasound-guided excision of fibroadenomas: 9 years' experience in a British breast unit,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3716
858,PB.35. How does semi-automated computer-derived CT measure of breast density compare with subjective assessments to measure mean glandular breast density in patients with breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3714
859,PB.27. Breast screening with MRI in high-risk women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3712
860,PB.22. Does mammographic compression force at breast screening influence the likelihood of subsequent screening attendance?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3710
861,PB.42. Influences upon presentation to the symptomatic breast clinic: is there an increase in symptomatic referrals due to the physical presence of the breast screening van within an area?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3708
862,PB.14. An analysis of subtle alterations in reading pattern with the introduction of digital mammography screening: South East Scotland Breast Screening Programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3706
863,PB.6. Management of radial scars on core biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3704
864,Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0447-1
865,Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0462-2
866,β1 and β4 integrins: from breast development to clinical practice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0459-x
867,Pathologic response prediction to neoadjuvant chemotherapy utilizing pretreatment near-infrared imaging parameters and tumor pathologic criteria,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0456-0
868,Ubiquitin-specific proteases as therapeutic targets for the treatment of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0461-3
869,"Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0426-6
870,Transducin (β)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0465-z
871,New concepts in breast cancer genomics and genetics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0460-4
872,Methylation profiling of ductal carcinoma in situand its relationship to histopathological features,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0423-9
873,Anatomical localization of progenitor cells in human breast tissue reveals enrichment of uncommitted cells within immature lobules,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0453-3
874,RETRACTED ARTICLE: Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0454-2
875,Functional variants at the 21q22.3 locus involved in breast cancer progression identified by screening of genome-wide estrogen response elements,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0455-1
876,TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0445-3
877,Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0451-5
878,DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0450-6
879,Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0425-7
880,Risk of contralateral second primary breast cancer according to hormone receptor status in Germany,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0452-4
881,Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0429-3
882,Elevated DDX21 regulates c-Jun activity and rRNA processing in human breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0449-z
883,Risk determination and prevention of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0446-2
884,Significance of glioma-associated oncogene homolog 1 (GLI1)expression in claudin-low breast cancer and crosstalk with the nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) pathway,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0444-4
885,Cas proteins: dodgy scaffolding in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0443-5
886,Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0441-7
887,Integrin-mediated resistance to epidermal growth factor receptor-targeted therapy: an inflammatory situation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0448-0
888,Digital mammographic density and breast cancer risk: a case–control study of six alternative density assessment methods,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0439-1
889,The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0442-6
890,A novel role for ezrin in breast cancer angio/lymphangiogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0438-2
891,miR-638 mediated regulation of BRCA1affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0435-5
892,Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A–dependent phospho-Akt inactivation in estrogen receptor–negative human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0431-9
893,Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0440-8
894,The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0436-4
895,Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0434-6
896,"Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0430-x
897,"Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathways",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0437-3
898,Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen–urokinase plasminogen activator receptor system–regulated secretion during breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0433-7
899,Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0432-8
900,Molecular effects of lapatinib in patients with HER2 positive ductal carcinoma in situ,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3695
901,Biology of breast cancer in young women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0427-5
902,Mammographic features associated with interval breast cancers in screening programs,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0417-7
903,P2Y2receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3694
904,Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0424-8
905,uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0428-4
906,Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0414-x
907,Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0422-x
908,"Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0418-6
909,The dynamic range of circulating tumor DNA in metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0421-y
910,PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0406-x
911,Identification of a novel AMPK-PEA15 axis in the anoikis-resistant growth of mammary cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0420-z
912,A joint analysis of metabolomics and genetics of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0415-9
913,Dual HER2 blockade: preclinical and clinical data,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0419-5
914,Physical activity and telomere length in early stage breast cancer survivors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0413-y
915,Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0412-z
916,MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3693
917,"Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0410-1
918,A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0407-9
919,The influence of tamoxifen on normal mouse mammary gland homeostasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0411-0
920,Tumor homologous recombination deficiency assays: another step closer to clinical application?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0409-7
921,"Nestin positively regulates the Wnt/β-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0408-8
922,Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-014-0405-y
923,Ubiquitin-conjugating enzyme complex Uev1A-Ubc13 promotes breast cancer metastasis through nuclear factor-кB mediated matrix metalloproteinase-1 gene regulation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3692
924,Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3691
925,Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3689
926,Evaluating the predictive value of biomarkers for efficacy outcomes in response to pertuzumab- and trastuzumab-based therapy: an exploratory analysis of the TRYPHAENA study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3690
927,Developing a new generation of breast cancer clinical gene expression tests,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3688
928,Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3687
929,"Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populations",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3686
930,Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3685
931,Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3684
932,Relationship of PIK3CA mutation and pathway activity with antiproliferative response to aromatase inhibition,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3683
933,Drug repurposing screen identifies lestaurtinib amplifies the ability of the poly (ADP-ribose) polymerase 1 inhibitor AG14361 to kill breast cancer associated gene-1 mutant and wild type breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3682
934,Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3681
935,The molecular landscape of the normal human breast – defining normal,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3680
936,Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3679
937,Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3677
938,Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3678
939,Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3676
940,Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3675
941,Construction and evaluation of a novel humanized HER2-specific chimeric receptor,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3674
942,Mesenchymal precursor cells maintain the differentiation and proliferation potentials of breast epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3673
943,A genomic analysis of mouse models of breast cancer reveals molecular features ofmouse models and relationships to human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3672
944,Adjusting the incidence increase when screening for statistical lead time will always give estimates of overdiagnosis close to zero,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3671
945,Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3670
946,"Rare key functional domain missense substitutions in MRE11A, RAD50, and NBNcontribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3669
947,An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3668
948,JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3667
949,Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3666
950,C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3665
951,VAV3 mediates resistance to breast cancer endocrine therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3664
952,Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3663
953,Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3662
954,Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: a randomized phase II study of patients with previously untreated HER2-positive metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3661
955,Endocrine therapy: defining the path of least resistance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3659
956,The mechanistic target for rapamycin pathway is related to the phosphorylation score for estrogen receptor-α in human breast tumors in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3660
957,Breast cancer intra-tumor heterogeneity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3658
958,CARM1 and BAF155: an example of how chromatin remodeling factors can be relocalized and contribute to cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3657
959,"Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3656
960,New insights into the role of ID proteins in breast cancer metastasis: a MET affair,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3654
961,Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3655
962,Polarity gene alterations in pure invasive micropapillary carcinomas of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3653
963,"Retinoblastoma tumor suppressor pathway in breast cancer: prognosis, precision medicine, and therapeutic interventions",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3652
964,Breast cancer brain metastases: evidence for neuronal-like adaptation in a ‘breast-to-brain’ transition?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3651
965,Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3650
966,Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3649
967,Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3648
968,International study on inter-reader variability for circulating tumor cells in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3647
969,Smoking at time of diagnosis and breast cancer-specific survival: new findings and systematic review with meta-analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3646
970,Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3645
971,"Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3644
972,"Effects of an exercise and hypocaloric healthy eating intervention on indices of psychological health status, hypothalamic-pituitary-adrenal axis regulation and immune function after early-stage breast cancer: a randomised controlled trial",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3643
973,"Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2− breast cancer patients: results from the GEICAM 9906 trial",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3642
974,Mammographic texture resemblance generalizes as an independent risk factor for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3641
975,Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3640
976,A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3639
977,Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice Research Datalink,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3638
978,Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3637
979,Status of adjuvant endocrine therapy for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3636
980,Outsmarting cancer: the power of hybrid genomic/proteomic biomarkers to predict drug response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3635
981,Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3634
982,Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3633
983,Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3632
984,Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3631
985,Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3630
986,Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3629
987,N-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3628
988,Early but not late pregnancy induces lifelong reductions in the proportion of mammary progesterone sensing cells and epithelial Wnt signaling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3626
989,Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3627
990,A BRCA1deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3625
991,In silicoanalysis of microRNA-510 as a potential oncomir in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3624
992,Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3623
993,Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3622
994,Trastuzumab emtansine: mechanisms of action and drug resistance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3621
995,"Immune approaches to the treatment of breast cancer, around the corner?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3620
996,Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3619
997,A potential mechanism for extracellular matrix induction of breast cancer cell normality,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3617
998,Clinical development of mTOR inhibitors in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3618
999,Dickkopf-1 is regulated by the mevalonate pathway in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3616
1000,Individual xenograft as a personalized therapeutic resort for women with metastatic triple-negative breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3615
1001,A novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3614
1002,Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3613
1003,Identification and characterization of locus-specific methylation patterns within novel loci undergoing hypermethylation during breast cancer pathogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3612
1004,Runx2 activates PI3K/Akt signaling via mTORC2 regulation in invasive breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3611
1005,Paracrine signaling in mammary gland development: what can we learn about intratumoral heterogeneity?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3610
1006,Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3609
1007,Targeting RET–interleukin-6 crosstalk to impair metastatic dissemination in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3608
1008,Significant overlap between human genome-wide association-study nominated breast cancer risk alleles and rat mammary cancer susceptibility loci,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3607
1009,"PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3606
1010,PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3605
1011,Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3604
1012,Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3603
1013,Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3602
1014,Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3601
1015,Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3600
1016,Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3599
1017,Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3598
1018,Interplay of choline metabolites and genes in patient-derived breast cancer xenografts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3597
1019,"Birth weight, childhood body mass index, and height in relation to mammographic density and breast cancer: a register-based cohort study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3596
1020,Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3595
1021,Pregnancy-associated breast cancers are driven by differences in adipose stromal cells present during lactation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3594
1022,New insights into lineage restriction of mammary gland epithelium using parity-identified mammary epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3593
1023,Pygopus 2: tilting the Wnt-Notch balance in mammary epithelial lineage determination,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3592
1024,Cancer dormancy: time to explore its clinical relevance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3590
1025,Common breast cancer risk variants in the post-COGS era: a comprehensive review,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3591
1026,RAD51Cdeletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3589
1027,Integrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like properties,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3588
1028,"Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3587
1029,Next generation sequencing-based expression profiling identifies signatures from benign stromal proliferations that define stromal components of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3586
1030,A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3585
1031,Evaluation of ultra-deep targeted sequencing for personalized breast cancer care,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3584
1032,Refining the role of BRCA1 in combating oxidative stress,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3583
1033,Advances in circulating tumor cells (ACTC): from basic research to clinical practice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3582
1034,GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3581
1035,Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3580
1036,Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3579
1037,"Ltbp1Lis focally induced in embryonic mammary mesenchyme, demarcates the ductal luminal lineage and is upregulated during involution",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3578
1038,A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3577
1039,A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3576
1040,Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3575
1041,PB.53: Are ethnic minorities more likely to develop triple-negative breast cancer? A systematic review,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3553
1042,PB.51: Axillary lymph node ultrasound and fine needle aspiration in preoperative staging of breast cancer: re-audit,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3551
1043,PB.49: Preoperative axillary staging in breast cancer patients: repeat sampling in cases of suspicious ultrasound or inconclusive cytology,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3549
1044,PB.47: Mammography in symptomatic women aged 35 to 39 years,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3547
1045,PB.45: Evaluation of a pilot MRI breast surveillance project for young women at high risk of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3545
1046,"PB.20: Accuracy of specimen radiograph in determining lesion presence in excised specimens, correlating histological and radiological margins",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3520
1047,PB.16: Contrast-enhanced digital mammography: a single-centre experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3516
1048,PB.14: Visibility of screen-detected invasive carcinoma on digital breast tomosynthesis: do we need two views?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3514
1049,PB.11: Identifying women at high risk of developing breast cancer: implications of adjusting for inter-observer variability in visual analogue scale assessment of percentage breast density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3512
1050,PB.06: Preliminary results in the performance comparison between the size ratio and colour scoring breast ultrasound elastographic techniques,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3508
1051,Cytochrome P450 2E1 (CYP2E1) regulates the response to oxidative stress and migration of breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3574
1052,PB.52: Incidence and clinical significance of focal breast uptake at 18-fluorine fluorodeoxyglucose PET-CT in patients without known breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3552
1053,PB.50: Axillary lymph node ultrasound in breast cancer patients: what minimum threshold for diffuse cortical thickening predicts nodal involvement?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3550
1054,PB.48: Old habits die hard: breast imaging of symptomatic 35 to 39 year olds,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3548
1055,PB.46: Peutz-Jeghers Syndrome and carcinoma of the breast: call for new breast imaging surveillance guidelines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3546
1056,PB.44: Audit of interval cancers from family history breast screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3544
1057,"PB.43: Review of the determinants of poor screening uptake at City, Sandwell and Walsall Breast Screening Units and the steps taken to improve attendance",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3543
1058,PB.42: Arbitration of round masses: understanding the variability of recall rates,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3542
1059,PB.41: Audit of screening-detected breast cancers with discordant interpretations on double-read screening mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3541
1060,PB.40: Clinical recall audit: are we following national guidelines?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3540
1061,PB.39: Minimising the impact of breast screening extension: a 1-year experience of a South West breast screening unit,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3539
1062,"PB.38: In the context of overdiagnosis, does size matter?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3538
1063,"PB.37: Screen-detected, noncalcified, mammographic lesions with normal or benign ultrasound findings: is stereotactic biopsy necessary?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3537
1064,PB.36: Double reporting of patients discharged from the assessment clinic: the North Lancashire and South Cumbria experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3536
1065,PB.35: Comparison of large-bore vacuum-assisted biopsy and surgical diagnostic excision biopsy in B3 breast lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3535
1066,PB.34: Results by letter for low-risk breast biopsies: an audit of current practice at Nottingham Breast Institute,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3534
1067,PB.33: Vacuum-assisted biopsy for lesions of uncertain malignant potential: further evidence of its suitability as a safe alternative to surgery,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3533
1068,PB.32: Does vacuum-assisted biopsy decrease the B3 rate in stereotactic biopsy of breast lesions?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3532
1069,PB.31: B3 lesions and vacuum-assisted biopsy: a national survey to gauge current practice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3531
1070,PB.30: What is your biopsy threshold in symptomatic clinic and what should it be? B2:B5 biopsy ratio: 18 months in our centre,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3530
1071,PB.29: Ultrasound-guided vacuum-assisted percutaneous excision of breast papillomas: results of long-term follow-up,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3529
1072,PB.28: Is second-time vacuum-assisted biopsy effective in improving preoperative diagnosis rate of screen-detected DCIS?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3528
1073,PB.26: Significance of flat epithelial atypia at image guided breast biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3526
1074,"PB.25: Relationship between volumetric breast density, age and hormonal factors",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3525
1075,PB.24: Is digital breast tomosynthesis helpful within a symptomatic one-stop breast clinic for characterisation of subtle findings?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3524
1076,PB.23: Effect of detector type on cancer detection in digital mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3523
1077,PB.22: Does the Nottingham predictor of bidimensional product of calcium accurately predict the success of wide local excision for ductal carcinoma in situ surgery in our centre?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3522
1078,PB.21: Relationship between volumetric breast density and socioeconomic status,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3521
1079,PB.19: Investigation of a novel method for breast discomfort reduction during mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3519
1080,PB.18: Factors affecting breast density assessment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3518
1081,PB.17: Inter-observer agreement in visual analogue scale assessment of percentage breast density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3517
1082,PB.15: Pain in mammography: where and why does it arise?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3515
1083,PB.13: Comparison between analogue and digital mammography: a reader's perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3513
1084,"PB.10: Breast compression, compressed breast thickness and volumetric breast density",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3511
1085,PB.09: Clinical audit of technical recall data for blur following the introduction of the breath hold technique in breast screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3510
1086,PB.07: Why are some fibroadenomas stiff using shear wave elastography?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3509
1087,4.6: Anisotropy in solid breast lesions at shear wave elastography: relationship to the radial plane and implications for benign/malignant differentiation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3502
1088,PB.05: MRI-guided vacuum-assisted breast biopsy at 3T: initial experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3507
1089,4.5: Diagnosing breast cancer in a high-risk cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3501
1090,PB.04: MRI In lobular and mixed lobular/ductal carcinomas: can we preselect cases based on imaging appearance?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3506
1091,4.3: Upgrades of B5a (non-invasive) core biopsies to invasive disease at final surgery: a retrospective review across the Scottish Breast Screening Programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3500
1092,PB.03: Evaluating the role of breast MRI at mid-cycle chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3505
1093,PB.02: Magnetic resonance imaging axilla: friend or foe?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3504
1094,4.2: Vacuum biopsy in the management of lobular in situneoplasia: a single-centre experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3499
1095,PB.01: Second-look ultrasound examination of the breast following MRI: MR and sonographic findings,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3503
1096,4.1: Nonbiopsy of presumed fibroadenomas in patients <30 years: is it safe? A single unit experience and review of European practice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3498
1097,Transforming growth factor-β signalling controls human breast cancer metastasis in a zebrafish xenograft model,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3573
1098,Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3572
1099,The Third International Inflammatory Breast Cancer Conference,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3571
1100,Mammographic density and risk of breast cancer by age and tumor characteristics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3570
1101,Priming BCL-2 to kill: the combination therapy of tamoxifen and ABT-199 in ER+ breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3568
1102,An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3567
1103,Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3569
1104,Top Notch cancer stem cells by paracrine NF-κB signaling in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3565
1105,Help us find the cures,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3566
1106,AXL/epidermal growth factor receptor (EGFR) complexes in breast cancer - culprits for resistance to EGFR inhibitors?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3564
1107,Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3563
1108,Par-4 prevents breast cancer recurrence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3562
1109,Pubertal high fat diet: effects on mammary cancer development,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3561
1110,"Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3560
1111,Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3559
1112,Clinical application of high-throughput genomic technologies for treatment selection in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3558
1113,"The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3557
1114,Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3556
1115,"‘The charmingest place’: non-coding RNA, lineage tracing, tumor heterogeneity, metastasis and metabolism - new methods in mammary gland development and cancer: the fifth ENBDC Workshop",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3497
1116,The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3496
1117,Association of CYP2D6metabolizer status with mammographic density change in response to tamoxifen treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3495
1118,Misuse of blood serum to assess exposure to bisphenol A and phthalates,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3494
1119,Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3493
1120,Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3487
1121,Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3486
1122,Circulating nucleic acids as biomarkers in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3446
1123,Assessing tumor contrast in radiographically dense breast tissue using Diffuse Optical Spectroscopic Imaging (DOSI),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3485
1124,Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3484
1125,Pregnancy offers new insights into mechanisms of breast cancer risk and resistance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3482
1126,Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3483
1127,Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3481
1128,An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3480
1129,Decision aids for breast cancer chemoprevention,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3479
1130,"Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3478
1131,Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3477
1132,Role of HGF in epithelial–stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3476
1133,A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3475
1134,AutoDensity: an automated method to measure mammographic breast density that predicts breast cancer risk and screening outcomes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3474
1135,A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3473
1136,Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3472
1137,Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3471
1138,Association between mammographic density and basal-like and luminal A breast cancer subtypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3470
1139,Mammary Carcinoma Cell Derived Cyclooxygenase 2 Suppresses Tumor Immune Surveillanceby Enhancing Intratumoral Immune Checkpoint Activity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3469
1140,Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3468
1141,Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3467
1142,Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3436
1143,"Sox4, EMT programs, and the metastatic progression of breast cancers: mastering the masters of EMT",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3466
1144,Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3465
1145,MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3464
1146,PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3463
1147,Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3462
1148,LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3461
1149,Pharmacologic reversion of epigenetic silencing of the PRKD1promoter blocks breast tumor cell invasion and metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3460
1150,Evidence for a multipotent mammary progenitor with pregnancy-specific activity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3459
1151,HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3458
1152,Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3457
1153,Progestin effects on cell proliferation pathways in the postmenopausal mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3456
1154,Pitfalls in accurate estimation of overdiagnosis: implications for screening policy and compliance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3448
1155,Spectral discrimination of breast pathologies in situusing spatial frequency domain imaging,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3455
1156,On the role of tyrosine phosphatases as negative regulators of STAT signaling in breast cancers: new findings and future perspectives,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3437
1157,The genomic map of breast cancer: which roads lead to better targeted therapies?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3435
1158,"Platelets, coagulation and fibrinolysis in breast cancer progression",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3425
1159,β1-integrin via NF-κB signaling is essential for acquisition of invasiveness in a model of radiation treated in situ breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3454
1160,Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3453
1161,Development of a screen to identify selective small molecules active against patient-derived metastatic and chemoresistant breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3452
1162,Change of mammographic density predicts the risk of contralateral breast cancer - a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3451
1163,Possible influence of mammographic density on local and locoregional recurrence of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3450
1164,Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3449
1165,Notch activation stimulates migration of breast cancer cells and promotes tumor growth,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3447
1166,Analysis of polymorphisms in the circadian-related genes and breast cancer risk in Norwegian nurses working night shifts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3445
1167,BreastMark: An Integrated Approach to Mining Publicly Available Transcriptomic Datasets Relating to Breast Cancer Outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3444
1168,DNA methylation in ductal carcinoma in situof the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3420
1169,Profilin-1 versus profilin-2: two faces of the same coin?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3433
1170,Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3429
1171,COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3434
1172,Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3441
1173,Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3443
1174,Elevated expression of syntenin in breast cancer is correlated with lymph node metastasis and poor patient survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3442
1175,Mammographic density and survival in interval breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3440
1176,A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3439
1177,Stromal-cell and cancer-cell exosomes leading the metastatic exodus for the promised niche,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3426
1178,Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3438
1179,Circulating serum xenoestrogens and mammographic breast density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3432
1180,Amphiregulin mediates progesterone-induced mammary ductal development during puberty,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3431
1181,Mammographic density and breast cancer: a comparison of related and unrelated controls in the Breast Cancer Family Registry,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3430
1182,Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3428
1183,Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3427
1184,Illuminating luminal B: QSOX1 as a subtype-specific biomarker,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3417
1185,High mammographic density in women of Ashkenazi Jewish descent,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3424
1186,The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3423
1187,"Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3422
1188,Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3421
1189,Delivery of gene silencing agents for breast cancer therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3413
1190,Pregnancy protection of breast cancer: new insights reveal unanswered questions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3414
1191,Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3419
1192,The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3408
1193,Microwave imaging for neoadjuvant chemotherapy monitoring: initial clinical experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3418
1194,"Activating mutations and senescence secretome: new insights into HER2 activation, drug sensitivity and metastatic progression",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3406
1195,Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3416
1196,miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3415
1197,Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3412
1198,Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3411
1199,Closing escape routes: inhibition of IL-8 signaling enhances the anti-tumor efficacy of PI3K inhibitors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3400
1200,HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3410
1201,A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3409
1202,"The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3401
1203,Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3407
1204,Elf5 - breast cancer's little helper,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3397
1205,Risk of breast cancer in Lynch syndrome: a systematic review,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3405
1206,Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3404
1207,"Embryonic mammary signature subsets are activated in Brca1
-/-
 and basal-like breast cancers",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3403
1208,HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3402
1209,It takes two to tango in the microenvironment!,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3388
1210,"DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3399
1211,Endoplasmic reticulum stress induces PRNP prion protein gene expression in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3398
1212,Metformin: a case of divide and conquer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3387
1213,Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3396
1214,Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3395
1215,Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3394
1216,A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3393
1217,Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3392
1218,Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3391
1219,Unraveling the 'TGF-β paradox' one metastamir at a time,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3383
1220,Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3382
1221,Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3390
1222,Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3371
1223,Optical imaging correlates with magnetic resonance imaging breast density and revealscomposition changes during neoadjuvant chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3389
1224,Needles in a haystack: finding recurrent genomic changes in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3364
1225,Breast cancer in women using digoxin: tumor characteristics and relapse risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3386
1226,A functional link between FOXA1 and breast cancer SNPs,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3360
1227,Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3385
1228,HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3384
1229,Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3381
1230,Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3380
1231,Combinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3379
1232,Patient-derived breast tumor xenografts facilitating personalized cancer therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3355
1233,Mammographic density as a predictor of breast cancer survival: the Multiethnic Cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3378
1234,RhoB modifies estrogen responses in breast cancer cells by influencing expression of the estrogen receptor,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3377
1235,"The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3376
1236,BMP/Coco antagonism as a deterministic factor of metastasis dormancy in lung,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3350
1237,Visualizing movement in the tumor microenvironment landscape,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3359
1238,"Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3375
1239,"Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3374
1240,How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3335
1241,Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3373
1242,Comparison of percent density from raw and processed full-field digital mammography data,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3372
1243,Erratum to: Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3370
1244,Who do they think they are? Wnt-responsive cells reveal their family trees,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3351
1245,Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3336
1246,The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3369
1247,Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3368
1248,Interplay between neural-cadherin and vascular endothelial-cadherin in breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3367
1249,YAP-Hippo signalling downstream of leukemia inhibitory factor receptor: implications for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3349
1250,Maintenance of S-nitrosothiol homeostasis plays an important role in growth suppression of estrogen receptor-positive breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3366
1251,Modelling the overdiagnosis of breast cancer due to mammography screening in womenaged 40 to 49 in the United Kingdom,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3365
1252,Alcohol and breast cancer risk among Asian-American women in Los Angeles County,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3363
1253,A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3362
1254,ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3361
1255,Erratum to: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3353
1256,ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3358
1257,Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3237
1258,The influence of mammogram acquisition on the mammographic density and breast cancer association in the mayo mammography health study cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3357
1259,Migratory gene expression signature predicts poor patient outcome: Are cancer stem cells to blame?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3338
1260,Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3356
1261,FGFR1 amplification and the progression of non-invasive to invasive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3340
1262,Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3332
1263,The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3354
1264,S-nitrosylation of Ras in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3331
1265,Mammograms in 35-year-old to 39-year-old symptomatic patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3320
1266,Screening breast MRI in high-risk women undergoing prophylactic mastectomy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3316
1267,Breast clinicians: their contribution to the breast screening programme in England and implications of the current age structure,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3314
1268,Predicting risk of malignancy in subgroups of B3 breast lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3312
1269,Should the breast be a check area on standard CT thorax examinations?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3310
1270,Abstract withdrawn,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3308
1271,Breast screening with magnetic resonance imaging in high-risk women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3306
1272,Classification of interval breast cancers and their presentation since screening: impact on long-term survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3302
1273,False negative assessments: an effective quality assurance method,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3300
1274,Fibroadenoma: to biopsy or not to biopsy? That is the question,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3299
1275,MRI for PIP implant rupture: appearances and rupture rate,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3297
1276,Annual screening of moderate-risk women: a review of 10 years experience within the NHS Breast Screening Programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3290
1277,Does imaging correctly influence the surgical management in the setting of neoadjuvant chemotherapy?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3286
1278,Contrast-enhanced MRI in evaluating the contralateral breast for synchronous malignancy in patients with invasive lobular cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3284
1279,Repeatability of breast density visual assessment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3282
1280,Role of targeted reassurance breast ultrasound in women with symptoms of a breast lump and normal clinical examination,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3280
1281,Abstract withdrawn by author,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3276
1282,The Nottingham Prognostic Index: 5-year and 10-year survival data for all-cause survival within a screened population,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3274
1283,Breast density measurement for personalised screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3272
1284,Abstracts P1 - P16 are educational and not included for publication online,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3271
1285,Abstracts P1 - P16 are educational and not included for publication online,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3270
1286,Abstracts P1 - P16 are educational and not included for publication online,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3269
1287,Abstracts P1 - P16 are educational and not included for publication online,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3268
1288,Abstracts P1 - P16 are educational and not included for publication online,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3267
1289,Abstracts P1 - P16 are educational and not included for publication online,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3266
1290,Abstracts P1 - P16 are educational and not included for publication online,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3265
1291,Abstracts P1 - P16 are educational and not included for publication online,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3264
1292,Abstracts P1 - P16 are educational and not included for publication online,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3263
1293,Abstracts P1 - P16 are educational and not included for publication online,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3262
1294,Abstracts P1 - P16 are educational and not included for publication online,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3261
1295,Abstracts P1 - P16 are educational and not included for publication online,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3260
1296,Abstracts P1 - P16 are educational and not included for publication online,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3259
1297,Abstracts P1 - P16 are educational and not included for publication online,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3258
1298,Is ultrasound axillary staging less accurate in invasive lobular breast cancer than in ductal breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3251
1299,Abstracts P1 - P16 are educational and not included for publication online,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3257
1300,Abstracts P1 - P16 are educational and not included for publication online,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3256
1301,Vacuum-assisted core biopsy of the breast: a 3-year single-centre experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3315
1302,Breast MRI quality assurance in practice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3313
1303,Node-positive breast cancers diagnosed in 2011 at York Teaching Hospitals NHS Trust: an analysis of the adequacy of current preoperative assessment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3311
1304,Indications for marker clip in the setting of neoadjuvant/neoendocrine therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3309
1305,A radiological and pathological analysis of screen-detected and interval-detected breast cancers in Belfast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3307
1306,Preoperative ultrasound and FNA in the diagnosis of axillary involvement in invasive breast cancer: correlation with intraoperative one-stop nucleic acid amplification and final histology,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3305
1307,Abstract withdrawn,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3304
1308,Computer-aided detection of screening breast cancer: a novel approach based on genetic programming,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3303
1309,"Benign appearing breast lesions age 30 and below: to biopsy, or not to biopsy?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3301
1310,Review of the Welsh mammographic screening programme for women who underwent mantle irradiation for Hodgkin lymphoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3298
1311,Comparing the use of PGMI scoring systems used in the UK and Norway to assess the technical quality of screening mammograms: a pilot study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3296
1312,Use of ultrasound in the assessment of screen-detected malignant microcalcifications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3295
1313,Assessment of the dynamic range in dynamic contrast-enhanced magnetic resonance imaging breast examinations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3294
1314,"Comparison of recall, biopsy, and cancer detection rates in the Southern Derbyshire screening programme between 2006 and 2009 using hard-copy mammography and in 2009 to 2012 following the full introduction of soft-copy reporting",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3293
1315,Imaging features of noncalcified DCIS,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3292
1316,Survey of clinical recalls from breast screening at Nottingham Breast Institute: implications for practice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3291
1317,Clinical recall from the NHS Breast Screening Programme: is it worth doing?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3289
1318,Abstract withdrawn,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3288
1319,Film-reading workload in the West Midlands,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3287
1320,Imaging the breast following neoadjuvant chemotherapy: does improvement of imaging findings in the axilla predict pathological response in the breast?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3285
1321,Structured evaluation of the effectiveness of an interactive tool for developing interpretation skills in mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3283
1322,A comparison of reading times in full-field digital mammography and digital breast tomosynthesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3281
1323,Fatigue and performance in interpreting breast screening mammograms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3279
1324,Abstract withdrawn,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3278
1325,3T MR imaging: diffusion-weighted and dynamic contrast-enhanced - relationship of apparent diffusion coefficient value and maximum percentage enhancement in invasive lobular carcinoma of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3277
1326,Impact of full-field digital mammography on diagnostic work-up and surgical management of mammographic microcalcification,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3275
1327,"Changes in recall rate, biopsy rate and cancer detection since the introduction of digital mammography",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3273
1328,Gamma probe and ultrasound-guided percutaneous localisation of the sentinel lymph node in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3255
1329,Long-term survival of interval breast cancers in breast cancer screening in Wales,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3254
1330,Use of MRI fusion second-look ultrasound in breast cancer: can MRI US fusion reduce the need for MRI-guided biopsy?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3253
1331,Positive predictive value of MRI vacuum biopsies in the diagnosis of nonmass-like lesions of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3252
1332,Utility of MRI in low and low to moderate density breasts with invasive lobular carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3250
1333,Chemosensitivity and p53; new tricks by an old dog,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3326
1334,MEK inhibition as a strategy for targeting residual breast cancer cells with low DUSP4 expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3327
1335,Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3352
1336,Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3348
1337,"Triple-negative breast cancer and PTEN (phosphatase and tensin homologue)loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3347
1338,"Retraction Note: Effects of a pre-visit educational website on information recall and needs fulfilment in breast cancer genetic counselling, a randomized controlled trial",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3339
1339,Who's driving anyway? Herculean efforts to identify the drivers of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3325
1340,Sex hormone changes during weight loss and maintenance in overweight and obese postmenopausal African-American and non-African-American women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3346
1341,Vascular endothelial growth factor receptor-1 mRNA overexpression in peripheral blood as a useful prognostic marker in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3345
1342,Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3344
1343,Regulation of mRNA expression in breast cancer - a cis-tematic trans-action,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3227
1344,Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3233
1345,Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-users,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3337
1346,Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3343
1347,p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3342
1348,"High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patients",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3341
1349,Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3334
1350,"Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3333
1351,Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3330
1352,Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3329
1353,Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3328
1354,Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3324
1355,Breast vibro-acoustography: initial results show promise,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3323
1356,New insights into signalling networks regulating breast cancer stem cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3209
1357,DNA damage as a result of psychological stress: implications for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3189
1358,Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3223
1359,A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3322
1360,NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitro,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3321
1361,Integration of ERα-PELP1-HER2 signaling by LSD1 (KDM1A/AOF2) offers combinatorial therapeutic opportunities to circumventing hormone resistance in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3249
1362,Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3319
1363,Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3318
1364,High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3317
1365,Slugging their way to immortality: driving mammary epithelial cells into a stem cell-like state,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3188
1366,Retinoids and breast cancer: new clues to increase their activity and selectivity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3245
1367,The interaction between ER and NFκB in resistance to endocrine therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3196
1368,Tumour morphology of early-onset breast cancers predicts breast cancer risk for first-degree relatives: the Australian Breast Cancer Family Registry,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3248
1369,Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3247
1370,Is breast cancer a part of Lynch syndrome?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3241
1371,Gene-expression profiling of microdissected breast cancer microvasculature identifies distinct tumor vascular subtypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3246
1372,Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3244
1373,Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3243
1374,Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3242
1375,Breast density predicts endocrine treatment outcome in the adjuvant setting,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3235
1376,A single proteolytic cleavage within the lower hinge of trastuzumab reduces immune effector function and in vivo efficacy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3240
1377,Hippo inactivation feeds tumor-initiating cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3190
1378,FGFR1 is amplified during the progression of in situto invasive breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3239
1379,High-throughput mammographic-density measurement: a tool for risk prediction of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3238
1380,The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3236
1381,Mammographic density as a mediator for breast cancer risk: analytic approaches,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3157
1382,Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3234
1383,Do not jump too quickly to conclusions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3213
1384,Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3232
1385,"Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3231
1386,New tricks for metastasis-associated macrophages,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3143
1387,Battle over CCL2 for control of the metastatic niche: neutrophils versus monocytes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3149
1388,"New methods in mammary gland development and cancer: proteomics, epigenetics, symmetric division and metastasis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3216
1389,ER and PR signaling nodes during mammary gland development,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3166
1390,Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3230
1391,Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3229
1392,"Height, adiposity and body fat distribution and breast density in young women",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3228
1393,Is the tide turning against breast screening?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3212
1394,Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3226
1395,CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3225
1396,Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3224
1397,Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3222
1398,Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3221
1399,Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3220
1400,Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3219
1401,"Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO)",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3218
1402,Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3217
1403,Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3215
1404,Prognostic signatures in breast cancer: correlation does not imply causation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3173
1405,To bind or not to bind - FoxA1 determines estrogen receptor action in breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3146
1406,BOLERO-2 - will this change practice in advanced breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3126
1407,Targeted therapies in breast cancer: are heart and vessels also being targeted?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3142
1408,Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3139
1409,"γ-Secretase inhibition promotes cell death, Noxa upregulation, and sensitization to BH3 mimetic ABT-737 in human breast cancer cells",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3214
1410,Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3211
1411,"Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3210
1412,Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3208
1413,17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3207
1414,Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: Pooled results from three countries,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3206
1415,"Breast carcinoma and Lynch syndrome: molecular analysis of tumors arising in mutation carriers, non-carriers, and sporadic cases",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3205
1416,Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3204
1417,Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3203
1418,Vitamin D and the mammary gland: a review on its role in normal development and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3178
1419,Targeting breast cancer vaccines to dendritic cells: improved immunological responses with less protein?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3184
1420,"Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3201
1421,Comprehensive splicing functional analysis of DNA variants of the BRCA2 gene by hybrid minigenes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3202
1422,JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3200
1423,Die and let live: harnessing BikDD to combat breast cancer stem cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3125
1424,CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3199
1425,Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3198
1426,Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3197
1427,"Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic model",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3195
1428,"MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3194
1429,Back to the embryonic stage: Nodal as a biomarker for breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3177
1430,Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3192
1431,Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3191
1432,Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3187
1433,"Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3186
1434,Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3185
1435,Estrogen-related receptor alpha: an orphan finds a family,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3124
1436,Crk adaptor proteins act as key signaling integrators for breast tumorigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3183
1437,Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3182
1438,"Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3181
1439,Biomarkers characterization of circulating tumour cells in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3180
1440,Prognostic and predictive value of TP53mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3179
1441,Adjuvant treatment of HER2-positive breast cancer: winning efforts continue to improve HER2-positive patient outcome long-term,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3120
1442,"Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3176
1443,CIP2A is a target of bortezomib in human triple negative breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3175
1444,PTHrP and breast cancer: more than hypercalcemia and bone metastases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3129
1445,Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3174
1446,Frequency of the CHEK2 1100delC mutation among women with early-onset and bilateral breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3159
1447,Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3171
1448,In vivo proton magnetic resonance spectroscopy of breast cancer: a review of the literature,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3132
1449,Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3170
1450,Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3169
1451,Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3168
1452,In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3167
1453,"Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3172
1454,RAC1 GTPase plays an important role in γ-irradiation induced G2/M checkpoint activation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3164
1455,BRCA1 as tumor suppressor: lord without its RING?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3118
1456,Characterizing mammographic images by using generic texture features,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3163
1457,"Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3162
1458,Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3161
1459,A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3158
1460,Occurrence of breast cancer subtypes in adolescent and young adult women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3156
1461,Reproductive aging-associated common genetic variants and the risk of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3155
1462,Functional characterization of the 19q12 amplicon in grade III breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3154
1463,Current approaches to the management of Her2-negative metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3064
1464,Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3153
1465,Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3152
1466,Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3151
1467,Relevance of PTEN loss in brain metastasis formation in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3150
1468,The mammary stem cell conundrum: is it unipotent or multipotent?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3123
1469,BRCA1 as a tumor suppressor linked to the regulation of epigenetic states: keeping oncomiRs under control,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3119
1470,Are breast cancers driven by fusion genes?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3122
1471,Advances in molecular imaging for breast cancer detection and characterization,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3094
1472,CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3148
1473,Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3147
1474,ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3145
1475,Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3144
1476,"Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3141
1477,Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3140
1478,Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3138
1479,"Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3137
1480,Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53mutation and poor clinical outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3136
1481,Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3135
1482,Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3134
1483,"Effects of a pre-visit educational website on information recall and needs fulfilment in breast cancer genetic counselling, a randomized controlled trial",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3133
1484,Erratum to: A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3130
1485,Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3131
1486,Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3128
1487,Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3127
1488,"Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3121
1489,Premenopausal serum androgens and breast cancer risk: a nested case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3117
1490,Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3116
1491,Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3115
1492,Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3114
1493,"PIK3CAmutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3113
1494,The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3112
1495,Key signaling nodes in mammary gland development and cancer: Smad signal integration in epithelial cell plasticity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3066
1496,The role and function of cadherins in the mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3065
1497,Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3111
1498,Initiating breast cancer by PIK3CA mutation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3103
1499,Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3110
1500,Germline DNA copy number variation in familial and early-onset breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3109
1501,Contribution of CXCL12 secretion to invasion of breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3108
1502,Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3107
1503,Use of glucocorticoids and risk of breast cancer: a Danish population-based case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3106
1504,Do we need biomarkers to predict the benefit of adding adjuvant taxanes for treatment of breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3093
1505,Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3105
1506,"Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3104
1507,The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3092
1508,Do fatty breasts increase or decrease breast cancer risk?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3081
1509,Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3102
1510,Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3101
1511,STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3100
1512,Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3099
1513,"Epithelial-mesenchymal transition, cancer stem cells and treatment resistance",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2938
1514,Understanding the mechanisms of aromatase inhibitor resistance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2931
1515,MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3098
1516,Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3097
1517,MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3096
1518,Molecular profiling of patient-derived breast cancer xenografts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3095
1519,Steps solidifying a role for SEPT9 in breast cancer suggest that greater strides are needed,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3056
1520,Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3091
1521,Balancing harms and benefits of service mammography screening programs: a cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3090
1522,Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3089
1523,No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3088
1524,Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3087
1525,Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background: a population-based cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3086
1526,Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3085
1527,"Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3084
1528,Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3083
1529,Effect of dietary patterns differing in carbohydrate and fat content on blood lipidand glucose profiles based on weight-loss success of breast-cancer survivors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3082
1530,Long-term prognosis of breast cancer detected by mammography screening or other methods,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3080
1531,Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3079
1532,"A genome-wide linkage study of mammographic density, a risk factor for breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3078
1533,A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3077
1534,Variants on the promoter region of PTEN affect breast cancer progression and patient survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3076
1535,Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3075
1536,Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3074
1537,Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3073
1538,New insights into the role of androgen and oestrogen receptors in molecular apocrine breast tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3036
1539,'Omic approaches to preventing or managing metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2923
1540,Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3072
1541,Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3071
1542,Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3070
1543,β1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2905
1544,Luminal-B breast cancer and novel therapeutic targets,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2904
1545,"Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3069
1546,Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3068
1547,Cancer's sweet tooth for serine,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2932
1548,Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3067
1549,Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3063
1550,CHEK2 contribution to hereditary breast cancer in non-BRCAfamilies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3062
1551,"Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3061
1552,A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3060
1553,miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3059
1554,Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3058
1555,"Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3057
1556,Interpretation and molecular validation of biomarker studies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3014
1557,Translational breast cancer research in luminal breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3013
1558,Molecular heterogeneity of luminal breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3012
1559,The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3033
1560,Design of RESILIENCE: a phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3011
1561,Quantitative proteomics reveals novel proteins and central pathways associated with endocrine resistance in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3032
1562,Targeting HER2 in breast cancer: beyond trastuzumab,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3010
1563,microRNA and protein expression in breast cancer formalin-fixed paraffin-embedded samples,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3031
1564,NoncodingRNAs: from bench to bedside,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3009
1565,Role of CCND1 and C-MYC oncogenes in metastatic breast cancer patients treated by herceptin,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3030
1566,DNA repair and breast cancer: therapeutic opportunities,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3008
1567,The phosphatidylinositol-3 kinase/mTOR pathway: new agents,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3007
1568,BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3029
1569,Lobular carcinoma of the breast: outcome of 205 patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3028
1570,Insulin resistance in breast cancer: relevance and clinical implications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3006
1571,Getting deep in the luminal B breast cancer subtype and its ki67 cut-off value,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3027
1572,Epigenetics of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3004
1573,Epithelial-mesenchymal transition as a mechanism for the progression of breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3003
1574,Oestrogen receptor status predicts for local recurrence following wide local excision for breast tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3026
1575,Immunity and autoimmunity in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3005
1576,Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3025
1577,Nestin and collagen triple helix repeat containing 1 in breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3024
1578,Poly(ADP-ribose) polymerase inhibitor development: are we in the right direction?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3002
1579,Abstract withdrawn,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3023
1580,Molecular classification of triple-negative tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3001
1581,Clinical features and prognosis of tubular breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3022
1582,Gene pathways associated with prognosis and chemotherapy sensitivity in different molecular subtypes of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3000
1583,Sensitization of epithelial growth factor receptors by nicotine exposure to promote breast cancer cell growth,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3055
1584,ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3054
1585,Assessment of the axilla in primary operable breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2999
1586,Mammography as a diagnostic tool in women aged 35 to 39 presenting to the symptomatic breast clinic,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2997
1587,Use of ultrasound elasticity imaging to monitor the response of a primary breast cancer to neoadjuvant chemotherapy in one patient in a pilot study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2995
1588,TOMMY Trial (a comparison of tomosynthesis with digital mammography in the UK NHS breast screening programme) setting up a multicentre imaging trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2980
1589,Comparison of dedicated digital specimen radiography with direct digital specimen mammography images,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2978
1590,Improving the validity of breast density assessment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2976
1591,Audit of accuracy of ultrasound-guided axillary core biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2974
1592,Risk factors for lymph node metastasis in patients with unifocal breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2972
1593,"An audit of breast imaging scoring by radiologists, in cases of proven malignancy",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2970
1594,"Preoperative estimation of the prognosis of invasive breast cancer, based on ultrasound size, core biopsy grade and percutaneous axillary lymph node biopsy",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2968
1595,Comparison of mammographic findings and need for ultrasound and biopsy in women undergoing wide local excision and either intraoperative radiotherapy or external beam whole breast irradiation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2966
1596,"Arbitration cancers: analysis from two screening rounds for the Coventry, Solihull and Warwickshire screening service",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2964
1597,Image quality and compression force: the forgotten link in optimisation of digital mammography?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2962
1598,Ultrasound staging and fine needle aspiration cytology: how well do they predict breast cancer nodal involvement?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2960
1599,Quantification of breast cancer risk based on the UK five-point classification system,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2958
1600,Comparison of analogue and digital mammographic appearances of screen-detected invasive breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2956
1601,Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3053
1602,What pathology is an indication for vacuum-assisted biopsy?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2998
1603,Assessment of patient doses during mammography practice at Kenyatta National Hospital,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2996
1604,Extended opening hours of the one-stop shop,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2994
1605,MRI characteristics of lobular carcinoma of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2993
1606,Occult breast carcinoma presenting with axillary lymphadenopathy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2992
1607,Should we be using nonscreening symptomatic units' mammogram machines for screening? Women's attitudes and factors likely to affect whether they attend,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2991
1608,Abstract withdrawn by author,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2990
1609,Size matters,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2989
1610,Should general practitioner access to breast imaging and 2WW co-exist?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2988
1611,Impact of presurgical breast MRI in a district general hospital,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2987
1612,"Quantification of the UK five-point breast imaging classification and mapping to BI-RADS: to facilitate comparison of reporting, research and published literature",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2986
1613,Preoperative sonographic axillary staging in breast cancer: correlation with sentinel node sampling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2985
1614,Abstract withdrawn by author,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2984
1615,Role of MRI as a problem-solving tool in screening assessment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2983
1616,Can mammographic features predict invasive carcinoma at screening assessment?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2982
1617,Detection of clinically and mammographically occult cancer by bilateral whole breast ultrasound: experience from a district general hospital,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2981
1618,Cross-Atlantic differences in reading the same breast screening cases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2979
1619,Can digital breast tomosynthesis offer an alternative to MRI in preoperative imaging of lobular carcinoma?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2977
1620,Dependence of detectability of microcalcification clusters on quality of mammography images,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2975
1621,Can radiation dose in mammography be further reduced by increasing the image quality?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2973
1622,"Every second counts: digital and analogue mammography - comparison of reading times at the Queen Elizabeth Breast Screening Unit, Gateshead, UK",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2971
1623,Abstract withdrawn by author,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2969
1624,Vacuum-assisted core biopsy of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2967
1625,Early identification of substandard breast screening performers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2965
1626,Large-bore vacuum-assisted biopsy of axillary lymphadenopathy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2963
1627,Incidence and outcome of 18-fluorodeoxyglucose positron emission tomography/computed tomography-detected breast lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2961
1628,Abstract withdrawn by author,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2959
1629,A comparison of the accuracy of digital breast tomosynthesis with supplementary views in the diagnostic workup of mammographic lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2952
1630,Apparent diffusion coefficient of normal breast tissue during the menstrual cycle at 3 Tesla,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2957
1631,Correlation of ethnicity with breast density as assessed by Quantra™,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2951
1632,Full-field digital mammography: a retrograde step for small screen-detected cancers?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2950
1633,Objective critical appraisal of mammography images in clinical audit: can we achieve this?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2955
1634,Correlations between shear wave elastography and mammographic findings in invasive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2949
1635,Outcomes following B3/B4 needle core biopsy in South East London Breast Screening Service 2000 to 2010,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2954
1636,Symptomatic breast services in Ireland: how do they compare with national and international standards?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2948
1637,Mammographic image unsharpness: a predictable phenomenon?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2953
1638,Automated breast volume scanner: an initial experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2947
1639,Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3050
1640,Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3052
1641,Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2937
1642,Clinical relevance and biology of circulating tumor cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2940
1643,The microenvironment in breast cancer progression: biology and implications for treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2912
1644,Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3037
1645,Epigenetics in breast cancer: what's new?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2925
1646,Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3039
1647,Mammographic density and breast cancer risk: current understanding and future prospects,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2942
1648,Breast cancer: current state and future promise,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3045
1649,"Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC - PACS 01 randomized trial",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3051
1650,"Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3048
1651,Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3049
1652,MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3047
1653,Replacement of E-cadherin by N-cadherin in the mammary gland leads to fibrocystic changes and tumor formation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3046
1654,Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3044
1655,Minimal residual disease and circulating tumor cells in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2906
1656,"Three interrelated themes in current breast cancer research: gene addiction, phenotypic plasticity, and cancer stem cells",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2887
1657,Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3043
1658,Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3042
1659,Nondense mammographic area and risk of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3041
1660,The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3040
1661,"The devil is in the methods: lineage tracing, functional screens and sequencing, hormones, tumour-stroma interactions, and expansion of human breast tumours as xenografts",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3021
1662,Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3038
1663,The amplifier effect: how Pin1 empowers mutant p53,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2941
1664,Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2921
1665,Rats: gnawing through the barriers to understanding genetic susceptibility and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2939
1666,A clinically relevant gene signature in triple negative and basal-like breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3035
1667,Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3034
1668,Male breast carcinoma: increased awareness needed,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2930
1669,Genomic and phenotypic analysis of BRCA2mutated breast cancers reveals co-occurring changes linked to progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3020
1670,Generation of tumor-initiating cells by exogenous delivery of OCT4transcription factor,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3019
1671,erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3018
1672,"A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3017
1673,The chemokine receptor CX3CR1 is directly involved in the arrest of breast cancer cells to the skeleton,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3016
1674,Breast tumors from CHEK2 1100delC- mutation carriers: genomic landscape and clinical implications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3015
1675,Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2946
1676,"Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2945
1677,Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2944
1678,Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2943
1679,A protective role for BRCA2 at stalled replication forks,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2918
1680,β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2936
1681,NF-kappaB activation within macrophages leads to an anti-tumor phenotype in a mammary tumor lung metastasis model,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2935
1682,Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2934
1683,The 'alternative' EMT switch,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2915
1684,Estrogen receptor degradation: a CUE for endocrine resistance?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2914
1685,Poly(ADP-ribose) polymerase inhibition: a new direction for BRCAand triple-negative breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2877
1686,Vitamin D and breast cancer: interpreting current evidence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2846
1687,Targeting bone metastases starting from the preneoplastic niche: home sweet home,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2911
1688,The non-protein coding breast cancer susceptibility locus Mcs5a acts in a non-mammary cell-autonomous fashion through the immune system and modulates T-cell homeostasis and functions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2933
1689,"Cannibalism, cell survival, and endocrine resistance in breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2870
1690,Choosing the right cell line for breast cancer research,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2889
1691,Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2929
1692,Transcriptome analysis of embryonic mammary cells reveals insights into mammary lineage establishment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2928
1693,Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2927
1694,Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2926
1695,"Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2924
1696,Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2922
1697,"NF-κB, stem cells and breast cancer: the links get stronger",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2886
1698,Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2920
1699,Rare variants in the ATMgene and risk of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2919
1700,Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2917
1701,Erratum to: An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2909
1702,Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2916
1703,Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2892
1704,Erratum to: Functional magnetic resonance: biomarkers of response in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2910
1705,"Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2913
1706,"Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2890
1707,Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2908
1708,Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2903
1709,Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2902
1710,Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2901
1711,Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2907
1712,NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2900
1713,The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2898
1714,Waking up dormant tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2872
1715,"Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2876
1716,"miR-200c at the nexus of epithelial-mesenchymal transition, resistance to apoptosis, and the breast cancer stem cell phenotype",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2885
1717,Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2897
1718,Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2896
1719,Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11gene expression in forming surface P-selectin ligands in aggressive breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2895
1720,"Impact of UGT2B7 
His268Tyr
 polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2894
1721,Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2899
1722,Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2893
1723,Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2891
1724,Spotlight on Geminin,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2881
1725,Notch signaling as a therapeutic target for breast cancer treatment?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2875
1726,"Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2837
1727,EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2871
1728,Who is in the driver's seat in 8p12 amplifications? ZNF703 in luminal B breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2873
1729,Jekyll or Hyde: does Matrigel provide a more or less physiological environment in mammary repopulating assays?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2851
1730,From bone to breast and back - the bone cytokine RANKL and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2842
1731,Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silicobased mechanism,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2888
1732,Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2878
1733,"Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2884
1734,Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2883
1735,Optimal tumor sampling for immunostaining of biomarkers in breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2882
1736,Coffee consumption modifies risk of estrogen-receptor negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2879
1737,Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2880
1738,Heating cancer stem cells to reduce tumor relapse,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2847
1739,"Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2869
1740,Stress and breast cancer: from epidemiology to molecular biology,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2836
1741,Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2868
1742,More on FOX News: FOXA1 on the horizon of estrogen receptor function and endocrine response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2849
1743,Targets of miR-200c mediate suppression of cell motility and anoikis resistance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2867
1744,Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2866
1745,Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2865
1746,Cell fate takes a slug in BRCA1-associated breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2840
1747,Therapeutic targets for bone metastases in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2835
1748,"Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2864
1749,Prospective isolation and characterization of committed and multipotent progenitors from immortalized mouse mammary epithelial cells with morphogenic potential,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2863
1750,Exploring the link between MORF4L1 and risk of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2862
1751,miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2861
1752,"Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2860
1753,Stratifying triple-negative breast cancer: which definition(s) to use?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2852
1754,"The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2859
1755,Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2858
1756,Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2857
1757,"Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2856
1758,The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2855
1759,Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2854
1760,Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2853
1761,ERBB receptors in cancer: signaling from the inside,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2829
1762,Nanomedicine: making controllable magnetic drug delivery possible for the treatment of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2830
1763,Signaling pathways in breast cancer metastasis - novel insights from functional genomics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2831
1764,Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2818
1765,"Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2850
1766,Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2848
1767,Impact of oncogenic K-RASon YB-1 phosphorylation induced by ionizing radiation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2845
1768,Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2844
1769,Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2843
1770,Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2841
1771,Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2839
1772,Alternative TFAP2A isoforms have distinct activities in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2838
1773,Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2834
1774,Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2833
1775,"Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2832
1776,Functional magnetic resonance: biomarkers of response in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2815
1777,Do aromatase inhibitors have adverse effects on cognitive function?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2806
1778,The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2828
1779,Mutation screening of RAD51C in male breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2823
1780,Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2789
1781,During hormone depletion or tamoxifen treatment of breast cancer cells the estrogen receptor apoprotein supports cell cycling through the retinoic acid receptor α1 apoprotein,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2827
1782,Circulating microRNAs: promising breast cancer biomarkers - authors' response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2812
1783,Circulating microRNAs: promising breast cancer Biomarkers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2798
1784,Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2826
1785,The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2825
1786,Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2824
1787,Breast cancer genome heterogeneity: a challenge to personalised medicine?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2807
1788,Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2822
1789,Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2821
1790,Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2820
1791,High hopes for RANKL: will the mouse model live up to its promise?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2805
1792,A local basis for progesterone action during mammary tumorigenesis - no longer RANK and file,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2802
1793,Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2819
1794,3D culture reveals a signaling network,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2800
1795,Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2817
1796,Appraisal of progenitor markers in the context of molecular classification of breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2792
1797,Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2799
1798,Gene signatures of breast cancer progression and metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2791
1799,"Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2814
1800,Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2813
1801,p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2811
1802,"Rare, evolutionarily unlikely missense substitutions in CHEK2contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2810
1803,Chasing the immortal strand: evidence for nature's way of protecting the breast genome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2793
1804,Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ERα and growth factors via MAPK pathway,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2809
1805,α-Tocopheryloxyacetic acid: a novel chemotherapeutic that stimulates the antitumor immune response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2808
1806,A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2804
1807,"Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivotumor growth",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2803
1808,"α-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2801
1809,"Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2797
1810,A PALB2 mutation associated with high risk of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2796
1811,"Breast cancer research output, 1945-2008: a bibliometric and density-equalizing analysis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2795
1812,Pre-analytic variables and phospho-specific antibodies: the Achilles heel of immunohistochemistry,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2782
1813,Are current development programs realising the full potential of new agents?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2752
1814,Deciding priorities in a clinical studies group,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2751
1815,Deciding priorities in Pharma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2750
1816,Introduction: are current drug development programmes realising the full potential of new agents?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2749
1817,Angiogenesis - still a worthwhile target for breast cancer therapy?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2748
1818,Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2747
1819,Genome-wide case-control study of musculoskeletal adverse events and functional genomics in women receiving aromatase inhibitors: going beyond associations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2746
1820,Designing adjuvant treatment based on biological measurements in the neoadjuvant setting,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2745
1821,Session 6 introduction,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2744
1822,Randomized adjuvant trials in oncology: a necessity or time-consuming luxury?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2743
1823,Classical peer review: an empty gun,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2742
1824,Introduction to session on undue and disproportionate influences,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2741
1825,Emerging breast cancer epidemic: impact on palliative care,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2740
1826,The emerging breast cancer epidemic: early diagnosis and treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2739
1827,Breast cancer prevention in the developing world,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2738
1828,Emerging breast cancer epidemic: evidence from Africa,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2737
1829,The globalisation of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2736
1830,Molecular profiling contributes more than routine histology and immonohistochemistry to breast cancer diagnostics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2735
1831,Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2734
1832,Systems pathology,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2733
1833,Contribution of biomarkers to personalized medicine,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2732
1834,Predictive and prognostic factors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2731
1835,Controversies in Breast Cancer 2010,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2730
1836,Prevention of bone metastases and management of bone health in early breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2768
1837,Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2794
1838,Basal-like breast cancers: the phenotypic disparity between the cancer-initiating cells and tumor histology,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2764
1839,Breast cancer metastasis to the bone: mechanisms of bone loss,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2781
1840,Anti-tumour activity of bisphosphonates in preclinical models of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2769
1841,A prophylactic vaccine for breast cancer? Why not?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2775
1842,Prognostic gene network modules in breast cancer hold promise,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2774
1843,Risk factors for ductal and lobular breast cancer: results from the nurses' health study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2790
1844,Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2788
1845,Quantitative shear wave ultrasound elastography: initial experience in solid breast masses,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2787
1846,Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2786
1847,Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2mutation carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2785
1848,Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2784
1849,"Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2783
1850,Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2780
1851,Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2779
1852,Using mammographic density to predict breast cancer risk: dense area or percentage dense area,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2778
1853,Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2777
1854,Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2776
1855,Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2773
1856,A genome-wide association scan on estrogen receptor-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2772
1857,Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2771
1858,Optical breast cancer margin assessment: an observational study of the effects of tissue heterogeneity on optical contrast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2770
1859,Key signaling nodes in mammary gland development and cancer: β-catenin,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2723
1860,Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2766
1861,Breast cancer in young women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2647
1862,Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2762
1863,Green tea drinking and subsequent risk of breast cancer in a population to based cohort of Japanese women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2756
1864,Role of dietary fatty acids in mammary gland development and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2646
1865,Role of miR-10b in breast cancer metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2720
1866,Breast cancer in 35 to 39 year olds and imaging: is changing to ultrasound without mammography going to be safe? What are the workload implications?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2717
1867,Educational abstract,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2715
1868,Breast cancer screening in the over 70s,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2713
1869,Educational abstract,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2712
1870,An audit of pain in ultrasound-guided breast core biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2711
1871,Educational abstract,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2709
1872,Educational abstract,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2707
1873,Benign solitary breast masses in the prevalent screening round: do they contribute to a high recall rate?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2705
1874,Educational abstract,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2704
1875,Educational abstract,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2703
1876,Educational abstract,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2698
1877,Variability in film reader estimates of breast density in the PERFORMS scheme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2695
1878,"A retrospective review of triple-negative breast cancer cases: are there common features in the clinical presentation, imaging and risk factors?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2693
1879,Malignant microcalcification: prediction of excision margins by separating calcified and noncalcified core biopsies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2691
1880,Educational abstract,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2689
1881,Incident cancer cases: what can we learn from the previous screening round?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2687
1882,Screening MRI in patients at high risk of breast carcinoma from the Manchester family history clinic: our initial 2-year experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2685
1883,Educational abstract,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2684
1884,Does a second image-guided biopsy contribute to the management of B3 lesions?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2683
1885,Educational abstract,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2681
1886,Educational abstract,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2679
1887,Educational abstract,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2678
1888,Fine needle aspiration versus touch imprint cytology in ultrasound-guided core of breast masses,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2677
1889,Educational abstract,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2675
1890,Educational abstract,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2674
1891,Negative predictive value for atypia and malignancy of 14-gauge core biopsy of breast papillomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2673
1892,Educational abstract,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2669
1893,An investigation of workstation image manipulation usage when examining FFDM images,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2662
1894,Promoting early symptomatic presentation in older women with breast cancer in the NHS breast screening programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2660
1895,Surveillance following breast cancer: is it cost-effective?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2658
1896,MR visible only lesions: what are the predictors for malignant outcome?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2652
1897,Two-view 2D digital mammography versus one-view digital breast tomosynthesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2656
1898,Size matters: second breast cancer size following treatment for primary cancer as a predictor of survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2650
1899,Breast density as a predictor of breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2654
1900,Validation of a new automated volumetric breast density measurement system as a marker of breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2648
1901,Ultrasound of the axilla: analysing nodal cortical thickness,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2716
1902,Are there features on imaging or core biopsy that can predict tumour-positive margins after breast-conserving surgery?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2714
1903,What is involved in a comprehensive breast MRI service? Implications for service provision,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2710
1904,Correlation of preoperative ultrasound and mammographic measurement of malignant breast masses with operative histology,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2708
1905,Breast MRI screening for high-risk family history: the Sheffield experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2706
1906,Interval breast cancers: positive influencing behaviour,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2702
1907,Benefits of CT-angiography localisation in the surgical planning of deep inferior epigastric perforator flap breast reconstruction,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2701
1908,Single voxel proton magnetic resonance spectroscopy of breast cancer at 3T,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2700
1909,Breast histoscanning: the development of a novel technique to improve tissue characterization during breast ultrasound,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2699
1910,How can the prevalent round recall rate be reduced?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2697
1911,Seeding of tumour cells following breast biopsy: a literature review,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2696
1912,Is digital better?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2694
1913,"Initial experience with MicroPure™, a new ultrasound image processing function to improve calcification visualisation",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2692
1914,Role of imaging in gynaecomastia: results of a Royal College of Radiologists Breast Group Annual Scientific Meeting 2009 survey,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2690
1915,Vacuum-assisted core biopsy of B3 lesions showing atypia on needle core biopsy: a worthwhile exercise?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2688
1916,Current clinical use of the [18F]FDG PET/CT in breast cancer patients: an audit of local referral patterns,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2686
1917,An audit to assess the impact of introducing a protocol of bilateral whole breast and axillary ultrasound for assessment of screen-detected cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2682
1918,Effect of the introduction of preoperative MRI scans for lobular cancer in an individual breast unit,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2680
1919,Axillary lymph node fine needle aspiration in breast cancer staging: diagnostic impact of a second 20G spinal needle,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2676
1920,Effect of region of interest size in quantitative diffusion-weighted magnetic resonance imaging of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2672
1921,Comparison of 1.5T and 3T in assessment of suspicious breast lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2671
1922,Clinical value of hybrid imaging for staging breast cancer in a district general hospital,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2670
1923,A novel threshold-independent computer-aided detection algorithm for breast MRI,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2668
1924,Can touch imprint cytology replace fine needle aspiration within current clinical practice?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2667
1925,Sensitivity of integral computer-aided detection with full-field digital mammography for detection of breast cancer according to different histopathological tumor types and appearances,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2666
1926,Texture analysis applied to full-field digital mammography: ability to discriminate between invasive ductal and invasive lobular breast cancer - preliminary results,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2665
1927,To recognise the imaging of complications from Macrolane™ injection,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2664
1928,Preliminary assessment of ShearWave™ elastography features in predicting breast lesion malignancy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2663
1929,Mammographic follow-up of patients after treatment for breast cancer: is 5 years enough?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2661
1930,A pilot study to evaluate assisted freehand ultrasound elasticity imaging in the sizing of early breast cancer: a comparison of B-mode and assisted freehand ultrasound elasticity ultrasound with histopathology measurements,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2659
1931,"Comparison of film screen, computed radiography and direct digital mammography in the Southern Derby screening programme",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2653
1932,Accuracy of breast cancer detection with full-field digital mammography and integral computer-aided detection correlated with breast density as assessed by a new automated volumetric breast density measurement system,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2657
1933,Reduced breast biopsy rates with a combined high temporal and high spatial resolution MR imaging protocol at 3 Tesla,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2651
1934,Flat epithelial atypia: biological significance on core biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2655
1935,Ultrasound elastography as an adjuvant to conventional ultrasound in the preoperative assessment of axillary lymph nodes in suspected breast cancer: a pilot study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2649
1936,Triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2574
1937,Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2573
1938,Present and future evolution of advanced breast cancer therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2572
1939,Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2755
1940,"Immortalized, premalignant epithelial cell populations contain long-lived, label-retaining cells that asymmetrically divide and retain their template DNA",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2754
1941,Can phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibition ERase them all?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2718
1942,A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2753
1943,17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2729
1944,A novel approach for the generation of genetically modified mammary epithelial cell cultures yields new insights into TGFβ signaling in the mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2728
1945,"Family history of later-onset breast cancer, breast healthy behavior and invasive breast cancer among postmenopausal women: a cohort study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2727
1946,Effectiveness of tocotrienol-rich fraction combined with tamoxifen in the management of women with early breast cancer: a pilot clinical trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2726
1947,Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2725
1948,"Ferroportin and hepcidin: a new hope in diagnosis, prognosis, and therapy for breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2641
1949,RARα1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2724
1950,An ELISA-based high throughput protein truncation test for inherited breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2722
1951,Antiangiogenic therapy for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2642
1952,DNA methylation epigenotypes in breast cancer molecular subtypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2721
1953,Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2719
1954,Receptor conversion in distant breast cancer metastases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2645
1955,Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2644
1956,Mammary stem cells and cancer: roles of Wnt signaling in plain view,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2631
1957,P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2643
1958,Targeting breast cancer stem cells: fishing season open!,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2636
1959,Akt is required for Stat5 activation and mammary differentiation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2640
1960,Radiosensitization of mammary carcinoma cells by telomere homolog oligonucleotide pretreatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2639
1961,"Methods in Mammary Gland Development and Cancer: the second ENDBC meeting - intravital imaging, genomics, modeling and metastasis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2630
1962,Experimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2638
1963,Regulation of breast cancer cell motility by T-cell lymphoma invasion and metastasis-inducing protein,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2637
1964,Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2635
1965,"Penta-O-galloyl-β-D-glucose induces G1arrest and DNA replicative S-phase arrest independently of P21 cyclin-dependent kinase inhibitor 1A, P27 cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple-negative xenograft growth",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2634
1966,Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2633
1967,A prophylactic vaccine for breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2628
1968,Ovarian steroid hormones: what's hot in the stem cell pool?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2627
1969,Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2632
1970,Spatial organization acts on cell signaling: how physical force contributes to the development of cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2623
1971,The Met oncogene and basal-like breast cancer: another culprit to watch out for?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2617
1972,CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2629
1973,Microarray data analysis in neoadjuvant biomarker studies in estrogen receptor-positive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2616
1974,RAD51C germline mutations in breast and ovarian cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2619
1975,Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2626
1976,Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2625
1977,Columnar cell lesions and subsequent breast cancer risk: a nested case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2624
1978,Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2622
1979,Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2609
1980,Homeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2621
1981,Breast cancer incidence and overdiagnosis in Catalonia (Spain),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2620
1982,Association of invasion-promoting tenascin-C additional domains with breast cancers in young women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2618
1983,Breast cancer prognostic classification in the molecular era: the role of histological grade,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2607
1984,"ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2615
1985,MYBsuppresses differentiation and apoptosis of human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2614
1986,What's new on circulating tumor cells? A meeting report,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2601
1987,BRCA1: linking HOX to breast cancer suppression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2600
1988,Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2613
1989,Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2612
1990,"Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2611
1991,Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2610
1992,Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2608
1993,Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2606
1994,Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2605
1995,Mammostrat®as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2604
1996,HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2603
1997,Tumor senescence and radioresistant tumor-initiating cells (TICs): let sleeping dogs lie!,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2597
1998,Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2602
1999,Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2599
2000,The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2598
2001,Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2585
2002,Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2596
2003,RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2595
2004,Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2594
2005,Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2593
2006,Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2592
2007,The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2591
2008,Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2584
2009,Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2590
2010,Pregnancy-related factors and the risk of breast carcinoma in situand invasive breast cancer among postmenopausal women in the California Teachers Study cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2589
2011,Association between the spread of circulating tumor cells and breast cancer subtypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2582
2012,The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2578
2013,Just when you thought it was safe to go into the membrane: the growing complexities of extra-nuclear progesterone signaling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2580
2014,Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2588
2015,Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2587
2016,Tumour-associated carbohydrate antigens in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2577
2017,"Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-α and survivin",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2586
2018,Senescence evasion by MCF-7 human breast tumor-initiating cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2583
2019,What do we learn from HER2-positive breast cancer genomic profiles?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2571
2020,Breast tumors: of mice and women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2569
2021,Breast cancer-specific mutations in CK1ε inhibit Wnt/β-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2581
2022,Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2579
2023,"Psychosocial impact of breast cancer diagnosis and treatment in African, Caribbean and South Asian women",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2552
2024,Opticin: a potent anti-angiogenic/antiproliferative agent for breast cancer therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2550
2025,"Genetic engineering of pharmacologically regulated T cells, specific for breast cancer target antigens",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2548
2026,Recruitment of insulin receptor substrate-1 by erbB3 impacts on IGF-IR signalling in oestrogen receptor-positive breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2546
2027,Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2544
2028,FKBPL: a novel prognostic and predictive biomarker?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2542
2029,Predicting interaction networks of breast cancer risk genes using multiple microarray data,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2540
2030,Reduced MCPH1 expression in breast cancer and response to chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2538
2031,Mitochondrial translocator protein modulates metabolism and pharmacologically induced apoptosis in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2536
2032,Expression of migration stimulating factor in breast tissues and its clinical significance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2534
2033,miR-433 overexpression attenuates the spindle assembly checkpoint response to paclitaxel,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2532
2034,"Identification of molecular subtypes within a formalin-fixed, paraffin-embedded breast cancer tumour cohort",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2530
2035,A novel tumour-based test to identify breast cancer due to BRCA1 and BRCA2 mutations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2528
2036,Thioredoxin and related redox systems as targets in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2526
2037,C-terminal binding proteins play a critical nuclear function in the mitotic fidelity of breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2515
2038,Macrophage-mediated breast cancer cell chemotaxis: the role of sphingosine kinase-1 activation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2513
2039,Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2511
2040,Regulation of the apoptotic genes in breast cancer cells by the transcription factor CTCF,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2509
2041,Phosphoinositide 3-kinase class II beta is a novel target in breast cancer therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2507
2042,"D133P53, directly transactivated by p53, prevents p53-mediated apoptosis without inhibiting p53-mediated cell cycle arrest",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2505
2043,"Suppression of the NF-κB co-factor, Bcl3, delays the metastatic progression of breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2503
2044,Differentiation therapy: targeting breast cancer stem cells to reduce resistance to radiotherapy and chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2496
2045,Regulation of mammary epithelial architecture by PTEN,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2501
2046,New regulators of the BRCA1 response to genotoxic stress,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2494
2047,Recent advances in treatment of metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2491
2048,Biomarkers for the diagnosis and prediction of therapeutic response in clinical breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2490
2049,Activin B functions downstream of BRCA1 in stem cell maintenance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2498
2050,Tissue banking,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2489
2051,Modelling breast cancer in a three-dimensional heterotypic culture system,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2556
2052,A TRAIL-R1-specific ligand in combination with doxorubicin selectively targets primary breast tumour cells for apoptosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2555
2053,Breast cancer knowledge among women with learning disabilities and their experiences of breast mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2554
2054,Intensity and features of acute postoperative pain after mastectomy and breast-conserving surgery,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2553
2055,Completion of 5-year adjuvant endocrine therapy in the community,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2551
2056,Radiotherapy fraction size sensitivity is modulated by DNA repair systems,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2549
2057,Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53 mutant Her2 and triple negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2547
2058,CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2545
2059,Stick or switch? Audit of the use of switch therapy from tamoxifen to an aromatase inhibitor in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2543
2060,Microarray based expression profiling of BRCA1 mutated human tumours using a breast-specific platform to identify a profile of BRCA1 deficiency,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2541
2061,Anti-HER2 imaging agents for breast cancer imaging,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2539
2062,Identification of proteins and signalling pathways involved in neoadjuvant chemotherapy responsiveness of breast tumours using proteomics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2537
2063,Lack of correlation between markers of breast cancer initiating cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2535
2064,Breast calcification: the 'Cinderella' breast element?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2533
2065,"Evaluating gene expression in formalin-fixed, paraffin-embedded breast cancer tissues using DASL®",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2531
2066,Melanoma-associated antigen family protein-D4: clinical significance and functional relevance in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2529
2067,Could side population cells be an indicator of progression to hormone nonresponsive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2527
2068,Incorporating tumour pathology information into breast cancer risk prediction algorithms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2576
2069,Effect of intermittent versus continuous energy restriction on weight loss and breast cancer risk biomarkers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2525
2070,An integrated informatics platform to facilitate transforming tissue into knowledge,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2524
2071,A randomised controlled trial of the psychoneuroimmunological effects of reflexology in women with early-stage breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2523
2072,"Polymorphisms, endogenous hormone levels and familial breast cancer risk in premenopausal women",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2522
2073,Assessing the functional role of caspase-8 gene variants in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2521
2074,Clinicopathologic and molecular predictors of axillary lymph node metastasis in early-stage breast cancer: a mathematical predictive model,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2520
2075,Insulin-like growth factor binding protein-2 alters the sensitivity of breast cancer cells to chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2519
2076,Developmental protein HOXC11 cooperates with SRC-1 in breast cancer: an adaptive response to endocrine therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2518
2077,Transcriptional regulation of cyclin-dependent kinase inhibitor 1A (P21) by the transcription factor AP-2γ,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2517
2078,RhoBTB2 in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2516
2079,"PLU-1/Jarid1B contributes to estrogen-induced cell proliferation in the normal mammary gland and in breast cancer, and is required for embryonic survival",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2514
2080,ADAMTS15 metalloproteinase inhibits breast cancer cell migration,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2512
2081,Fulvestrant-induced expression of erbB3 and erbB4 sensitizes ER-positive breast cancer cells to heregulins,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2510
2082,MicroRNA-92 targets the 3' untranslated region of ERβ1 mRNA and post-transcriptionally regulates its expression in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2508
2083,Loss of CSMD1 disrupts mammary epithelial morphogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2506
2084,Identification of signalling pathways downstream of BRCA1 and p63,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2504
2085,Transforming growth factor-beta co-receptor endoglin suppresses breast cancer invasion and metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2497
2086,Genetic analysis of lobular carcinoma in situ and associated invasive lobular cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2502
2087,DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2495
2088,A novel and selective PDK1 inhibitor reduces breast cancer cell invasion and tumour growth,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2500
2089,FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2499
2090,Upregulation of ADAM proteases and HER ligands through a feedback loop mediates acquired resistance to trastuzumab in HER2-amplified breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2493
2091,Male versus female breast cancer: a comparative study of 523 matched cases reveals differences behind similarity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2492
2092,Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2575
2093,"At last, a predictive and prognostic marker for radiotherapy?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2567
2094,Cyclophosphamide- metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2570
2095,High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2568
2096,Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2566
2097,Interfering with inflammation: a new strategy to block breast cancer self-renewal and progression?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2563
2098,On the theory of tumor self-seeding: implications for metastasis progression in humans,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2561
2099,Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2565
2100,Effects of childhood body size on breast cancer tumour characteristics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2564
2101,Trichostatin A enhances acetylation as well as protein stability of ERα through induction of p300 protein,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2562
2102,Key signalling nodes in mammary gland development and cancer. Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2558
2103,Radiation resistance in breast cancer: are CD44+/CD24-/proteosomelow/PKH26+cells to blame?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2559
2104,Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2560
2105,MicroRNAs and their target gene networks in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2484
2106,Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2483
2107,"Potential prognostic value of heat-shock protein 90 in the presence of phosphatidylinositol-3-kinase overexpression or loss of PTEN, in invasive breast cancers",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2557
2108,Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2488
2109,The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2487
2110,Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2486
2111,Effects of lovastatin on breast cancer cells: a proteo-metabonomic study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2485
2112,Erratum to: PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2480
2113,"Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2482
2114,Risk of breast cancer among daughters of mothers with diabetes: a population-based cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2481
2115,Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2479
2116,Recent declines in breast cancer incidence: mounting evidence that reduced use of menopausal hormones is largely responsible,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2463
2117,Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2478
2118,Promotion of variant human mammary epithelial cell outgrowth by ionizing radiation: an agent-based model supported by in vitro studies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2477
2119,Familial relative risks for breast cancer by pathological subtype: a population-based cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2476
2120,Estrogen receptor action in three dimensions - looping the loop,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2470
2121,"Have the roles of two functional polymorphisms in breast cancer, R72P in P53 and MDM2-309 in MDM2, become clearer?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2474
2122,Tracking the genomic evolution of breast cancer metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2469
2123,ABL-N-induced apoptosis in human breast cancer cells is partially mediated by c-Jun NH2-terminal kinase activation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2475
2124,MicroRNAs: shortcuts in dealing with molecular complexity?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2455
2125,The more things change ... the more things change: developmental plasticity of tumor-initiating mammary epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2459
2126,(-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2473
2127,Gene expression profiling of peripheral blood cells for early detection of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2472
2128,Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2471
2129,Effect of training-sample size and classification difficulty on the accuracy of genomic predictors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2468
2130,Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2467
2131,"Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2466
2132,Risk factors for breast cancer in postmenopausal Caucasian and Chinese-Canadian women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2465
2133,PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2464
2134,MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: a nested case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2462
2135,Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2461
2136,Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2444
2137,Foundation clinical trials,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2442
2138,The role of preclinical animal models in breast cancer drug development,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2441
2139,Breast screening has increased the number of mastectomies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2438
2140,Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2437
2141,"Introduction to sessions on guidelines and endocrine therapy, the influence of breast screening on number of mastectomies and the challenge between molecular science and traditional dogma in the treatment of breast cancer. Introduction to Session 6",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2436
2142,Breast tumour stroma is a prognostic indicator and target for therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2435
2143,Who would have thought a single Ki67 measurement would predict long-term outcome?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2434
2144,"Who would have thought it! Influence on outcome of radiotherapy, Ki67 and stroma. Introduction to Session 5",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2432
2145,Gene expression profiling of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2430
2146,The potential of new technologies/approaches. Introduction to Sessions 3 and 4,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2428
2147,Tailored targeted therapy for all: a realistic and worthwhile objective against,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2427
2148,Debate: tailored targeted therapy for all - a realistic and worthwhile objective? Introduction to Session 2,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2425
2149,Risk factors. Introduction to Session 1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2421
2150,Controversies in Breast Cancer 2009,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2420
2151,"Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2460
2152,Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2443
2153,Are current drug development programmes realising the full potential of new agents? The scenario,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2440
2154,Are current drug development programmes realising the full potential of new agents? Introduction to Sessions 7 and 8,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2439
2155,Radiation impact in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2433
2156,Next-generation sequencing,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2431
2157,Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2429
2158,Tailored targeted therapy for all: a realistic and worthwhile objective?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2426
2159,Mammographic density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2423
2160,Alcohol consumption and breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2422
2161,Underarm antiperspirants/deodorants and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2424
2162,Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2458
2163,Human mammary cancer progression model recapitulates methylation events associated with breast premalignancy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2457
2164,Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2456
2165,CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER+disease,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2454
2166,PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2451
2167,"Rah, rah, ROS: metabolic changes caused by loss of adhesion induce cell death",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2417
2168,Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2453
2169,Hypoxia-inducible factor-1α and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2452
2170,Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2overexpression in breast cancer cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2450
2171,"Dynamic regulation of CD24 and the invasive, CD44posCD24negphenotype in breast cancer cell lines",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2449
2172,Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2447
2173,Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2448
2174,From normal cell types to malignant phenotypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2418
2175,Epithelial to mesenchymal transition and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2416
2176,A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2445
2177,"Hes-6, an inhibitor of Hes-1, is regulated by 17β-estradiol and promotes breast cancer cell proliferation",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2446
2178,Androgens and the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2413
2179,"PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2419
2180,Update on the use of aromatase inhibitors in early-stage breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2410
2181,Underestimation of invasive malignancy on conventional core biopsy of breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2403
2182,Efficacy of intra-operative wire localisation of breast lesions using ultrasound,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2401
2183,Correlation of age and hormone replacement therapy with breast density as assessed by Quantra™,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2398
2184,A 5-year case review of granulomatous mastitis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2396
2185,Screen-detected ductal carcinoma in situ - fine needle aspiration versus core biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2392
2186,Negative axillary ultrasound in primary breast cancer: how reassured should we really be?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2390
2187,Haematoma-directed ultrasound guidewire localisation of breast lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2388
2188,Screen-detected breast cancer: does presence of minimal signs on previous mammograms predict staging/grading of cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2387
2189,Is mammogram indicated in patients presenting with breast pain alone in the presence of a normal clinical examination?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2386
2190,Performance in digital mammography with and without film prior mammograms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2385
2191,Breast screening unit size and performance on self-assessment (PERFORMS),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2383
2192,In the NHS breast screening programme does radiographer-reported clinical history add value to mammography?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2381
2193,Role of large volume 'mammotome' biopsy in the management of screen-detected radial scars,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2379
2194,How important is mammographic image manipulation when examining digital screening cases?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2377
2195,Breast cancers missed by the arbitration process,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2375
2196,Multistatic radar: first trials of a new breast imaging modality,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2369
2197,Does breast magnetic resonance imaging measurement correlate with pathology in assessment of primary breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2373
2198,Pathological features and patterns of metastatic disease in locally advanced inflammatory and non-inflammatory breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2367
2199,Is it safe practice not to biopsy fibroadenomas in women under 30?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2371
2200,"Digital breast tomosynthesis: a comparison of the accuracy of digital breast tomosynthesis, two-dimensional digital mammography and two-dimensional screening mammography (film-screen)",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2365
2201,Cancers found at breast screening: is the radiologist giving the surgeon all the information he needs in the referral letter?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2402
2202,Breast cancer screening - how do we communicate with women of South Asian origin?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2400
2203,The feasibility of vision-supported computer-based training in digital mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2399
2204,Axillary lymph node ultrasound and fine needle aspiration in pre-operative breast cancer staging,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2397
2205,Preoperative ultrasound assessment of axillary lymph nodes in breast cancer: histopathological correlation in 100 cases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2395
2206,Abstract withdrawn,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2394
2207,Can we predict the likelihood of malignancy in mammographically indeterminate microcalcification?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2393
2208,Axillary ultrasound in staging breast cancer: diagnostic accuracy and effect on subsequent axillary surgery - the Plymouth experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2391
2209,Breast imaging and biopsy in women after therapeutic mammoplasty: comparison with women after wide local excision,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2389
2210,A survey of UK breast surgeons and radiologists to determine current and aspired mammography surveillance practice after treatment for primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2384
2211,Comparison of ultrasound localisation techniques for impalpable breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2382
2212,"Ultrasound-guided, large-bore, vacuum-assisted needle excision of fibroadenomata of the breast: a patient satisfaction survey",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2380
2213,Incident round cancers - imaging characteristics at diagnosis and on the previous screening round,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2378
2214,R3 breast lesions - are we categorising and managing them correctly?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2376
2215,Interval cancer review in the Leicestershire symptomatic breast service,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2370
2216,Does magnetic resonance imaging alter the clinical management of patients with breast cancer? A three year single centre experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2374
2217,Surgical management of women with screen-detected breast cancer: preoperative factors indicating risk of multiple operations versus a single operation in women undergoing surgery for screen detected breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2368
2218,"''Might be something, might not'' - what happens when indeterminate grade screening mamograms are arbitrated?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2372
2219,Optimal mammography reading volumes: evidence from real life,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2366
2220,Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2414
2221,Key signalling nodes in mammary gland development and cancer: Myc,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2406
2222,Notch versus the proteasome: what is the target of γ-secretase inhibitor-I?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2407
2223,Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2412
2224,BU-32: a novel proteasome inhibitor for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2411
2225,Circulating tumor cells in blood of primary breast cancer patients assessed by a novel RT-PCR test kit and comparison with status of bone marrow-disseminated tumor cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2405
2226,Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2409
2227,Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2361
2228,Estrogen and progesterone receptors have distinct roles in the establishment of the hyperplastic phenotype in PR-A transgenic mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2408
2229,Development of 'synthetic lethal' strategies to target BRCA1-deficient breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2362
2230,Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2404
2231,The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2364
2232,Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2363
2233,Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-β signaling and metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2360
2234,Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2359
2235,An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2358
2236,Magnetic resonance imaging of the natural history of in situmammary neoplasia in transgenic mice: a pilot study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2357
2237,Erratum to: Genomic profiling of breast tumours in relation to BRCAabnormalities and phenotypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2355
2238,Physical activity and breast cancer survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2351
2239,Recent advances in systemic therapy. When HER2 is not the target: advances in the treatment of HER2-negative metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2237
2240,Recent advances in systemic therapy for breast cancer: new technologies for a new era,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2254
2241,Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2356
2242,BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2354
2243,Resident macrophages influence stem cell activity in the mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2353
2244,Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2352
2245,It's all in the details: methods in breast development and cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2346
2246,Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2350
2247,Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2349
2248,MicroRNA expression profiling of male breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2348
2249,"The cytotoxicity of γ-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by γ-secretase inhibition",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2347
2250,Is there more to Wnt signalling in breast cancer than stabilisation of β-catenin?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2336
2251,Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2345
2252,An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2344
2253,Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2343
2254,Transforming growth factor-beta and mutant p53 conspire to induce metastasis by antagonizing p63: a (ternary) complex affair,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2337
2255,"Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2342
2256,Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2340
2257,A novel role for signal transducer and activator of transcription 5b (STAT5b) in β1-integrin-mediated human breast cancer cell migration,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2341
2258,Presence of HER4 associates with increased sensitivity to Herceptin™ in patients with metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2339
2259,"Plasma carotenoids, retinol, and tocopherols and postmenopausal breast cancer risk in the Multiethnic Cohort Study: a nested case-control study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2338
2260,Recent advances in systemic therapy: Advances in systemic therapy for HER2-positive metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2324
2261,Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2335
2262,Genomic profiling of breast tumours in relation to BRCAabnormalities and phenotypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2334
2263,Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2333
2264,Increased levels of active c-Src distinguish invasive from in situ lobular lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2332
2265,Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2331
2266,Dynamics of different-sized solid-state nanocrystals as tracers for a drug-delivery system in the interstitium of a human tumor xenograft,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2330
2267,The role of YY1 in reduced HP1α gene expression in invasive human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2329
2268,Challenges in studying the etiology of breast cancer subtypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2323
2269,Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2328
2270,"A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and nonsteroidal (anastrozole) aromatase inhibitors on biomarkers in postmenopausal women with hormone receptor-positive locally advanced breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2316
2271,Sentinel lymph node biopsy in breast cancer: day surgery and local anaesthetic approach,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2315
2272,Biopsy confirmation of metastatic breast cancer: interim results of a prospective biopsy study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2314
2273,"Employing multiplex immunofluorescence to quantify Her2 and phosphorylated Her2 in formalin-fixed, paraffin-embedded breast tumor specimens",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2313
2274,ZD6474 in combination with paclitaxel and UVB irradiation enhances the antiproliferative effect and apoptosis on breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2311
2275,Clinical features and prognosis of triple-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2309
2276,Sentinel lymph node biopsy for breast cancer: how many nodes to stop at? Experience at a tertiary centre in Singapore,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2305
2277,nab-Paclitaxel (Abraxane®): an albumin-bound cytotoxic exploiting natural delivery mechanisms into tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2282
2278,Future role of bevacizumab in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2281
2279,Advanced topics in BRCA1/BRCA2 analysis by genetic analyzer and real-time PCR,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2303
2280,"Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2+breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2280
2281,Breast tumor heterogeneity: causes and consequences,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2279
2282,Role of the BRCA1 gene in stem cells and treatment of mammary gland cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2301
2283,Bisphosphonates in the adjuvant treatment of early breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2278
2284,"Targeting the tumour microenvironment: denosumab, a new RANKL inhibitor",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2277
2285,Differential expression of cytoplasmic and stromal β-arrestin-1 is associated with separate aspects of tumor behavior in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2298
2286,Controversies in the hormonal adjuvant therapy of postmenopausal patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2276
2287,Controversies in hormonal adjuvant therapy for premenopausal patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2275
2288,"VEGF-A, VEGF-C, VEGF-R2, EGFR and HER2 in serum plus EGFR in tissue of patients with triple-negative breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2296
2289,Adjuvant therapy after preoperative treatment for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2273
2290,Inactivation of the retinoblastoma tumour suppressor pathway in premenopausal breast cancer is associated with resistance to tamoxifen,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2294
2291,Other new radiotherapy techniques,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2271
2292,Prognostic value HER-2/neu expression in T1 to T3 breast cancer with axillary lymph node metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2292
2293,Immediate versus delayed repair of partial mastectomy defects in breast conservation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2269
2294,Breast carcinoma: molecular markers and subtypes to predict patients at risk of developing metastatic disease,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2290
2295,Axillary staging: new approaches and treatment of minimal disease,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2267
2296,Breast cancer presenting as axillary abscess and unilateral lymphedema,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2288
2297,Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2265
2298,HER2 assessment using fluorescence in situ hybridization compared with OncotypeDX and association with risk of breast cancer death,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2286
2299,"Magnetic resonance imaging for diagnosis, staging, and follow-up",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2263
2300,Gail's model as first step for early diagnosis: National Cancer Institute of Naples experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2284
2301,Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2327
2302,Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2326
2303,Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2312
2304,Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2310
2305,Circulating epithelial tumor cells in patients with metastatic breast cancer treated with bevacizumab,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2308
2306,Efficacy and safety of the administration of bevacizumab in combination with first-line chemotherapy for the treatment of advanced breast carcinoma: ATHENA MO19391 study results in Spanish patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2307
2307,Sentinel node in breast cancer: retrospective analysis of 212 patients and factors associated with lymphatic involvement,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2306
2308,Molecular mechanisms of resistance to HER2-targeted therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2283
2309,Breast cancer survivors and lymphoedema: the relevance of education,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2304
2310,Advanced topics in array comparative genomic hybridization for diagnosis of hereditary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2302
2311,Phase I study of combination therapy with weekly paclitaxel and cyclophosphatamide for advanced or recurrent breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2300
2312,Value of diffusion-weighted imaging in differentiating benign from malignant breast lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2299
2313,A supernumerary muscle complicated axillary lymphadenectomy: case report,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2297
2314,Adjuvant therapy of HER2+ breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2274
2315,Risk of breast cancer amongst women who start smoking as teenagers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2295
2316,Biomarkers and predictive factors of response to neoadjuvant treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2272
2317,Role of p27 in tamoxifen response in breast cancer cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2293
2318,Prophylactic contralateral surgery: current recommendations and techniques,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2270
2319,How many sentinel lymph nodes should we excise?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2291
2320,Surgical management of the breast and axilla after neoadjuvant treatment: the role of sentinel node biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2268
2321,Epidemiological changes in premenopausal patients with breast cancer: a two-decade retrospective study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2289
2322,Clinical utility and future of genetic profiles for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2266
2323,Population-based study of hormone receptor status comparing OncotypeDX with standard immunohistochemistry,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2287
2324,Genetic profile sets: differences and preferences,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2264
2325,"Metabolic syndrome, hyperinsulinaemia and body mass index as risk factors in breast cancer: National Cancer Institute of Naples experience",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2285
2326,Identifying and assessing women at high risk for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2262
2327,"Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2325
2328,HER-2 positive breast cancer: decreasing proportion but stable incidence in Finnish population from 1982 to 2005,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2322
2329,Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2321
2330,Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2320
2331,Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2319
2332,The spatial distribution of radiodense breast tissue: a longitudinal study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2318
2333,Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2255
2334,WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2317
2335,Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2261
2336,"Links between transforming growth factor-β and canonical Wnt signaling yield new insights into breast cancer susceptibility, suppression and tumor heterogeneity",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2253
2337,A constant risk for familial breast cancer? A population-based family study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2260
2338,PI-3 kinase activity is necessary for ERK1/2-induced disruption of mammary epithelial architecture,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2259
2339,Anti-VEGF therapy as adjuvant therapy: clouds on the horizon?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2250
2340,Immunohistochemical characterization of subtypes of male breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2258
2341,Co-incidental increase in gene copy number of ERBB2 and LRIG1 in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2248
2342,"MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2257
2343,Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2256
2344,"QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2252
2345,Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2251
2346,"Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2249
2347,The multiplex bead array approach to identifying serum biomarkers associated with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2247
2348,Number crunching in the cancer stem cell market,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2243
2349,Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2246
2350,Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2245
2351,FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2239
2352,Recent advances in systemic therapy. New diagnostics and biological predictors of outcome in early breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2238
2353,Loss of TGF-β or Wnt5a results in an increase in Wnt/β-catenin activity and redirects mammary tumour phenotype,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2244
2354,The breast cancer somatic 'muta-ome': tackling the complexity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2236
2355,Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2235
2356,Triple-negative breast cancers are increased in black women regardless of age or body mass index,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2242
2357,TLE3 as a candidate biomarker of response to taxane therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2241
2358,Recent advances in systemic therapy. Advances in adjuvant systemic chemotherapy of early breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2226
2359,Peroxisome proliferator-activated receptor-γ protects ERBB2-positive breast cancer cells from palmitate toxicity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2240
2360,Recent advances in systemic therapy. Advances in neoadjuvant (primary) systemic therapy with cytotoxic agents,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2227
2361,T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2234
2362,The transition from ductal carcinoma in situto invasive breast cancer: the other side of the coin,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2228
2363,Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2233
2364,"Transforming growth factor-β in breast cancer: too much, too late",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2224
2365,Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2232
2366,Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2231
2367,Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2230
2368,Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2229
2369,"Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2225
2370,A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2genes based on cancer family history,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2223
2371,Gene expression profiling of the tumor microenvironment during breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2222
2372,Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2221
2373,Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2220
2374,Do Asian breast cancer patients have poorer survival than their western counterparts? A comparison between Singapore and Stockholm,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2219
2375,Novel multicellular organotypic models of normal and malignant breast: tools for dissecting the role of the microenvironment in breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2218
2376,Are we HER-ting for innovation in neoadjuvant breast cancer trial design?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2209
2377,Erratum to: Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2216
2378,Phosphoinositide 3-kinase targeting by the β galactoside binding protein cytokine negates akt gene expression and leads aggressive breast cancer cells to apoptotic death,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2217
2379,CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2215
2380,Eph receptors in breast cancer: roles in tumor promotion and tumor suppression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2207
2381,Breast cancer stroma frequently recruits fetal derived cells during pregnancy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1860
2382,EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2214
2383,Optimizing the implementation of future treatment using surrogate end-points,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2186
2384,Neoadjuvant/presurgical treatments,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2184
2385,Introduction to sessions on 'Optimizing the implementation of future treatments – time to abandon traditional methods',http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2181
2386,Identification and mechanisms of endocrine resistance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2179
2387,Markers of endocrine sensitivity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2178
2388,By looking back we can see the way forward: enhancing the gains achieved with antihormone therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2176
2389,"Introduction to sessions on 'Endocrine therapy: where have we come from, where are we at and where are we going to?'",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2175
2390,Psychosocial aspects of risk appraisal,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2174
2391,Assessing risk for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2173
2392,Identification of personal risk of breast cancer: genetics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2172
2393,Should lifestyle modifications be promoted to prevent breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2171
2394,Introduction to sessions on 'Predicting personal risk for breast cancer',http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2169
2395,Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors: the case against,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2168
2396,Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors: the case for,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2167
2397,How much can improved molecular and pathologic discriminants change local therapy?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2165
2398,Thirty years of experience with mammography screening: a new approach to the diagnosis and treatment of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2163
2399,"Introduction to sessions on 'What can surgeons do for us (and we for them): radiology, pathology, molecular biology and local therapy'",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2162
2400,Controversies in Breast Cancer 2008,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2161
2401,The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2213
2402,Evaluation of biological agents targeted at early-stage disease,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2185
2403,Who should participate in clinical trials and who not? Can clinical trials be made more efficient and effective?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2183
2404,"Strength and weakness of phase I to IV trials, with an emphasis on translational aspects",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2182
2405,Integration of endocrine therapy with targeted agents,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2180
2406,Pharmacogenetics and pharmacogenomics of endocrine agents for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2177
2407,Assessing individual risk for breast cancer: role of oestrogens and androgens,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2170
2408,Introduction to the sessions on 'Debate: Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors',http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2166
2409,The utility of conventional and molecular pathology in managing breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2164
2410,The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2212
2411,Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2211
2412,Proteomic analysis of tumor necrosis factor-α resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2210
2413,Molecular imaging as a tool for translating breast cancer science,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2126
2414,Mechanisms of metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1988
2415,Approaches towards expression profiling the response to treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2196
2416,Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2208
2417,Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2206
2418,Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2205
2419,Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2204
2420,PAI-1 and functional blockade of SNAI1 in breast cancer cell migration,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2203
2421,Osteopontin: a new role for a familiar actor,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2199
2422,Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2194
2423,Putative growth characteristics of micrometastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2197
2424,Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2202
2425,Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2201
2426,PGRMC1: a new biomarker for the estrogen receptor in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2191
2427,A functional Notch–survivin gene signature in basal breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2200
2428,ErbB3 is required for ductal morphogenesis in the mouse mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2198
2429,IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2195
2430,"Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulation",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2193
2431,"A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2192
2432,Local control by radiotherapy: is that all there is?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2160
2433,Functional genomic analysis of drug sensitivity pathways to guide adjuvant strategies in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2159
2434,Prospective study of physical activity and risk of postmenopausal breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2190
2435,Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2189
2436,Selective segregation of DNA strands persists in long label retaining mammary cells during pregnancy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2188
2437,Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2187
2438,Erratum to: BCoR-L1variation and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2153
2439,A candidate molecular signature associated with tamoxifen failure in primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2158
2440,Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2157
2441,Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2156
2442,Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2155
2443,Targeting aspartate aminotransferase in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2154
2444,Recurrence dynamics does not depend on the recurrence site,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2152
2445,On the way to specifically targeting minimal residual disease?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2148
2446,Highway to heaven: mammary gland development and differentiation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2147
2447,Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2151
2448,Gene products of chromosome 11q and their association with CCND1gene amplification and tamoxifen resistance in premenopausal breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2150
2449,Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2149
2450,Luminal B breast tumors are not HER2 positive – authors' response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2141
2451,Luminal B breast tumors are not HER2 positive,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2134
2452,Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2146
2453,The evolving role of oestrogen receptor β in clinical breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2140
2454,Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2145
2455,"Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2144
2456,Breast cancer stem cell markers – the rocky road to clinical applications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2130
2457,ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2143
2458,Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2125
2459,The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2142
2460,A gene signature of loss of oestrogen receptor (ER) function and oxidative stress links ER-positive breast tumours with an absent progesterone receptor and a poor prognosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2135
2461,A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2139
2462,Regulation of cancer stem cells by p53,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2133
2463,A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2138
2464,Variable size computer-aided detection prompts and mammography film reader decisions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2137
2465,Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2136
2466,Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2132
2467,Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2116
2468,Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2131
2469,Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2129
2470,Comparison of molecular phenotypes of ductal carcinoma in situand invasive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2128
2471,Breast cancer susceptibility loci and mammographic density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2127
2472,Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2124
2473,Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2115
2474,Molecular targeted therapies for breast cancer treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2112
2475,"Visually assessed breast density, breast cancer risk and the importance of the craniocaudal view",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2123
2476,Breast cancer stem cells: implications for therapy of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2111
2477,Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2122
2478,Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2121
2479,Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2120
2480,Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2119
2481,Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2118
2482,The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2117
2483,"Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2114
2484,The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2113
2485,Digital screening on a mobile unit: the Coventry experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2074
2486,What makes a good mammographer? Looking at the homogeneity of those groups who perform best and least well on the PERFORMS self-assessment scheme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2072
2487,Effectiveness of screening a small population,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2070
2488,Variations in excision biopsy rates for women with B3/C3 results do not account for high benign open biopsy rates in the NHS Breast Screening Programme: a regional study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2068
2489,An audit reviewing the management of fibroadenomas with the advent of Mammotome in the breast unit in Bradford,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2066
2490,Study of the availability of digital mammography for premenopausal women in the Valencian Breast Cancer Early Detection Program,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2064
2491,Breast biopsy pathology request forms: are the radiologists completing them correctly and legibly?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2037
2492,Vacuum-assisted breast biopsy: comparison of three systems,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2035
2493,Breast tomosynthesis in practice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2033
2494,Full field digital mammography: which equipment?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2031
2495,Comparison of vacuum biopsy systems,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2029
2496,Assistant practitioner job satisfaction and retention,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2027
2497,Comparison of practitioner and assistant practitioner mammograms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2026
2498,The future of breast radiography: UK perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2025
2499,Ultrasound elastography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2002
2500,Positron emission tomography in breast disease,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2000
2501,"The scope for a rapid digitiser of mammograms and other large-file, high-resolution images",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2086
2502,A review of breast cancers found in the Welsh Family History screening programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2084
2503,Mammographic interpretation training: what exactly do film-readers want?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2083
2504,Eliciting requirements for a mammography training application,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2082
2505,Imaging features of male breast cancer: a pictorial review,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2081
2506,Does size matter? A review of screen-detected microcalcifications seen at breast screening assessment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2080
2507,Promoting early presentation of breast cancer amongst older women: radiographers' experiences of taking on a new role,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2079
2508,Lateral-approach stereotactic vacuum-assisted 10 G breast biopsy using Vacora for indeterminate microcalcifications: results of a single-institution assessment of 172 procedures,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2078
2509,Assessing mammography film-reader performance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2077
2510,Initial experience with a new ultrasound imaging technique to measure tissue viscoelasticity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2076
2511,Managing interval cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2075
2512,"Implementing barcode film-reading in the National Health Service Breast Screening Programme: the good, the bad and the ugly",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2071
2513,Integration of the independent sector and the National Health Service in breast radiology: a working example,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2069
2514,The West Midlands screening histories results,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2065
2515,Additional application of 1H-spectroscopic (3D-MRSI) and diffusion-weighted magnetic resonance imaging (MRI) in breast MRI at 3 T: is there a diagnostic value in comparison with high temporal and spatial resolution morphologic and dynamic MRI in patients with breast lesions?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2063
2516,Radial scars: to excise or not to excise?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2061
2517,Derby results and practical experience of breast imaging in women following supradiaphragmatic irradiation for Hodgkin's disease,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2059
2518,Large-volume Mammotome biopsy may reduce the need for surgery in screen-detected papillary lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2055
2519,Consensus approach to discrepancies arising from independent double reading of screening mammograms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2051
2520,Predicting the presence of invasive carcinoma from the extent of mammographic malignant microcalcification and grade of ductal carcinoma in situon core biopsy: results from a National Health Service Screening Programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2049
2521,Interval cancer data collection within the South West Quality Assurance Reference Centre,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2046
2522,Only skin deep: a pictorial review of skin and subcutaneous lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2045
2523,The seated mammographer: a radical improvement in ergonomics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2044
2524,Comparison between the NVQ Level 3 in Diagnostic and Therapeutic Care and the BTec Professional Development Certificate for assistant practitioners in imaging: the Derby experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2043
2525,A practical perspective of computerised radiography on a mobile screening van,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2042
2526,Breast cancer in young identical twins,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2041
2527,Audit of a radiographer/nurse-led family history breast cancer clinic,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2040
2528,Can computed tomography replace nuclear medicine scans in the staging of breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2039
2529,Breast screening assessment clinics: as easy as ABC,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2038
2530,Columnar cell lesions with atypia: radiological features and surgical outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2036
2531,"Accuracy of preoperative size prediction in infiltrating lobular carcinoma: comparison of mammography, ultrasound and clinical examination",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2034
2532,Quality assurance of full field digital mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2032
2533,Follow-up results after vacuum excision,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2030
2534,Can we manage B3 lesions better?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2028
2535,The future of breast radiography: European perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2024
2536,The first two years of digital mammographic screening in New Zealand,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2022
2537,How does the location of a satellite screening site affect uptake?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2020
2538,Two systematic reviews to compare effects of double reading and computer-aided detection on both cancer detection and recall rate,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2018
2539,Medico-legal issues in breast imaging,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2016
2540,"Evaluation of the diagnostic value of high temporal and spatial resolution morphologic, dynamic, spectroscopic and diffusion-weighted magnetic resonance imaging in patients with breast lesions at 3 T",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2014
2541,Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane Project,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2012
2542,Contrast enhanced and dual energy mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2011
2543,CADET 2 results/computer-aided detection update,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2010
2544,Magnetic resonance imaging in breast cancer: results of the COMICE trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2008
2545,Introduction to proton (H) magnetic resonance spectroscopy of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2007
2546,Magnetic resonance imaging of ductal carcinoma in situ,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2006
2547,Promoting early presentation of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2005
2548,Minimising oncological treatment of early breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2004
2549,Minimising surgical treatment of early breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2003
2550,Ultra-small iron particle-enhanced magnetic resonance imaging of axillary lymph nodes in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2001
2551,Common uses of immunohistochemistry in interpreting lesions of the breast: a pictorial review,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2085
2552,Abstract withdrawn,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2073
2553,Abstract withdrawn,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2067
2554,"Infection control in the mammography units of New South Wales, Australia and the Republic of Ireland",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2062
2555,Maximising round length in a large National Health Service breast screening unit,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2060
2556,Digital breast screening: does it do what it says on the tin?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2058
2557,Abstract withdrawn,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2057
2558,Significance of new benign densities seen on screening mammograms of women older than 60 years of age,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2056
2559,The developing role of mammographers in performing sentinel node injections in a specialist breast care centre,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2054
2560,Abstract withdrawn,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2053
2561,Evidence to support the use of ultrasound in addition to mammography as part of breast cancer follow-up surveillance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2052
2562,HILINA: minimising the breast compression time at stereoguided biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2050
2563,Metastases to the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2048
2564,Abstract withdrawn,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2047
2565,Should prior film mammograms be digitised during the transition to digital mammography?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2023
2566,Would male radiographers have an impact on breast screening programme performance?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2021
2567,Interval cancer developing within 3 years after recall to assessment: a review of the South East Wales cases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2019
2568,Is it feasible to train diagnostic radiographers to deliver a psycho-educational intervention to promote early presentation of breast cancer amongst older women? A pilot study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2017
2569,Ultrasound-guided axillary node core biopsy in the staging of newly diagnosed breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2015
2570,Evaluating tumour response to primary radiochemotherapy in breast cancer patients: what role for breast magnetic resonance imaging?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2013
2571,Three-dimensional mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2009
2572,Prognosis of small screen-detected invasive breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1999
2573,Risk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2110
2574,SELDI-TOF proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2107
2575,"PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2109
2576,Mammographic density. Measurement of mammographic density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2102
2577,The CD44+/CD24-phenotype is enriched in basal-like breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2108
2578,Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2106
2579,Jab1 is a target of EGFR signaling in ERα-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2105
2580,"Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2099
2581,Mammary carcinoma behavior is programmed in the precancer stem cell,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2104
2582,Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2103
2583,Alternative splicing and the progesterone receptor in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2097
2584,The future of mammary stem cell biology: the power of in vivotransplants – authors' response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1993
2585,The future of mammary stem cell biology: the power of in vivo transplants,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1986
2586,Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2101
2587,Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2100
2588,Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2098
2589,Identification of components of the ubiquitin system as targets for therapeutic intervention,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1963
2590,Quantitative proteomics reveals proteins associated with radiotherapy resistance in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1943
2591,Health inequalities in breast cancer screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1941
2592,Urinary and serum biomarkers of phytoestrogen exposure are not associated with breast cancer risk in the European Prospective into Cancer Norfolk study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1939
2593,The effect of intermittent versus chronic energy restriction on breast cancer risk biomarkers in premenopausal women: a randomised pilot trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1937
2594,Abnormal expression of p53 isoforms can be associated with poor survival in primary breast tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1936
2595,D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1911
2596,Inhibition of apoptosis by Notch signalling in breast epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1904
2597,Accurate prediction of BRCA1 and BRCA2 heterozygous genotypes using expression profiling of lymphocytes after irradiation-induced DNA damage,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1902
2598,Surviving breast cancer: can women expect to 'get back to normal'?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1878
2599,Molecular diversity of human breast cancer: clinical and therapeutic implications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1876
2600,Chromosomal instability in the pathogenesis and treatment of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1877
2601,PARP-1 inhibitor monotherapy and combination therapy in a preclinical mouse model of Brca2 mutant breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1979
2602,Primary ductal carcinoma in situmammosphere formation: importance of the epidermal growth factor and Notch receptor signalling pathways,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1978
2603,Homeopathy service in an NHS hospital breast cancer clinic: outcome study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1977
2604,What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study (PIMMS),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1975
2605,"Exploring the breast cancer experiences, needs and preferences of women aged 70 years and over: a study in progress",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1969
2606,Investigation of immunoregulatory mechanisms relating to poor surgical wound healing and breast cancer recurrence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1967
2607,Mechanisms of apoptosis and cell-cycle arrest in subcutaneous breast tumours treated sequentially with doxorubicin followed by zoledronic acid,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1965
2608,C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1961
2609,Bevacizumab resistance in breast cancer: are neuropilins the key?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1959
2610,TARGIT: an international trial of intraoperative versus external beam radiotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1957
2611,Prospective Study of Outcome in Sporadic versus Hereditary Breast Cancer: pros and cons of running a cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1955
2612,Identification and definition of novel clinical phenotypes of breast cancer through consensus derived from automated clustering methods,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1953
2613,Prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1947
2614,Development of anti-MUC1 DNA aptamers for the imaging and radiotherapy of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1946
2615,Proteomic screening of 725 antibodies simultaneously using antibody microarray technology to identify proteins associated with radiotherapy resistance in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1945
2616,Identification of proteins associated with radiotherapy resistance in breast cancer cells: a combined proteomic and microarray screening approach,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1944
2617,"MCPH1, a potential predictor for response to cancer chemotherapy",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1942
2618,Adherence to hormone therapy in a chemoprevention randomised trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1940
2619,Living with genetic risk of breast cancer: what have we learned?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1938
2620,"Cytochrome P450 modulates the therapeutic actions of tamoxifen, as evidenced in novel breast cancer models",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1934
2621,Association of gene variants in the TGF-beta signalling pathways with invasive breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1932
2622,"Assessment of angiogenesis in the hyperplasia preinvasive, invasive breast carcinoma sequence",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1930
2623,Proapoptotic protein Bid is regulated by phosphorylation during anoikis and the cell cycle,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1928
2624,Zinc transporter HKE4 as a new target in antihormone resistance of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1926
2625,Insulin-like growth factor binding protein 3 modulates epidermal growth factor (EGF)-induced growth of breast epithelial cells by altering EGF receptor internalization,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1924
2626,Matrix metalloproteinase-8 is a regulator of the clinical aggressiveness of mammary tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1922
2627,"Characterization of a cytoskeletal signaling pathway underpinning CD44-initiated, integrin-mediated adhesion of breast cancer cells to bone marrow endothelium",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1920
2628,Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1918
2629,Association of MMP8 gene variation with breast cancer prognosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1916
2630,Downregulation of 15-hydroxyprostaglandin dehydrogenase in hormone-resistant breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1914
2631,Understanding and exploiting changes in O-linked glycosylation in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1913
2632,De novo expression of αvβ6 integrin by myoepithelial cells in ductal carcinoma in situ may be an important marker of disease progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1912
2633,Investigation of the roles of novel apoptosis-controlling genes in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1910
2634,Reelin expression in breast tumours is associated with increased survival and is controlled by promoter methylation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1909
2635,Modelling estrogen receptor alpha-positive breast cancer by transformation of normal human mammary epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1907
2636,Regulation of cyclin D1by the BRCA1–BARD1 complex,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1906
2637,TopBP1 contains transcriptional regulatory domains and regulates gene pathways involved in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1905
2638,Investigation into the molecular mechanism of the antiapoptotic functions of CTCF in breast cancer cells using a proteomics approach,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1903
2639,TSC22 in mammary gland development and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1901
2640,Cellular localization of the proto-oncogenic p53 inhibitor AGR2 protein in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1898
2641,p53β isoform modulates differentially p53 transcriptional activity in response to stress,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1896
2642,Role of poly(ADPribosyl)ation of CTCF in cancer and normal breast cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1894
2643,A novel role for C-terminal binding proteins in the regulation of mitotic fidelity in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1892
2644,Development of breast cancer immunotherapy using MUC1-retargeted T lymphocytes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1881
2645,Chromosome translocations in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1890
2646,Activation of TGF-beta signalling in breast cancer metastatic cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1880
2647,Lineage commitment in mammary epithelium is regulated by type 2 cytokines and Stat6,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1888
2648,"Suppression of the NF-κB cofactor Bcl3 inhibits mammary epithelial cell apoptosis and, in breast tumours, correlates with poor prognosis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1884
2649,Two functionally distinct epithelial progenitors exist within the luminal cell compartment of the mouse mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1886
2650,"Dietary patterns across the life course, mammographic density and implications for breast cancer: results from a British prospective cohort",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1882
2651,Food choice and phytoestrogen consumption in women previously treated for postmenopausal breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1976
2652,'More positive about mammography' – reactions of women to a false positive recall: a qualitative study of women at risk of familial breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1974
2653,Diagnosed with breast cancer whilst on a family history screening programme: an exploratory qualitative study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1973
2654,'The sooner the better' or 'too much too soon'? A pilot prospective longitudinal study to evaluate quality of life and body image following immediate latissimus dorsi breast reconstruction,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1972
2655,The QUEST study: a multicentre randomised trial to assess the impact of the type and timing of breast reconstruction on quality of life following mastectomy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1971
2656,"Exploring the acceptability of, and preferences for, an ongoing support network for known BRCA1 and BRCA2 mutation carriers",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1970
2657,Discrepancies and challenge of ductal carcinoma in situfor health professionals,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1968
2658,An exploration of the management of menopausal symptoms for women with a diagnosis of breast cancer: lay and professional experiences and expectations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1966
2659,Pretreatment of breast cancer cells with doxorubicin facilitates the subsequent uptake of zoledronic acid,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1964
2660,Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1962
2661,Brk expression may affect the differentiation status of breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1960
2662,"Cambridge Breast Intensity Modulated Radiotherapy Trial: dosimetry results for 1,139 patients",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1958
2663,Lymphovascular invasion in breast cancer: improved methods of detection and clinical significance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1956
2664,Detection of gene amplification in matched tumour and plasma DNA from breast cancer patients by quantitative PCR,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1954
2665,Chemotherapy-induced modulation of [18F]Fluoro-2-deoxy-D-glucose incorporation at the tumour cell level,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1952
2666,Development of functional assays for BRCA1 missense mutations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1951
2667,Identification and role of migration stimulating factor isoforms in breast carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1950
2668,Expression analysis of novel biomarkers for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1949
2669,High-throughput optical proteomics and breast cancer patient profiling: novel applications to individualise prognosis and treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1948
2670,Multicentre study of CASP8 polymorphisms in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1935
2671,"From association to cause: fine mapping of the TNRC9gene region, a novel susceptibility locus identified in the first genome-wide association study for breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1933
2672,Altered myoepithelial cell expression and function in cancer-containing breasts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1931
2673,Breast cancer and environmental risk factors: an appraisal of the scientific evidence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1929
2674,Stromal fibroblasts with nuclear β-catenin are present within breast tumours and increase proliferation and invasion of epithelial breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1927
2675,Anti-oestrogen therapy switches off tumour suppressors and proapoptotic genes in breast cancer and reveals a new therapeutic opportunity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1925
2676,Actions of IGF-I are differentially regulated by fatty acids in normal and breast cancer epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1923
2677,Identification of genes involved in the formation of lymph node metastasis from human tumour xenograft models of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1921
2678,Role of CLEVER-1 in breast cancer metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1919
2679,CD44 signalling increases cathepsin K and MT1MMP expression to potentiate breast cancer cell invasion through collagen I,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1917
2680,"Plasma MMP1, MMP8 and MMP13 expression in breast cancer: protective role of MMP8 against lymph node metastasis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1915
2681,Regulation of estrogen receptor beta by 5' untranslated regions in breast carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1908
2682,Coactivation of estrogen receptor alpha by the DEAD-box RNA helicases p68 and p72 and its role in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1900
2683,Investigating h-Prune activation of Wnt signalling in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1899
2684,Inhibitor of apoptosis proteins as a therapeutic target in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1897
2685,NRG1is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1895
2686,RASSF2 can suppress the growth of breast cancer cell lines and is epigenetically inactivated in breast tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1893
2687,ZNF366 is a novel corepressor for estrogen receptor alpha that mediates its effects through interaction with CtBP,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1891
2688,Topoisomerase II expression as a determinant of chromosomal radiosensitivity and possible susceptibility in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1889
2689,Interactions between BRCA2 protein and the meiosis-specific recombinase DMC1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1887
2690,Loss of oestrogen receptor alpha in long-term antioestrogen-resistant cells: reversal by a c-src inhibitor,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1883
2691,Use of BRCA1 protein:protein interactions to classify cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1879
2692,"Role of the Hsp90 cochaperone, FKBPL, in oestrogen receptor signalling and breast cancer growth and survival",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1885
2693,Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2096
2694,TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2095
2695,Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/-mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2094
2696,Intact and total insulin-like growth factor-binding protein-3 (IGFBP-3) levels in relation to breast cancer risk factors: a cross-sectional study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2093
2697,Breast cancer tumor growth estimated through mammography screening data,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2092
2698,Autoantibodies as potential biomarkers for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2091
2699,Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2090
2700,Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2089
2701,Cancer and fertility preservation: fertility preservation in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1991
2702,Evaluation of biological pathways involved in chemotherapy response in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2088
2703,TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2087
2704,Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1998
2705,"Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1997
2706,NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1996
2707,NHERF1: molecular brake on the PI3K pathway in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1992
2708,Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1995
2709,Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1994
2710,Cancer stem cell heterogeneity in hereditary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1990
2711,"Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1869
2712,"Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1989
2713,Inflammation and breast cancer. Metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1980
2714,Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1gene,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1987
2715,The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1985
2716,PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1984
2717,Evaluation of the current knowledge limitations in breast cancer research: a gap analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1983
2718,Breast cancer metastasis: a microRNA story,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1867
2719,"Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1982
2720,Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1866
2721,Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1981
2722,"Tissue factor, angiogenesis and tumour progression",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1871
2723,Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1868
2724,Breast Cancer Research– the first ten years,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1873
2725,Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1875
2726,Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1874
2727,Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1872
2728,Breast cancer subtypes and survival in patients with brain metastases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1870
2729,Re-evaluation of mammary stem cell biology based on in vivotransplantation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1856
2730,Prognostic ability of a panel of immunohistochemistry markers – retailoring of an 'old solution',http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1854
2731,Sugar and fat – that's where it's at: metabolic changes in tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1852
2732,Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2using five methods: results from a population-based study of young breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1865
2733,Chemopreventive effects of celecoxib are limited to hormonally responsive mammary carcinomas in the neu-induced retroviral rat model,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1864
2734,"Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1863
2735,"1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (p,p'-DDE) disrupts the estrogen-androgen balance regulating the growth of hormone-dependent breast cancer cells",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1862
2736,ESR1 and EGFgenetic variation in relation to breast cancer risk and survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1861
2737,Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1859
2738,BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1tumour phenotype,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1858
2739,Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1857
2740,Re-evaluating early breast neoplasia,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1853
2741,Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1855
2742,Fatal attraction: why breast cancer cells home to bone,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1848
2743,The combined immunodetection of AP-2α and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1851
2744,Intrauterine environments and breast cancer risk: meta-analysis and systematic review,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1850
2745,Derlin-1 is overexpressed in human breast carcinoma and protects cancer cells from endoplasmic reticulum stress-induced apoptosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1849
2746,The role of single nucleotide polymorphisms in breast cancer metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1842
2747,Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1847
2748,Na+/H+exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1846
2749,Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1845
2750,Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1844
2751,Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1831
2752,"Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1843
2753,Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1841
2754,Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-α mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1840
2755,"Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1839
2756,"Mammographic density, breast cancer risk and risk prediction",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1829
2757,Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1838
2758,Metabolic approaches to breast cancer treatment and prevention,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1825
2759,Clinical outcomes: to be a surrogate or not to be ...?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1824
2760,Endocrine and targeted treatments for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1823
2761,Oxford Overview,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1822
2762,Introduction to clinical research sessions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1821
2763,Oestrogen is bad for patients with breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1820
2764,The oestrogen paradox: an hypothesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1819
2765,The origins of oestrogen receptor negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1818
2766,Do classical oestrogen markers predict for clinical response to endocrine therapy?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1817
2767,"Surrogates are just surrogates, but helpful just the same",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1816
2768,Does presurgical treatment destroy important prognostic information,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1815
2769,Introduction: challenging established dogma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1814
2770,Current and future choices in endocrine therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1813
2771,Adjuvant treatment: the contribution of expression microarrays,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1812
2772,Short-term presurgical treatment for all?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1811
2773,Personalized surgical treatment of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1810
2774,Introduction to sessions on Personalising treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1809
2775,The dangers of complementary therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1808
2776,Benefits of complementary therapies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1807
2777,Decision making in local therapy for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1806
2778,Why patient recorded outcomes should be mandatory in and outside clinical trials to guide management of patients with metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1805
2779,Is breast cancer advocacy distorting the cancer budget to the disadvantage of other tumours?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1804
2780,A personal viewpoint against the motion that breast cancer patient advocacy groups unfairly distort the cancer budget,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1803
2781,Why patient representation might harm science?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1802
2782,The case for user involvement in research: the research priorities of cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1801
2783,Psychosocial controversies in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1800
2784,Preface: controversies in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1799
2785,Breast tumour angiogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1796
2786,A prospective pilot clinical trial evaluating the utility of a dynamic near-infrared imaging device for characterizing suspicious breast lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1837
2787,Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1832
2788,Adjuvant endocrine therapy for premenopausal women with early breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1830
2789,"CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1836
2790,Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1835
2791,Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1834
2792,Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1833
2793,The promise and limitations of genome-wide association studies to elucidate the causes of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1787
2794,Identification of a novel truncating PALB2mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1828
2795,Are triple-negative tumours and basal-like breast cancer synonymous?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1827
2796,Osteoactivin/HGFIN: is it a tumor suppressor or mediator of metastasis in breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1791
2797,Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1826
2798,International Web-based consultation on priorities for translational breast cancer research,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1798
2799,The protective side of progesterone,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1792
2800,Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1797
2801,Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1784
2802,Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1785
2803,Erratum to: Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1786
2804,Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1794
2805,"Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1793
2806,Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1790
2807,Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1789
2808,Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1788
2809,P-cadherin expression in breast cancer: a review,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1774
2810,Live or let die: oestrogen regulation of survival signalling in endocrine response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1779
2811,Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1763
2812,Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1783
2813,Different measures of smoking exposure and mammographic density in postmenopausal Norwegian women: a cross-sectional study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1782
2814,Transphosphorylation of kinase-dead HER3 and breast cancer progression: a new standpoint or an old concept revisited?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1773
2815,Dietary intake and breast density in high-risk women: a cross-sectional study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1781
2816,Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53codon 72 Arg>Pro polymorphism,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1780
2817,Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1778
2818,Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1777
2819,Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1776
2820,Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1775
2821,"A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1772
2822,Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1771
2823,Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplification,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1770
2824,Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1769
2825,Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1768
2826,"Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1767
2827,BP1 transcriptionally activates bcl-2and inhibits TNFα-induced cell death in MCF7 breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1766
2828,Breast cancer risk-assessment models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1750
2829,Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1755
2830,Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1765
2831,Role of human HGFIN/nmbin breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1764
2832,Correlation between CpG methylation profiles and hormone receptor status in breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1762
2833,"1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1761
2834,Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1760
2835,Amping up estrogen receptors in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1748
2836,BCoR-L1 variation and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1759
2837,Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1746
2838,No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1758
2839,Inflammation and breast cancer. Inflammatory component of mammary carcinogenesis in ErbB2 transgenic mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1745
2840,Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1757
2841,GnRH and LHRgene variants predict adverse outcome in premenopausal breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1756
2842,Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1754
2843,Mammary stem cell number as a determinate of breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1741
2844,Characterization of a negative transcriptional element in the BRCA1 promoter,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1753
2845,Analysis of the cellular centrosome in fine-needle aspirations of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1752
2846,The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1751
2847,Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1736
2848,Breast cancer is a promising target for vaccination using cancer-testis antigens known to elicit immune responses,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1749
2849,Application of the multicellular tumour spheroid model to screen PET tracers for analysis of early response of chemotherapy in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1747
2850,Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1740
2851,The effect of psychosocial factors on breast cancer outcome: a systematic review,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1744
2852,Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1678
2853,"The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1743
2854,Expression of truncated Int6/eIF3e in mammary alveolar epithelium leads to persistent hyperplasia and tumorigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1742
2855,Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1739
2856,Accuracy of computed tomography perfusion in assessing metastatic involvement of enlarged axillary lymph nodes in patients with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1738
2857,Estrogen receptor-β: why may it influence clinical outcome in estrogen receptor-α positive breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1735
2858,Identification of women with an increased risk of developing radiation-induced breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1733
2859,Is breast cancer prognosis inherited?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1737
2860,Significance of nuclear medicine: 99mTc-MDP in the detection of breast cancer bone metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1730
2861,"Preliminary safety data of preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1729
2862,First clinical results on the potential of intraoperative imaging for sentinel lymph node biopsy in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1728
2863,Epigenetics of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1704
2864,Tachosil® to reduce the morbidity of axillary lymph node dissection in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1727
2865,Chemotherapy in metastatic disease: an overview,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1703
2866,Identification of individuals with hereditary predisposition to breast cancer and other breast cancer-associated forms of malignant neoplasms: data of the Belarusian Cancer Registry,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1726
2867,Neoadjuvant endocrine therapy: clinical and biological issues,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1702
2868,Algorithm for identification of individuals with hereditary predisposition to breast cancer and other breast cancer-associated forms of malignant neoplasms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1725
2869,Preoperative systemic treatment for operable disease: biological correlates of response to neoadjuvant treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1701
2870,Minimal residue disease (MRD),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1724
2871,Adjuvant hormonal therapy for postmenopausal women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1700
2872,Comparison of side-effect profiles during active treatment versus follow-up in the International Breast Cancer Intervention Study I tamoxifen prevention trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1723
2873,Frequency of febrile neutropenia in patients treated with taxane/epirubicine and colony-stimulating growth factors for breast cancer: comparison of filgrastim/lenograstim with pegfilgrastim,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1722
2874,Standards and future strategies in adjuvant chemotherapy treatments,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1699
2875,Novel method of sentinel lymph node detection in malignant tumors using preparation 'UNIMAG',http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1721
2876,Present and future role of bisphosphonates in treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1698
2877,Diagnosis of familial breast cancer by multiplex PCR and clinical parameters,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1720
2878,"Treatment of metastatic disease after current adjuvant approaches (taxanes, aromatase inhibitors, trastuzumab)",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1697
2879,Triple-negative (basal-like) breast cancer: a new entity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1696
2880,BRCA1a has antitumor activity in triple-negative breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1719
2881,Clinical role of trastuzumab in metastatic breast cancer: experience of a center,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1718
2882,Current status of adjuvant endocrine therapy for premenopausal patients with primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1695
2883,Study of the combination gemcitabine and trastuzumab in the treatment of HER2+ metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1717
2884,Partial breast irradiation and intraoperative radiotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1694
2885,Positive axillary lymph node metastases in T1–T3 breast cancer: prognostic value of extracapsular extension,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1716
2886,Partial breast irradiation with an electron beam for patients submitted to conservative surgery,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1715
2887,Resveratrol downregulates acetyl-CoA carboxylase alpha and fatty acid synthase by activating AMP-activated protein kinase and suppressing the mammalian target of rapamycin signal pathway,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1714
2888,Treatment of the intact primary in women with metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1691
2889,Axillary study before surgery in patients with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1713
2890,Predictive value of HER2 expression for the selection of adjuvant chemotherapy in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1712
2891,Role of MR and digital mammography for screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1689
2892,A safety and efficacy study of bleomycin sulfate and electroporation in patients with metastatic or locally recurrent breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1711
2893,Saline instillation into the cavity after conservation surgery for breast cancer is a safe way of improving cosmesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1710
2894,Gene expression profiling for prognosis of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1687
2895,Do breast cancer tumours downsize as well as downgrade with neoadjuvant chemotherapy?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1709
2896,Circulating tumor and endothelial cells as predictors of response in metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1686
2897,Circulating tumor cells as predictors of recurrence in primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1685
2898,Retreatment with trastuzumab in Her2-positive metastatic breast cancer patients: a clinical study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1708
2899,Prognostic factors for the node-negative breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1707
2900,Assessing prognosis for early breast cancer: clinical versus genetic profiles,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1684
2901,Novel strategies for HER-2-positive metastatic disease: mechanisms and therapeutic options to overcome trastuzumab resistance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1706
2902,Present and future roles of bevacizumab in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1705
2903,The nipple sparing mastectomy: a 5-year experience at the European Institute of Oncology of Milan,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1693
2904,Immediate versus delayed breast reconstruction,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1692
2905,Surgical issues in the breast and axillary nodes in patients treated with neoadjuvant systemic therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1690
2906,Molecular and gene expression-based predictors of response to preoperative chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1688
2907,Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1679
2908,An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1734
2909,Molecular response to aromatase inhibitor treatment in primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1732
2910,Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1731
2911,HER-2 therapy. HER-2/neu diagnostics in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1664
2912,Tumour dormancy in breast cancer: an update,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1677
2913,Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1683
2914,Association of TP53codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1682
2915,Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1673
2916,Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1681
2917,Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1680
2918,HER2gene status in primary breast cancers and matched distant metastases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1676
2919,TP53mutation status and gene expression profiles are powerful prognostic markers of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1675
2920,Correlation of umbilical cord blood hormones and growth factors with stem cell potential: implications for the prenatal origin of breast cancer hypothesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1674
2921,Cooperation between Wnt and Notch signalling in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1671
2922,Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1672
2923,An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1670
2924,The ethics of CYP2D6 testing for patients considering tamoxifen,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1663
2925,"Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1669
2926,Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1668
2927,Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1667
2928,"Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1666
2929,FGFR1 amplification in breast carcinomas: a chromogenic in situhybridisation analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1665
2930,Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1662
2931,Roles for estrogen and progesterone in breast cancer prevention,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1659
2932,Gata-3 and mammary cell fate,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1661
2933,Association of estrogen receptor-α and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1660
2934,Confirmation of double-peaked time distribution of mortality among Asian breast cancer patients in a population-based study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1658
2935,HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1652
2936,Key stages in mammary gland development. Secretory activation in the mammary gland: it's not just about milk protein synthesis!,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1653
2937,Gene promoter hypermethylation in ductal lavage fluid from healthy BRCAgene mutation carriers and mutation-negative controls,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1657
2938,Involvement of α6β4integrin in the mechanisms that regulate breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1651
2939,The continuing search for cancer-causing somatic mutations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1654
2940,Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1656
2941,"Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1655
2942,"Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1650
2943,Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1649
2944,Oestrogen receptor negative breast cancers exhibit high cytokine content,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1648
2945,Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1647
2946,Obesity hormone leptin: a new target in breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1638
2947,Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1646
2948,Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1645
2949,"Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1644
2950,Risk of second primary cancer in men with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1643
2951,"Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1642
2952,"An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1641
2953,"Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1640
2954,HER2 therapy. HER2 (ERBB2): functional diversity from structurally conserved building blocks,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1633
2955,"Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1639
2956,Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1637
2957,Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1636
2958,"Lipid peroxidation, oxidative stress genes and dietary factors in breast cancer protection: a hypothesis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1628
2959,A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1635
2960,IGFBP3mRNA expression in benign and malignant breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1634
2961,SirT1 modulates the estrogen–insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1632
2962,p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1631
2963,Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1630
2964,"Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1629
2965,High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1619
2966,A quantum leap in our knowledge of breast cancer mutations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1624
2967,Analysis of Epstein-Barr virus reservoirs in paired blood and breast cancer primary biopsy specimens by real time PCR,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1627
2968,A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1626
2969,Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1625
2970,Measuring proliferation in breast cancer: practicalities and applications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1618
2971,"Comprehensive analysis of the ATM, CHEK2 and ERBB2genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1623
2972,Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1622
2973,"Cross-priming of cyclin B1, MUC-1 and survivin-specific CD8+T cells by dendritic cells loaded with killed allogeneic breast cancer cells",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1621
2974,"Intrauterine exposures, pregnancy estrogens and breast cancer risk: where do we currently stand?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1615
2975,International Agency for Research on Cancer Workshop on 'Expression array analyses in breast cancer taxonomy',http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1609
2976,HER2 therapy: Molecular mechanisms of trastuzumab resistance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1612
2977,Is transforming growth factor beta signalling required for breast cancer metastatic cell motility?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1599
2978,Setting a lower risk threshold for surveillance within breast cancer family services,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1597
2979,Breast cancer follow-up: a focus group and interview study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1595
2980,Development of breast cancer immunotherapy using MUC1 retargeted T lymphocytes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1593
2981,Synergistic effects of cytotoxic drugs and antiresorptive agents in vitro and in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1591
2982,The Cambridge breast intensity modulated radiotherapy trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1589
2983,Development of anti-MUC1 DNA aptamers for the imaging and radiotherapy of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1587
2984,Breast cancer in relation to childhood parental divorce and early adult psychiatric disorder in a British birth cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1585
2985,Association of gene variants in the transforming growth factor beta signalling pathways with invasive breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1583
2986,Progress towards unlocking the secrets of oestrogen receptor beta in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1579
2987,"AGR2, a novel metastasis inducing protein with an effect on breast cancer patient survival",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1570
2988,Role of CASP8 D302H and other apoptosis gene variants in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1566
2989,Microarray studies reveal novel genes associated with endocrine resistance in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1554
2990,Inhibitor of apoptosis proteins in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1564
2991,Novel roles for integrins in tumour angiogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1552
2992,Poly(ADPribosyl)ation of CTCF: role in breast tumourigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1562
2993,Regulation of human breast stem cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1550
2994,The NEUREGULIN1gene and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1560
2995,Regulation of recombinational repair by the familial breast cancer susceptibility protein BRCA2,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1548
2996,Characterisation of the tumour suppressor gene ZACin breast tissue,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1558
2997,Evolution of aromatase inhibitors as an endocrine treatment for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1546
2998,Translating breast cancer research into clinical practice — new approaches and better outcomes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1545
2999,Loss of C-terminal binding protein transcriptional corepressor leads to aberrant mitosis and cell death in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1556
3000,Breast cancer susceptibility after BRCA1/2: finding the genes and potential practical applications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1544
3001,GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1617
3002,Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1616
3003,Role of macrophages in breast cancer angiogenesis in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1598
3004,'I haven't had breast cancer but I've had a mastectomy anyway': do women with ductal carcinoma in situhave appearance concerns?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1596
3005,Effects of combined treatment with Zometa and Taxol on endothelial cells in vitro,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1594
3006,Development of small-molecule transforming growth factor beta antagonists,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1592
3007,Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1590
3008,Global histone modifications in breast cancer and their prognostic significance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1588
3009,Increased regulatory T-cell numbers distinguish high-risk breast cancer patients and those at risk of late relapse,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1586
3010,Effect of intermittent versus chronic energy restriction on breast cancer risk biomarkers in premenopausal women: a randomised pilot trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1584
3011,High-grade ER-negative tumour breast cancers are characteristic of both very young onset cases and patients with hereditary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1582
3012,Regulation of cytochrome P450s in breast cancer and their role for tumour growth and anticancer chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1581
3013,New molecular tools and optical technologies to dissect CXCR4 function in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1580
3014,Role of protein kinase B in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1578
3015,Expression of adrenomedullin in long-term oestrogen-deprived human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1577
3016,Role of the metastasis suppressor tetraspanin CD82/KAI 1 in regulation of signalling in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1576
3017,Functional analysis of altered Tenascin isoform expression in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1575
3018,Evaluation of migration-stimulating factor expression for breast cancer diagnosis and prognosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1574
3019,The emerging role of CD44 in regulating skeletal metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1573
3020,Role of the Brk tyrosine kinase in breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1572
3021,Insulin-like growth factor signalling in oestrogen nonresponsive breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1571
3022,Functional analysis of normal and DCIS modified breast myoepithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1569
3023,Potential role of cyclin D1in DNA damage response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1568
3024,Functional analysis of the breast cancer associated transcriptional repressor PLU-1/JARID1B,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1567
3025,Benefits of combined treatments using antiresorptive agents and cytotoxic drugs,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1555
3026,Characterization of peptide aptamers to the Anterior Gradient 2: a novel inhibitor of the tumour suppressor protein p53,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1565
3027,Genome-wide RNAi to identify genes that confer synthetic lethality with BRCA1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1553
3028,Investigating the role of Wnt signalling in lobuloalveolar development of the mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1563
3029,Aberrant activation of Notch signalling in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1551
3030,hCLK2 couples FANCD2 to stalled replication forks and functions in the mammalian S-phase checkpoint,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1561
3031,Chromosome translocations may play a significant role in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1549
3032,Role of BRCT motif containing proteins in Chk1 activation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1559
3033,BRCA1 transcriptionally regulates genes associated with the basal breast cancer phenotype,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1547
3034,Phenotypic characterization of mouse mammary epithelial stem and progenitor cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1557
3035,Predicting a local recurrence after breast-conserving therapy by gene expression profiling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1614
3036,Classification of ductal carcinoma in situ by gene expression profiling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1613
3037,Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1611
3038,CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1610
3039,Gene expression signatures of morphologically normal breast tissue identify basal-like tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1608
3040,Prevention of breast cancer using selective oestrogen receptor modulators (SERMs),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1601
3041,High-throughput genomic technology in research and clinical management of breast cancer. Exploiting the potential of gene expression profiling: is it ready for the clinic?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1605
3042,Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: Relation to tumor phenotype and clinical outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1607
3043,Erratum to: Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1606
3044,Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1604
3045,Plasma levels of leptin and mammographic density among postmenopausal women: a cross-sectional study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1603
3046,A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1602
3047,Magnetic resonance mammography in the evaluation of recurrence at the prior lumpectomy site after conservative surgery and radiotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1600
3048,Recent translational research: circulating tumor cells in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1541
3049,Identification of murine mammary stem cells: implications for studies of mammary development and carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1540
3050,In vitrosynergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1543
3051,Comparison of gene expression profiles in core biopsies and corresponding surgical breast cancer samples,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1542
3052,High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1528
3053,Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1539
3054,Estrogen receptor-α and progesterone receptor are expressed in label-retaining mammary epithelial cells that divide asymmetrically and retain their template DNA strands,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1538
3055,Single nucleotide polymorphisms and breast cancer: not yet a success story,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1529
3056,Mouse models of breast cancer metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1530
3057,p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1536
3058,Estrogenic microenvironment generated by organochlorine residues in adipose mammary tissue modulates biomarker expression in ERα-positive breast carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1534
3059,The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1533
3060,Association between manganese superoxide dismutase promoter gene polymorphism and breast cancer survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1532
3061,Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1531
3062,Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1525
3063,β3Integrin and Src facilitate transforming growth factor-β mediated induction of epithelial-mesenchymal transition in mammary epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1524
3064,Breast cancer prognosis by combinatorial analysis of gene expression data,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1512
3065,Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1526
3066,"Ductal-lobar organisation of human breast tissue, its relevance in disease and a research objective: vector mapping of parenchyma in complete breasts (the Astley Cooper project)",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1527
3067,Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case–control and a case–case comparison,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1514
3068,Epigenetic silencing and deletion of the BRCA1gene in sporadic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1522
3069,MUC1 alters oncogenic events and transcription in human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1515
3070,"Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1516
3071,Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1517
3072,Anti-erbB2 treatment induces cardiotoxicity by interfering with cell survival pathways,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1523
3073,When will tumor gene expression profiling be incorporated into clinical breast cancer decision making?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1519
3074,Stop! In the name of transforming growth factor-β: keeping estrogen receptor-α-positive mammary epithelial cells from proliferating,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1520
3075,Columnar cell change on core biopsy: radiological features and outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1493
3076,"Pharmacokinetic, shape and texture parameters: comparison with breast tumour grade",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1491
3077,Are there lessons to learn from review of false-negative assessment interval cancers?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1489
3078,'I want to go home': women with disability and the mammography procedure,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1487
3079,Interpretation of mammographic breast microcalcification: interobserver variability between radiologists and mammographers and analysis of best mammographic predictors of histopathological outcomes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1485
3080,Breast Cancer Clinical Outcome Measures Project: national results from year 1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1483
3081,An aid to the viewing and reporting of the mammograms of the augmented breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1481
3082,Imaging methods in differentiation between inflammatory breast cancer and post-treatment changes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1479
3083,Avoiding unnecessary sentinel node biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1477
3084,Targeting Asian women results in greater uptake for breast screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1475
3085,Workload analysis for clinical nurse specialists working in breast screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1460
3086,Reducing our recall to assessment rate in the prevalent round to achieve the NHSBSP QA Standard,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1456
3087,Calcification or artefact? A case study examining potential products which can mimic calcification in mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1454
3088,A brief history of breast medicine,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1452
3089,Breast surgery: state of the art,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1450
3090,Hormones and radiation as risk factors for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1449
3091,Workforce issues in breast imaging: the consultant radiologist's perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1448
3092,Workforce issues in breast imaging: radiographers as screen readers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1446
3093,Update on the FH01 study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1444
3094,Update on breast cancer genetics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1442
3095,Medico-legal aspects of delay in breast cancer diagnosis: the legal perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1440
3096,Medico-legal aspects of delay in breast cancer diagnosis: the surgeon's perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1438
3097,Audit of general practitioner referrals for breast pain to rapid access breast clinics at North Cheshire NHS Trust Hospital,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1436
3098,The 'ideal' symptomatic breast clinic,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1422
3099,Symptomatic breast clinics: the radiologist's perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1421
3100,Evaluation of digital mammography: update on the UK position,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1417
3101,Increased screening capacity by an extended working day on the mobile screening unit,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1502
3102,An audit of women attending for technical repeat mammography at the South West London Breast Screening Service between 1991 and 2004,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1500
3103,An audit of women attending for symptomatic recall following routine NHSBSP screening at the South West London Breast Screening Service between 1991 and 2004,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1499
3104,Failsafe batches: are we optimising their effectiveness for both the screening service and the woman?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1498
3105,"Audit of ultrasound-guided breast biopsy/fine needle aspiration, in response to increasing demand on service provision",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1497
3106,Breast screening histories: variation with time and impact on 10-year survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1496
3107,The NHSBSP age extension: completed first-round statistics from Southern Derbyshire – why it works for us!,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1495
3108,Use of health promotion to improve uptake in breast screening in Northamptonshire,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1494
3109,Usefulness of magnetic resonance imaging in benign and malignant breast lesions: a pictorial review,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1492
3110,Ultrasound breast imaging versus pathology; correlation of reported benign ultrasound scans with subsequent biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1490
3111,Audit to assess the quality of mammograms in a symptomatic service providing family history screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1488
3112,"'What's the point of it?': radiographers, women with disability and mammography screening",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1486
3113,Breast lesion localisation wires: a change in practice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1484
3114,Comparison of outcome data for screen-detected and symptomatic breast cancers diagnosed in the West Midlands region in 2002,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1482
3115,Knowledge about breast cancer and attitudes to seeking help with breast cancer symptoms among older women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1480
3116,Investigation and analysis of the benign surgical biopsy rate in the prevalent screening round (2001–2002),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1478
3117,Addressing pain on compression: women and radiographers working together,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1476
3118,Digital on the road down-under,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1474
3119,Digital mammography: the human factors implications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1472
3120,Education within the workplace: an overview – has the emphasis on education devalued the importance of experience?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1470
3121,Further mammographic views: the importance of getting it right,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1468
3122,Radiotherapy for screen-detected ductal carcinoma in situ: indications and utilization in the United Kingdom – findings from the Sloane Project,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1466
3123,Modelling of the impact of replacing four-node sampling with sentinel lymph node biopsy within the NHS Breast Screening Programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1464
3124,Audit of short-term recall in the National Health Service Breast Screening Programme in the West Midlands,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1463
3125,Pathology quality assurance: the use of control charts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1462
3126,West Midlands Breast Screening General Practice Information Pack,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1461
3127,Women's satisfaction with clinical nurse specialists at assessment clinics within the West Midlands Breast Screening Programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1459
3128,Using an aubergine as a phantom for practicing stereotactic guided core biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1458
3129,A radiographer-delivered intervention to promote early presentation of breast cancer among women as they leave the routine protection of the NHS breast screening programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1457
3130,An audit of preoperative magnetic resonance imaging staging of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1455
3131,Oncology update: what do all those acronyms mean?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1451
3132,Workforce issues in breast imaging: the consultant radiographer's perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1447
3133,Update on magnetic resonance screening and the MARIBS trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1445
3134,NICE family history guidance and implementation update,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1443
3135,Image-guided breast biopsy programme quality evaluation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1441
3136,Medico-legal aspects of delay in breast cancer diagnosis: the radiologists' perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1439
3137,Feasibility of surgeon performing ultrasound in symptomatic breast clinics: the Brighton experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1437
3138,Wide local excision of breast carcinomas: the effect of ultrasound and wire guidance on the Surgical Precision Index,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1435
3139,The Dutch experience of digital mammography in screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1433
3140,Image-guided biopsy of mammographic microcalcifications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1431
3141,Symptomatic and screening film-readers: a difference in reading style?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1429
3142,Clinical cases covering management of borderline lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1427
3143,Radiological predictors of successful therapeutic wide local excision of ductal carcinoma in situ : findings from the Sloane project,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1426
3144,Is the Mammotome excision of indeterminate impalpable lesions found incidentally on mammography best practice?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1425
3145,Audit of wide bore needle biopsies graded B3: does the final pathology justify the increasing rate of benign biopsy?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1424
3146,Dominance and nondominance of the radial scar/complex sclerosing lesion and associated pathology,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1423
3147,How are symptomatic services run in the United Kingdom?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1420
3148,DMISTifying digital mammography in the USA,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1419
3149,Digital mammography in the United Kingdom: the reality,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1418
3150,Breast interventional devices: how they evolve and define new subspecialities,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1416
3151,Barcode data entry for film reading: information loss and consequences,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1501
3152,"Mammography soft-copy reading: to digitise priors or not, that is the question",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1473
3153,Breast ultrasound training scheme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1471
3154,To assess the clinical usefulness of radio-opaque marker insertion into malignant breast tumours in patients undergoing neo-adjuvant chemotherapy prior to consideration of breast-conserving surgery,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1469
3155,Analysis of QA Team visit recommendation responses in order to find ways of improving the probability of completion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1467
3156,The Sloane Project: a UK prospective audit of screen-detected non-invasive carcinoma of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1465
3157,Abstract withdrawn,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1453
3158,Ultrasound and fine needle aspiration assessment of the axilla in patients with operable invasive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1434
3159,Experience of quality assurance across BUPA screening centres,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1432
3160,Promoting early breast cancer presentation in women after their final routine breast screening mammogram,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1430
3161,"Screening with digital mammography: 2-year experiences from Vestfold County, Norway",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1428
3162,Snail in the frame of malignant tumor recurrence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1521
3163,"Breast cancer, stem cells and prospects for therapy",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1513
3164,Array-CGH and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1510
3165,High-throughput genomic technology in research and clinical management of breast cancer. Evolving landscape of genetic epidemiological studies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1511
3166,Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1509
3167,The association of mammographic density with ductal carcinoma in situof the breast: the Multiethnic Cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1507
3168,The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1506
3169,"Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1508
3170,Keratin 6 is not essential for mammary gland development,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1504
3171,"The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1503
3172,Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835],http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1505
3173,Variation in the RAD51 gene and familial breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1415
3174,What can be learnt from models of incidence rates?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1414
3175,A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1412
3176,Erratum to: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026],http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1413
3177,Bone versus breast density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1407
3178,Is there a positive association between mammographic density and bone mineral density? Authors' response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1393
3179,Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1408
3180,Key stages in mammary gland development - The alveolar switch: coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1411
3181,The intraductal approach to the breast: raison d'être,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1410
3182,Overdiagnosis and overtreatment of breast cancer: Is overdiagnosis an issue for radiologists?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1396
3183,Overdiagnosis and overtreatment of breast cancer: Progression of ductal carcinoma in situ: the pathological perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1397
3184,Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1399
3185,Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1400
3186,Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1395
3187,Tumor-specific expression of αvβ3 integrin promotes spontaneous metastasis of breast cancer to bone,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1398
3188,Key stages in mammary gland development - Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1401
3189,HER4 in breast cancer: comparison of antibodies against intra- and extra-cellular domains of HER4,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1394
3190,Erratum to: Increased copy number at 3p14 in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1409
3191,Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1392
3192,"Growth of a human mammary tumor cell line is blocked by galangin, a naturally occurring bioflavonoid, and is accompanied by down-regulation of cyclins D3, E, and A",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1391
3193,Germline polymorphisms in SIPA1are associated with metastasis and other indicators of poor prognosis in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1389
3194,Spontaneous and therapeutic abortions and the risk of breast cancer among BRCAmutation carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1387
3195,Breast asymmetry and predisposition to breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1388
3196,Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026],http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1384
3197,Erratum to: Phase I clinical study of the recombinant antibody-toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1390
3198,Recent translational research: stem cells as the roots of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1385
3199,The key role of CD40 ligand in overcoming tumor-induced dendritic cell dysfunction,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1386
3200,Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1378
3201,Is there a positive association between mammographic density and bone mineral density?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1383
3202,Analysis of cancer risk and BRCA1 and BRCA2mutation prevalence in the kConFab familial breast cancer resource,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1377
3203,Recent translational research: Oncogene discovery by insertional mutagenesis gets a new boost,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1376
3204,Dendritic cell defects in patients with cancer: mechanisms and significance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1375
3205,Co-expression of estrogen receptor-alpha and targets of estrogen receptor action in proliferating monkey mammary epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1374
3206,Comprehensive copy number profiles of breast cancer cell model genomes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1370
3207,"Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1364
3208,The evolving paradigm of tissue-specific metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1373
3209,Overdiagnosis and overtreatment of breast cancer: Microsimulation modelling estimates based on observed screen and clinical data,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1369
3210,"Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1367
3211,Spontaneous apoptosis of blood dendritic cells in patients with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1361
3212,"CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1371
3213,BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1365
3214,Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1363
3215,New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1362
3216,Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1366
3217,Key stages in mammary gland development: The cues that regulate ductal branching morphogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1368
3218,Imaging in breast cancer – breast cancer imaging revisited,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1359
3219,Imaging in breast cancer: Diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1358
3220,High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1356
3221,Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1360
3222,A prospective study of XRCC1(X-ray cross-complementing group 1) polymorphisms and breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1355
3223,"Farnesyl-transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF-7 cell growth through estrogen receptor dependent and independent pathways",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1357
3224,Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1342
3225,Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1353
3226,Dehydroepiandrosterone inhibits the progression phase of mammary carcinogenesis by inducing cellular senescence via a p16-dependent but p53-independent mechanism,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1350
3227,Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1348
3228,Overdiagnosis and overtreatment of breast cancer: Rates of ductal carcinoma in situ: a US perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1346
3229,Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1347
3230,Overdiagnosis and overtreatment of breast cancer: Overdiagnosis and overtreatment in service screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1339
3231,Overdiagnosis and overtreatment of breast cancer: Estimates of overdiagnosis from two trials of mammographic screening for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1354
3232,Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1345
3233,"Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1344
3234,Breast cancer histological classification: agreement between the Office for National Statistics and the National Health Service Breast Screening Programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1352
3235,Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1351
3236,HER-2 overexpression differentially alters transforming growth factor-β responses in luminal versus mesenchymal human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1343
3237,"Allelic imbalances of chromosomes 8p and 18q and their roles in distant relapse of early stage, node-negative breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1349
3238,The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1340
3239,"Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1341
3240,A common missense variant in BRCA2 predisposes to early onset breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1338
3241,Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1335
3242,"Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1336
3243,Expression analysis of candidate breast tumour suppressor genes on chromosome 16q,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1337
3244,"XRCC1 and XPDgenetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1333
3245,25-Hydroxyvitamin D31α-hydroxylase expression in breast cancer and use of non-1α-hydroxylated vitamin D analogue,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1332
3246,Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1328
3247,Clinical trial update: International Breast Cancer Study Group,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1334
3248,Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1325
3249,Key stages in mammary gland development: The mammary end bud as a motile organ,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1331
3250,Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1329
3251,What does an orphan G-protein-coupled receptor have to do with estrogen?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1330
3252,CYP2D6 variants and the prediction of tamoxifen response in randomized patients: author response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1326
3253,Targeted therapy against Bcl-2-related proteins in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1323
3254,"Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1gene with missense sequence changes and in-frame deletions, but not polymorphisms",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1324
3255,Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1327
3256,Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1318
3257,Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1322
3258,"CYP17 and breast cancer: no overall effect, but what about interactions?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1320
3259,CYP17 gene polymorphism in relation to breast cancer risk: a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1319
3260,Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1317
3261,The estrogen receptor-α A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1315
3262,Overdiagnosis and breast cancer screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1321
3263,Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1313
3264,"Percentage density, Wolfe's and Tabár's mammographic patterns: agreement and association with risk factors for breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1308
3265,Cortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1316
3266,Overdiagnosis and overtreatment of breast cancer: Overdiagnosis in randomised controlled trials of breast cancer screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1314
3267,The use of cystatin C to inhibit epithelial–mesenchymal transition and morphological transformation stimulated by transforming growth factor-β,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1312
3268,Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2mutation carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1293
3269,A new option for early breast cancer patients previously irradiated for Hodgkin's disease: intraoperative radiotherapy with electrons (ELIOT),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1310
3270,A mathematical model for the effect of a false-negative sentinel node biopsy on breast cancer mortality: a tool for everyday use,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1311
3271,Key stages of mammary gland development: Molecular mechanisms involved in the formation of the embryonic mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1306
3272,Metastasis of hormone-independent breast cancer to lung and bone is decreased by α-difluoromethylornithine treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1292
3273,Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1296
3274,Imaging in breast cancer: Magnetic resonance imaging,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1309
3275,Treating breast cancer through novel inhibitors of the phosphatidylinositol 3'-kinase pathway,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1307
3276,"Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1294
3277,Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1304
3278,CYP2D6 genotype and tamoxifen response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1297
3279,"How many genes are needed for early detection of breast cancer, based on gene expression patterns in peripheral blood cells?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1295
3280,High expression of Lewisy/bantigens is associated with decreased survival in lymph node negative breast carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1305
3281,Strong evidence that the common variant S384F in BRCA2has no pathogenic relevance in hereditary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1291
3282,Proteomic identification of heat shock protein 90 as a candidate target for p53 mutation reactivation by PRIMA-1 in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1290
3283,Phosphorylation of estrogen receptor α serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1285
3284,Endocrinology and hormone therapy in breast cancer: New insight into estrogen receptor-α function and its implication for endocrine therapy resistance in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1287
3285,"The Fourth International Symposium on the Intraductal Approach to Breast Cancer, Santa Barbara, California, 10–13 March 2005",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1288
3286,Genotypes and haplotypes of the methyl-CpG-binding domain 2 modify breast cancer risk dependent upon menopausal status,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1283
3287,The expression of the ubiquitin ligase subunit Cks1 in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1278
3288,High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1282
3289,Understanding endocrine resistance: the critical need for sequential samples from clinical breast cancer and novel in vitromodels,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1289
3290,Myoepithelial cells: good fences make good neighbors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1286
3291,Treatment of solid tumors with immunotoxins,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1284
3292,Increased copy number at 3p14 in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1279
3293,Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1281
3294,Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1276
3295,Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1277
3296,Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1274
3297,Early stopping of clinical trials,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1280
3298,"Genes, genomes, and cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1082
3299,Abstract withdrawn,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1138
3300,Abstract withdrawn,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1047
3301,Functional genomic approaches to breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1084
3302,Update on HER2-directed therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1079
3303,Molecular profiling of early breast cancer in relation to detection of micrometastases and outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1078
3304,Molecular distinctions among ERBB2-overexpressing breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1065
3305,Expression profiling of peripheral blood cells for early detection,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1063
3306,Biological features and xenograft models of a very early human premalignant breast lesion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1061
3307,Genomic and transcriptional events associated with poor clinical responses to conventional therapies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1059
3308,Genetic and epigenetic changes in early carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1057
3309,Molecular approaches to understanding pregnancy-induced protection against breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1055
3310,Targeting estrogen to kill ER-positive and ER-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1053
3311,Potential mechanisms whereby estrogens induce breast cancer in women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1051
3312,High-throughput experimental verification of predicted tissue-specific and tumor-specific splice isoforms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1196
3313,Potentiated phospho-protein networks in cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1194
3314,Determining the factors affecting breast cancer infectivity by oncolytic adenovirus,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1192
3315,The extracellular matrix composition and responsiveness to breast carcinoma therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1188
3316,Brn-3b transcription factor in breast tumourigenesis: regulation of genes associated with growth and migration of cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1190
3317,Hypoxia promotes invasion and metastasis of breast cancer cells by increasing lysyl oxidase expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1186
3318,In vitro models for tumor protein d52 function in cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1136
3319,Predicting survival from gene expression data by generalized partial least squares regression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1173
3320,Mapping the location of recurring amplicons in array-CGH data,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1169
3321,"HIN-1, an inhibitor of cell growth, invasion, and AKT1 activation",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1134
3322,DNA copy number changes in breast cancer samples using array-CGH profiling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1171
3323,Chromosomal imbalances mapped by array-based comparative genomic hybridization in an integrated approach to combat breast cancer in Denmark,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1167
3324,HER2 upregulates fatty acid synthase and acetyl-CoA carboxylase at a translational level in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1132
3325,Identification of differentially expressed genes in canine mammary tumor cell lines using a newly developed canine-specific cDNA microarray,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1165
3326,Gene expression profiling in breast cancer challenges the existence of intermediate histological grade,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1163
3327,Genome-wide expression profiling of microdissected human breast tumor cells: tumor classification predictive of metastases and clinical outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1159
3328,Comparison of the expression profile in breast cancer and ovarian cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1161
3329,Cell differentiation and dominant signaling pathway signatures in the molecular classification of human breast cancer cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1155
3330,Breast tumors induced by high-dose radiation display similar genetic profiles,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1153
3331,Real-time PCR-based expression profiling of BRCA1-induced genes in primary breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1149
3332,Myoepithelial cell layer disruption and human breast cancer invasion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1128
3333,Immortalization-associated gene signature in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1130
3334,Cooperation between extracellular signaling and intracellular Ras activation leads to immortalization and epithelial-to-mesenchymal transition of variant human mammary epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1126
3335,The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1124
3336,Genomic analysis of human breast cancer in families and populations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1046
3337,Identification of molecular apocrine breast tumours by microarray analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1122
3338,Molecular prediction of tamoxifen resistance in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1118
3339,"Establishment and characterization of two breast cancer xenografts in immunodeficient mice for studies on hormone-dependent and hormone-independent tumor growth, progression and invasion",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1120
3340,HER2 and ERβ2 downregulate estrogen-responsive element-mediated transcription activity of ERα-positive cells in response to estrogen stimulation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1116
3341,Stromal and epithelial TGF-β signaling in mammary tumorigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1045
3342,Mammary development fate and breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1114
3343,Large-scale single nucleotide polymorphism analysis of candidates for low-penetrance breast cancer genes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1101
3344,Genome-wide scanning for linkage in 56 Dutch breast cancer families selected for a minimal probability of being due to BRCA1 or BRCA2,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1098
3345,Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1096
3346,Genetic determinants of breast cancer characteristics and outcome in women under 50 years of age,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1094
3347,Screening for germline rearrangements in BRCA1 and BRCA2in Norwegian families with breast or breast/ovarian cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1092
3348,Cigarette smoking and breast cancer risk among non-drinking women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1088
3349,"Identification of novel sequence alterations and the functional analysis of the BRCA1 promoter/5'-UTR in families from Upper Silesia, Poland",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1090
3350,The challenges in translating present knowledge of the molecular biology of breast cancer into clinical use,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1044
3351,Envisioning new targets and new approaches for molecular-based cancer therapeutics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1087
3352,Proteomic approaches to early detection of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1085
3353,The search for low-penetrance breast cancer genes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1083
3354,Development of CDK inhibitors as cancer therapeutics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1081
3355,Role of HER2 in local relapse and metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1077
3356,TP53 and additional pathways in therapy resistance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1075
3357,A single nucleotide polymorphism in the HDM-2 gene regulates the p53 apoptotic response and influences the age of onset of cancers in humans: the SNP 309 HDM-2 polymorphism,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1073
3358,Expression profiling as a prognostic and predictive factor in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1071
3359,High-resolution representational oligonucleotide microarray analysis and fluorescence in situ hybridization analysis of aneuploid and diploid breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1069
3360,The role of the tumor microenvironment in breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1060
3361,Predicting response/resistance to endocrine therapy for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1056
3362,ERβ in normal and malignant breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1054
3363,The future of breast cancer prevention,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1052
3364,RNA integrity number: towards standardization of RNA quality assessment for better reproducibility and reliability of gene expression experiments,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1197
3365,A model of the BRCA1/BRCA2 network,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1195
3366,SNPS in putative regulatory loci controlling gene expression in cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1050
3367,Identification of drug targets for the treatment of Basal-like tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1191
3368,ATM mutations associated with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1048
3369,Breast tumors induce the recruitment of AC133+KDR+ endothelial precursor cells mobilized by plasma vascular endothelial growth factor,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1187
3370,Monitoring of minimal residual cancer in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1185
3371,Detection of minimal disease in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1183
3372,Promoter composition predicts gene classes in microarray expression analyses of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1164
3373,Comparative expressed sequence hybridisation revealed distinct chromosomal regions of differential gene expression in breast cancer subtypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1162
3374,Lymph node metastases display gene expression profiles of their primary breast carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1158
3375,Reproducibility of molecular portraits in early stage breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1156
3376,Molecular characterization of breast cell lines: a tool for breast cancer studies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1154
3377,Gene expression studies in radiation-sensitive cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1152
3378,Expression profiling of Wnt pathway genes in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1148
3379,Development of a rapid screening approach for candidate gene sets in cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1150
3380,Hypermethylation of cyclin D2 and DAP kinase is associated with the lobular subtype of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1146
3381,Prognostic value genotypes and LOH at TP53 codon 72 and TP53mutations in primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1179
3382,Microcell-mediated transfer of chromosome 6 into the breast cancer cell line MDA-MB-231: a specific set of genes is involved in the reversion of the tumorigenic phenotype,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1144
3383,Cancer gene mutation discovery and detection using array-based resequencing,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1181
3384,Expression of wild-type and mutated TP53in breast carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1177
3385,Lack of evidence for nuclear IGFBP5 in mammary epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1142
3386,TP53 mutations among molecular subtypes of HER2-positive tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1175
3387,"Protein expression and gene amplification of primary cyclins (A, B1, D1, D3and E) and secondary cyclins (C and H) in relation to prognosis in breast cancer patients",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1140
3388,Essential functions of the Janus kinase 2 (Jak2) during mammary gland development and tumorigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1125
3389,Gene expression profiling to identify parity-induced changes in the human mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1123
3390,The interaction of the ER with ERBB2 and PI3K results in elevated levels of AKT and p90RSK in tamoxifen-resistant MCF-7 cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1119
3391,"The anti-estrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF7 breast cancer cells refractory to long-term estrogen deprivation through downregulation of ER and IGF signalling",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1117
3392,BRCA1 directly modulates gene expression required for estrogen biosynthesis: a possible mechanism of tissue-specific tumor suppression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1115
3393,Effects of oestrogen on gene expression in the epithelium and stroma of the normal human breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1113
3394,"Mutation screening of BRCA1, BRCA2 and CHEK2*1100delC in Slovak HBOC families",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1089
3395,"High prevalence of a BRCA1 gene founder mutation, 5083del19, in unselected breast–ovarian cancer patients from Southern Italy: genotype–phenotype correlations",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1091
3396,High-density screening of the Zbtb7gene in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1109
3397,A critical need for molecular markers of breast cancer risk and risk reduction,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1111
3398,Association of NCOA3 (AIB1) polymorphisms with breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1107
3399,The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1105
3400,"Comparison of methods for pharmacogenomics: SNaPshot, SNPstream UHT, Nanogen, and RFLP",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1103
3401,Dissection of molecular pathways of cancer by high-throughput biochip technologies and RNA interference,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1086
3402,Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1080
3403,Dynamic imaging of plasticity and escape in tumor cell invasion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1076
3404,Evading p53 action during tumor development and therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1074
3405,Genomic profiling of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1072
3406,Tailored therapies based upon tumor subtype biology,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1070
3407,Apoptotic chemotherapies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1068
3408,Targeting the cell cycle for prognosis and therapy of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1067
3409,Insulin-like growth factor regulation of mammary gland development and tumorigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1066
3410,Stem cells in human breast development and cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1064
3411,Regulation of epithelial cell polarity during carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1062
3412,A breast cancer progression model: the importance of three-dimensional tissue architecture and metalloproteinases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1058
3413,Magnetic resonance spectroscopy of breast cancer tissue used for tumor classification and lymph node prediction,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1193
3414,DNA damage response pathways in cancer causation and treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1049
3415,Characterization of extracellular matrix composition in breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1189
3416,Postoperative serum proteomic profiles and identification of biomarkers with prognosis value in high-risk early breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1184
3417,Detection of circulating cancer cells in peripheral blood as a prognostic factor in early breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1182
3418,Subclassification and molecular characterization of early stage breast carcinomas using Applied Biosystems Human Genome Survey Microarrays,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1157
3419,Application of microarray analyses to identify genes involved in radiation-induced fibrosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1151
3420,Methylation profiling of carcinogenesis-associated genes in sporadic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1147
3421,Epigenetic silencing of tropomyosin alters transforming growth factor beta control of cell invasion and metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1145
3422,Independent prognostic value of somatic TP53gene mutations in 1794 breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1178
3423,Identification of clinically relevant gene sets and pathways using functional models of breast tumor suppression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1143
3424,Deletions at the chromosome 3 common eliminated region 1 on 3p21.3 in human breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1139
3425,Evaluation of the arrayed primer extension resequencing assay for TP53mutation detection,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1180
3426,Mutant p53 exerts its gain of function through activation of the NF-κB pathway,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1176
3427,IL-8 is a novel marker for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1141
3428,Functional characterization of genes involved in the development of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1137
3429,Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1174
3430,Expression of STAT1 target genes and interferon gamma in human mammary carcinoma tissue,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1135
3431,Quality control of DNA with on-chip electrophoresis for oligonucleotide-array comparative genomic hybridization,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1172
3432,Outcome signature genes in breast cancer: is there a unique set?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1168
3433,Altered signaling in anti-estrogen-resistant human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1133
3434,Comparative genomic hybridization using oligonucleotide arrays and total genomic DNA,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1170
3435,Discovering genetic profiles by array-CGH in familial breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1166
3436,"6-(1-oxobutyl)-5,8-dimethoxy-1,4-naphthoquinone exerts anti-angiogenic activity via inhibition of vascular endothelial cell growth factor and hypoxia-inducible factor 1 alpha in hypoxia-exposed MCF breast cancer cells",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1131
3437,Morphogenesis of the mammary gland and the role of keratin expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1204
3438,Imprint as a reliable diagnostic tool in breast cancer and possible usefulness for research purposes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1129
3439,Ex vivo isolation of adult stem cells from normal and tumour mouse mammary parenchyma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1127
3440,Sex-hormone binding globulin receptor-mediated growth inhibition in breast cancer cells: a proteomics approach,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1121
3441,Gene expression profiling in whole-blood samples from postmenopausal women exposed to hormone replacement therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1112
3442,Polymorphisms in the CRK gene and their association with breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1108
3443,ZBTB7 HapMap in a worldwide population study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1110
3444,Alpha-1 antitrypsin genotypes in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1106
3445,Genetic polymorphisms in the 5' flanking region of glutathione S-transferase P1 affect promoter methylation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1104
3446,Chromosome-wide pharmacogenetics: localisation and linkage disequilibrium of genes coding for ROS metabolism and signalling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1102
3447,Who gets cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1099
3448,DNA polymorphisms of several genes and predisposition to breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1100
3449,Oral contraceptives and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1097
3450,Low-dose ionizing radiation significantly increases the risk of breast cancer among BRCA1/2 mutation carriers in the International BRCA1/2 Carrier Cohort Study (IBCCS),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1095
3451,Gene expression signature of hereditary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1160
3452,Hereditary breast cancer – a spectrum of pathogenic mutations and unknown variants of BRCA1 and BRCA2 genes in the Czech Republic: efficiency of testing and clinical follow-up,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1093
3453,Epigenetic silencing of DSC3 is a common event in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1273
3454,Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1261
3455,Early detection of breast cancer based on gene-expression patterns in peripheral blood cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1203
3456,Greatly increased occurrence of breast cancers in areas of mammographically dense tissue,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1260
3457,Impact of intercensal population projections and error of closure on breast cancer surveillance: examples from 10 California counties,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1266
3458,Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1036
3459,"Obesity promotes 7,12-dimethylbenz(a)anthracene-induced mammary tumor development in female zucker rats",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1263
3460,Mammary epithelial cell transformation: insights from cell culture and mouse models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1275
3461,Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1264
3462,Menopausal hormone therapy after breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1272
3463,Somatic mutation and gain of copy number of PIK3CA in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1262
3464,New agents for bone metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1234
3465,Letrozole efficacy is related to human aromatase CYP19 single nucleotide polymorphisms (SNPs) in metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1233
3466,Role of translational studies in optimizing palliative chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1232
3467,The role of Xeloda in metastasic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1230
3468,SOLTI (Solid Tumor Intensification) Group experience with high-dose chemotherapy treatment for early breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1228
3469,Prognostic studies in patients with high-risk primary breast cancer (HRPBC) receiving high-dose chemotherapy (HDC),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1226
3470,Adjuvant chemotherapy for operable breast cancer: old vs new schema,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1225
3471,Classical versus new prognostic factors for adjuvant treatment selection based on line software to estimate risk and benefit,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1224
3472,Tamoxifen resistance and adjuvant hormone therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1223
3473,Neoadjuvant treatment: the MD Anderson experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1222
3474,Preoperative hormonal therapy: results and implications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1220
3475,Chemoprevention: beyond tamoxifen,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1219
3476,Radiotherapy in early stage invasive breast cancer: current tendencies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1218
3477,"[ASCRIT] Antisense chemoradioimmunotherapy consisting of anti-POEM (Arg-Gly-Asp) scFv linked onto high-energy radioisotopes, vinorelbine-tartrate and 21-nucleotide double-stranded siRNA targeted to DNMT1 induce apoptosis in metastatic breast cancer (MBC) characterized by hypermethylated p53, p16, RASSF1A, RAR-b2, BRCA2, H1C1, ESRI1, CDH1, Trbeta1, GSTP1, CCND2 and overexpression of bcl-2, cdc25c, Raf-1 and α8β1 integrin",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1247
3478,Simultaneous breast reconstruction,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1217
3479,Expression of c-met gene in invasive ductal carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1246
3480,The axillary study with ultrasound and cytological puncture with fine needle in invasive breast cancer.,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1245
3481,Simultaneous reconstructive surgery for radical mastectomy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1214
3482,A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1244
3483,Circulating tumor cells and novel biomarkers for prognostic and biological of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1213
3484,A performance study of different soft-computing procedures for automatic detection of breast cancer malignancy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1243
3485,Minimal residual disease (MRD) in the bone marrow in ER-α-positive primary breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1212
3486,"Breast cancer-screening programme amongst unpriviledged women in Charleroi (Hainaut), Belgium",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1242
3487,The roles of PET and CT/PET as preoperative studies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1211
3488,Adjuvant radiotherapy after surgery in breast cancer: evaluation of acute toxicity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1241
3489,The role of magnetic resonance imaging as an imaging tool to assess disease status and residual disease in locally advanced breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1210
3490,Clinical profile and management of bilateral breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1240
3491,Present situation and future of genetic profiling for prognosis and treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1209
3492,"6-(1-oxobutyl)-5,8-dimetoxy-1,4-naphthoquinone inhibits the growth of MCF-7 cells via inhibition of angiogenesis and hypoxia inducible factor alpha",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1239
3493,Gene expression profile-based predictors of response to chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1208
3494,Nanoparticulate paclitaxel loaded into sterically stabilized mixed phospholipid micelles to improve chemotherapy of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1238
3495,Fibroadenoma of breast in Iranian women between 1994 and 2004,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1237
3496,Methods for gene expression profiling in clinical trials for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1207
3497,Gene expression profiles and molecular classification to predict distant metastasis and tamoxifen-resistant breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1206
3498,Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1236
3499,Cyclo-oxygenase-2 expression is associated with poor clinical outcome after doxorubicin-based chemotherapy in node-positive breast cancer: integration of tissue microarray,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1235
3500,The role of gene expression profiling by microarray analysis for prognostic classification of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1205
3501,Targeting the right chemotherapy for the right patient,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1231
3502,Oral vinorelbine in metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1229
3503,Efficacy of high-dose alkylating chemotherapy in the adjuvant treatment of HER2/neu-negative primary breast cancer: update of the Dutch randomized trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1227
3504,Primary chemotherapy for operable breast cancer: the NSABP experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1221
3505,Partial breast irradiation: why and how,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1216
3506,Sentinel node biopsy versus conventional axillary dissection in clinically node-negative breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1215
3507,Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1200
3508,Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1259
3509,Laminin isoform expression in breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1270
3510,Accelerated partial breast irradiation: a valid choice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1269
3511,Estrogen-repressed genes – key mediators of estrogen action?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1271
3512,Prime–boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+metastatic breast cancer in mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1199
3513,Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1035
3514,Alternative initiation and splicing in dicer gene expression in human breast cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1043
3515,"Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case–control study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1039
3516,"Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1198
3517,Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1042
3518,"CYP17genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1040
3519,Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1201
3520,Imaging in breast cancer: Magnetic resonance spectroscopy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1202
3521,"Erratum to: Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1265
3522,Genetic polymorphisms in the matrix metalloproteinase 12 gene (MMP12) and breast cancer risk and survival: the Shanghai Breast Cancer Study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1033
3523,TP53-binding protein variants and breast cancer risk: a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1038
3524,Mutation analysis of the ATRgene in breast and ovarian cancer families,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1037
3525,Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1041
3526,"Designing a HER2/neupromoter to drive α1,3galactosyltransferase expression for targeted anti-αGal antibody-mediated tumor cell killing",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1034
3527,Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague–Dawley rat,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1031
3528,Effects of milk fermented by Lactobacillus helveticusR389 on a murine breast cancer model,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1032
3529,Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1025
3530,Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1028
3531,CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case–control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1027
3532,Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivodetection of mammary tumors and multiple metastases in immune deficient mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1026
3533,Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1020
3534,The protective role of pregnancy in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1029
3535,Overexpression of β1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1011
3536,Endocrinology and hormone therapy in breast cancer: Selective oestrogen receptor modulators and downregulators for breast cancer – have they lost their way?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1023
3537,"Keystone symposium: The role of microenvironment in tumor induction and progression, Banff, Canada, 5–10 February 2005",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1030
3538,Accelerated partial breast irradiation: technically feasible but who will benefit?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1016
3539,Accelerated partial breast irradiation: the case for current use,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr992
3540,Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1019
3541,"Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1022
3542,"Morrow M, Jordan VC: Managing Breast Cancer Risk. 1st Edition. Hamilton, Ontario: BC Decker Inc",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1024
3543,The promise of microarrays in the management and treatment of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1018
3544,Microarrays and breast cancer clinical studies: forgetting what we have not yet learnt,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1017
3545,"Mammary stem cells, self-renewal pathways, and carcinogenesis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1021
3546,Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1015
3547,A case-only analysis of the interaction between N-acetyltransferase 2 haplotypes and tobacco smoke in breast cancer etiology,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1013
3548,c-erbB2 and topoisomerase IIα protein expression independently predict poor survival in primary human breast cancer: a retrospective study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1012
3549,The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1006
3550,Breast cancer and childhood anthropometry: emerging hypotheses?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1014
3551,A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1004
3552,The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1009
3553,Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1005
3554,Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1001
3555,Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr999
3556,Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr998
3557,"Assessment of the proliferative, apoptotic and cellular renovation indices of the human mammary epithelium during the follicular and luteal phases of the menstrual cycle",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr994
3558,Articles selected in January 2005,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1008
3559,Show me the genes – I will tell you who/how to treat!,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1010
3560,Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1002
3561,Dose-dense adjuvant chemotherapy for primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1007
3562,Do breast implants after a mastectomy affect subsequent prognosis and survival?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1003
3563,"Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr983
3564,"Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague–Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr989
3565,Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr993
3566,Clonogenic growth of human breast cancer cells co-cultured in direct contact with serum-activated fibroblasts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr995
3567,Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situhybridization and immunohistochemistry,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr996
3568,Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr991
3569,Therapy of breast disease: experts' overview,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1000
3570,Update on inflammatory breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr997
3571,Claudin 7 expression and localization in the normal murine mammary gland and murine mammary tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr988
3572,Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationships,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr978
3573,"SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case–control study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr976
3574,Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case–control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr982
3575,Clinical trial update: National Cancer Institute of Canada,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr979
3576,The challenge of measuring circulating estradiol at low concentrations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr987
3577,"Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr980
3578,High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr977
3579,Breast implants following mastectomy in women with early-stage breast cancer: prevalence and impact on survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr974
3580,Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr975
3581,Determining sensitivity to rapamycin and its analogues in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr985
3582,Recent translational research: computational studies of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr981
3583,Erratum to: Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr990
3584,The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr971
3585,Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr973
3586,Atm heterozygous deficiency enhances development of mammary carcinomas in p53heterozygous knockout mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr968
3587,Articles selected in November 2004,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr986
3588,Letrozole sensitizes breast cancer cells to ionizing radiation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr969
3589,Alphavirus replicon particles containing the gene for HER2/neuinhibit breast cancer growth and tumorigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr962
3590,Membrane estrogen receptor-α levels predict estrogen-induced ERK1/2 activation in MCF-7 cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr959
3591,New highlights on stroma–epithelial interactions in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr972
3592,Membrane estrogen receptor-α levels in MCF-7 breast cancer cells predict cAMP and proliferation responses,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr958
3593,Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr963
3594,Hypersensitive K303R oestrogen receptor-α variant not found in invasive carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr965
3595,Radiation and breast cancer: a review of current evidence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr970
3596,"Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr953
3597,Do early premalignant changes in normal breast epithelial cells predict cancer development?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr967
3598,Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr954
3599,Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr951
3600,Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr949
3601,Prenylation inhibitors stimulate both estrogen receptor α transcriptional activity through AF-1 and AF-2 and estrogen receptor β transcriptional activity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr956
3602,Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr948
3603,Towards an integrated model for breast cancer etiology: The crucial role of the number of mammary tissue-specific stem cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr966
3604,Systemic chemotherapy induces microsatellite instability in the peripheral blood mononuclear cells of breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr950
3605,The p53-dependent apoptotic pathway of breast cancer cells (BC-M1) induced by the bis-type bioreductive compound aziridinylnaphthoquinone,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr939
3606,p21-activated kinase signaling in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr961
3607,"Aromatase 2004, Edinburgh, UK, 6-8 September 2004",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr964
3608,Deficits in plasma oestradiol measurement in studies and management of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr960
3609,"Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: a population-based case-control study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr941
3610,Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr940
3611,Articles selected in September 2004,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr955
3612,"The 6th Milan Breast Cancer Conference, Milan, Italy, 16–18 June 2004",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr943
3613,Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr937
3614,An early peak of relapse after surgery for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr946
3615,"Bland K, Copeland E: The Breast, 3rd edition. London, Saunders; 2003. 1628 pp.",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr952
3616,"Location, location, location: regulation of breast cancer progression by the microenvironment",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr957
3617,Ratios of involved nodes in early breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr934
3618,Proteotypic classification of spontaneous and transgenic mammary neoplasms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr930
3619,"American Society for Clinical Oncology 40th Annual Meeting, New Orleans, LA, 5–8 June 2004: breast cancer highlights",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr944
3620,Endocrinology and hormone therapy in breast cancer: Aromatase inhibitors versus antioestrogens,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr945
3621,New targets for therapy in breast cancer: Farnesyltransferase inhibitors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr947
3622,Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr942
3623,Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr936
3624,"Birthweight, parental age, birth order and breast cancer risk in African-American and white women: a population-based case–control study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr931
3625,"Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr929
3626,Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr935
3627,The progesterone receptor Val660→Leu polymorphism and breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr928
3628,"Frequency of CHEK2 mutations in a population based, case–control study of breast cancer in young women",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr933
3629,The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr938
3630,"The Na+–H+exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr922
3631,The changing global patterns of female breast cancer incidence and mortality,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr932
3632,Articles selected in July 2004,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr925
3633,Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr920
3634,"Lee L, Stickland V, Wilson R, Evans A: Fundamentals of Mammography, 2nd edition. London, Churchill Livingstone",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr926
3635,New targets for therapy in breast cancer: Mammalian target of rapamycin (mTOR) antagonists,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr927
3636,Aspirin and breast cancer prevention – a link to ER status,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr923
3637,"Towards an integrated model for breast cancer etiology: The lifelong interplay of genes, lifestyle, and hormones",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr921
3638,Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr918
3639,Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu status,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr915
3640,Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr914
3641,p14ARF expression in invasive breast cancers and ductal carcinoma in situ– relationships to p53 and Hdm2,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr912
3642,Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr898
3643,New targets for therapy in breast cancer: Small molecule tyrosine kinase inhibitors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr919
3644,"A retinoid X receptor (RXR)-selective retinoid reveals that RXR-α is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr913
3645,EMSY links breast cancer gene 2 to the 'Royal Family',http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr916
3646,Recent translational research: microarray expression profiling of breast cancer – beyond classification and prognostic markers?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr917
3647,The four-tier system: the ups and downs of getting there,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr865
3648,The amalgamation of two breast imaging units in Leeds,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr864
3649,Chemoprevention for breast cancer: current status,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr851
3650,Mammographic screening with a breast cancer prevention programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr821
3651,Quality assurance of routinely collected data in the Computer Aided Detection Evaluation Trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr896
3652,The value of three-dimensional (3D) ultrasound examination in the assessment of small breast tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr894
3653,The effect of age and breast density on the sensitivity of mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr892
3654,Maintaining standards through coordinated follow-up of Quality Assurance (QA) Team visit recommendations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr890
3655,The value of arbitration in a breast screening programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr888
3656,The relevance of clinical audit results to commissioning services,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr886
3657,Audit of stereotactic core biopsies for microcalcification,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr884
3658,Mammographic tumour features can reliably predict the long-term outcome of women with 1–14 mm invasive breast cancer: suggestions for revision of current therapeutic practice and the TNM classification system,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr882
3659,Reclassification of interval cancers and implications for disclosure of audit,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr880
3660,The usefulness of diffuse pattern of distribution in 99mTc-(V) DMSA scintimammography in the evaluation of in situ breast carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr878
3661,Ductal carcinoma in situ (DCIS): the role of prognostic indicators in informing treatment and reducing local recurrence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr876
3662,BreastScreen Australia's experience taking services to rural and remote areas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr874
3663,Maximising the effectiveness of routine quality assurance team visits,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr873
3664,Monitoring radiographic data within the West Midlands National Health Service Breast Screening Programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr872
3665,A pilot's life for us,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr871
3666,General practitioner (GP) practices' perceptions of breast screening within the West Midlands,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr870
3667,Women's experiences of mammography within the West Midlands Breast Screening Programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr869
3668,Equity of access to breast and cervical screening for women with learning disabilities,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr868
3669,Are you getting in on the Act?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr867
3670,The road to ISO 9001:2000,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr866
3671,Cysts: are they always benign?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr863
3672,Breast compression revisited,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr862
3673,Image-guided interventional procedures of the breast: the development and delivery of a postgraduate programme of study from an academic and clinical perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr861
3674,The impact of digital stereotactic devices on examination times,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr859
3675,Phantom experiments for measuring elasticity of breast cancer by the echo technique,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr857
3676,Computer-aided detection (CAD): the case against,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr855
3677,Digital imaging: technical developments and UK perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr853
3678,Radiological results of the Age Trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr849
3679,Overview of recent changes to the National Health Service Breast Screening Programme (NHSBSP): impact on the service,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr847
3680,Workforce issues,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr845
3681,Ductal carcinoma in situ (DCIS): are we overtreating it?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr843
3682,"How spiculation affects the likelihood of malignancy in screen-detected masses: a review of 974 masses excised in the first 8 years of the East Sussex, Brighton & Hove Breast Screening Service",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr841
3683,Radiological and histological features of mammography screen-detected lesions having undergone benign surgical excision,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr840
3684,Screen-detected lobular carcinoma in situ (LCIS) of the breast: 166 cases within the National Health Service Breast Screening Programme (NHSBSP),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr839
3685,Can high-frequency ultrasound predict metastatic lymph nodes in patients with invasive breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr837
3686,The use of bilateral whole breast ultrasound to identify multifocal disease in newly diagnosed breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr836
3687,"Scintimammographic findings with 99mTc-(V)DMSA and 99mTc-MIBI in usual-type ductal epithelial hyperplasia (HUT) and apocrine metaplasia (AM) of the breast, in relation with the cell proliferation index (Ki-67) and the presence of estrogen receptors (ERs)",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr835
3688,Using magnetic resonance to diagnose breast cancer and predict therapeutic response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr834
3689,Size distribution of screen-detected and interval cancers according to breast density suggests reduced screening benefit for women with higher density breasts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr833
3690,"Hormone replacement therapy, percent mammographic density and the sensitivity of mammography",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr832
3691,Determinants of false positive recall rates in an Australian mammographic screening programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr831
3692,A 3-year audit of radiographer screen film reading,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr830
3693,Breast screening radiographers and radiologists: performance and confidence levels on the PERFORMS film sets,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr829
3694,Quality management: the key to achievement for the BreastScreen Australia Programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr828
3695,A case–control study to estimate the impact on breast cancer death of the breast screening programme in Wales,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr827
3696,The impact of mammographic screening on breast cancer mortality: overview of the evidence so far,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr826
3697,Biopsied in the USA,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr825
3698,Critical incident reporting in the National Health Service breast units,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr824
3699,Sonographic evaluation of solid breast nodules,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr822
3700,Developing new treatments for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr820
3701,Design of a retrospective study of computer-aided detection in mammographic screening: Computer Aided Detection Evaluation Trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr895
3702,Can the sensitivity/specificity of reporting indeterminate breast calcifications be improved?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr893
3703,Prospective estimation of rates of change in mammographic parenchymal patterns: influence of age and of hormone replacement (HRT) therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr891
3704,Assessment clinics at 'Avon Breast Screening Unit': what has changed in 5 years?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr889
3705,West Midlands screening histories project: methodology and use as an audit tool,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr887
3706,Lobular neoplasia diagnosed on stereotactic core biopsy: a management conundrum?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr885
3707,Screening-mammography-detected lesions undergoing benign surgical excision: review of mammography features and preoperative needle biopsy results,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr883
3708,The incidence of interval breast cancers from Wirral Breast Screening Unit between 1 January 1994 and 30 June 2000,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr881
3709,A review of interval cancers previously assessed in a mammographic screening programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr879
3710,Ductal carcinoma in situ (DCIS) down under: patterns of diagnosis and treatment in BreastScreen Victoria,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr877
3711,Breast cancer follow-up: a radiographer-led service,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr875
3712,Compression/encryption technology applied to Dicom/digitised mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr860
3713,The management of X-ray quality control data in mammography applications: an information technology approach to solving the problem,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr858
3714,Sonographic assessment of extent and aggressiveness of malignant breast disease,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr856
3715,Computer-aided detection (CAD): the case for,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr854
3716,Digital imaging: Digital Mammography Imaging Screening Trial Project,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr852
3717,Pathology results from the UK Age Trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr850
3718,Interim results from the Age Trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr848
3719,Two-view mammography: the Welsh experience and overview,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr846
3720,The Sloane Project,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr844
3721,Ductal carcinoma in situ (DCIS): are we overdetecting it?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr842
3722,Trends and predictors of size and grade for ductal carcinoma in situ (DCIS) in BreastScreen Victoria,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr838
3723,Patient safety: why do things go wrong?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr823
3724,Experimental manipulation of radiographic density in mouse mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr901
3725,Low-molecular-weight cyclin E: the missing link between biology and clinical outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr905
3726,Chromosomal instability and lack of cyclin E regulation in hCdc4 mutant human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr900
3727,Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-β and Neu pathway signaling studies: identification of a novel model for TGF-β-induced epithelial-to-mesenchymal transition,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr907
3728,Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr899
3729,"UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr818
3730,Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr815
3731,A multigene RT-PCR assay used to predict recurrence in early breast cancer: two presentations with contradictory results,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr911
3732,"Russo J, Russo IH: Molecular Basis of Breast Cancer: prevention and treatment. Berlin, Heidelberg, New York, Springer-Verlag",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr908
3733,Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr819
3734,Does diet affect breast cancer risk?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr909
3735,Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr906
3736,"Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr814
3737,Addition of granulocyte-colony stimulating factor (G-CSF) may further increase chemosensitive state in premenopausal node-positive breast cancer patients with induced angiogenesis after surgery,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr903
3738,Introducing Breast Cancer Research's updates on clinical trials,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr810
3739,Expression of hypoxia-inducible factor-1α and cell cycle proteins in invasive breast cancer are estrogen receptor related,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr813
3740,Extreme growth factor signalling can promote oestrogen receptor-α loss: therapeutic implications in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr904
3741,"Does the act of surgery provoke activation of ""latent"" metastases in early breast cancer?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr902
3742,Oestrogen receptor α gene haplotype and postmenopausal breast cancer risk: a case control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr811
3743,Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-α activation via the mitogen-activated protein kinase pathway,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr812
3744,Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case–control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr809
3745,Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr808
3746,S100A7 and the progression of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr816
3747,Articles selected in May 2004,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr817
3748,Frequency of the ATM IVS10-6T→G variant in Australian multiple-case breast cancer families,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr806
3749,Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr802
3750,The DNMT3B C→T promoter polymorphism and risk of breast cancer in a British population: a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr807
3751,"The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr801
3752,"Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16–20 March 2004",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr805
3753,Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr804
3754,"No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr803
3755,Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr798
3756,"Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr797
3757,Chemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sites,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr799
3758,Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr794
3759,Promoter methylation regulates cyclooxygenase expression in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr793
3760,S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situof the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr791
3761,First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr790
3762,Conjugated docosahexaenoic acid suppresses KPL-1 human breast cancer cell growth in vitro and in vivo: potential mechanisms of action,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr789
3763,Breast cancer research and the European Union Clinical Trials Directive,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr800
3764,The Icelandic founder mutation BRCA2 999del5: analysis of expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr785
3765,Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neuin a murine mammary carcinoma model,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr787
3766,Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case–control study of African Americans and whites,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr786
3767,Isoflavones and women's health,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr796
3768,Essential function for ErbB3 in breast cancer proliferation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr792
3769,Complementary yet distinct roles for oestrogen receptor-α and oestrogen receptor-β in mouse mammary epithelial proliferation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr795
3770,"Tavassoli FA, Devilee P: Pathology and Genetics: Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours series - volume IV. Lyon, France: IARC Press",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr788
3771,Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr784
3772,Epidermal growth factor suppresses induction by progestin of the adhesion protein desmoplakin in T47D breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr780
3773,Recent translational research: antiangiogenic therapy for breast cancer – where do we stand?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr782
3774,Phyto-oestrogens and breast cancer chemoprevention,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr781
3775,Induction by transforming growth factor-β1 of epithelial to mesenchymal transition is a rare event in vitro,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr778
3776,Changes in magnetic resonance mammography due to hormone replacement therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr779
3777,Prognostic molecular markers in early breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr777
3778,Study design: Evaluating gene–environment interactions in the etiology of breast cancer – the WECARE study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr771
3779,Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr775
3780,A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr774
3781,Identification of signaling pathways in early mammary gland development by mouse genetics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr776
3782,Outcome and Human Epithelial Growth Factor Receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr783
3783,Articles selected in February 2004,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr769
3784,Estrogen receptor-α polymorphism in a Taiwanese clinical breast cancer population: a case–control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr770
3785,Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr768
3786,"Red clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr773
3787,Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr767
3788,"DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-α, ER-β and androgen receptor status",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr766
3789,Multistep tumorigenesis and the microenvironment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr772
3790,Evolving views of involution,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr765
3791,"Donegan WL, Spratt JS: Cancer of the Breast 5th Edition. London, UK: Elsevier Science Ltd.; 2002. 1050pp",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr764
3792,Transforming growth factor-β induces Cdk2 relocalization to the cytoplasm coincident with dephosphorylation of retinoblastoma tumor suppressor protein,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr762
3793,"26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3–6 December 2003: update on clinical research",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr761
3794,A fly's eye view of tumor progression and metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr763
3795,Ductal approaches to assessment and management of women at high risk for developing breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr759
3796,Articles selected in December 2003,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr760
3797,"26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3–6 December 2003: update on preclinical and translational research",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr758
3798,Malignant myoepithelial cells are associated with the differentiated papillary structure and metastatic ability of a syngeneic murine mammary adenocarcinoma model,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr757
3799,WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr755
3800,"AACR Special Conference: SNPs, haplotypes, and cancer – applications in molecular epidemiology, Key Biscayne, Florida, USA, 13–17 September 2003",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr756
3801,Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr754
3802,"Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr753
3803,Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr752
3804,Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr751
3805,Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr746
3806,Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr745
3807,Prevention of breast cancer by recapitulation of pregnancy hormone levels,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr750
3808,Are BRCA1- and BRCA2-related breast cancers associated with increased mortality?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr748
3809,"AACR Special Conference: Advances in Breast Cancer Research – Genetics, Biology, and Clinical Implications, Huntington Beach, California, USA, 8–12 October 2003",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr747
3810,Introducing the concept of breast cancer stem cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr749
3811,Technology review: The use of electrical impedance scanning in the detection of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr744
3812,The diagnosis and management of pre-invasive breast disease: editor's reply,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr741
3813,Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr734
3814,Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr742
3815,Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr738
3816,Expression of androgen receptor and prostate-specific antigen in male breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr733
3817,The diagnosis and management of pre-invasive breast disease: another point of view,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr740
3818,Articles selected from Faculty of 1000 in November 2003,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr743
3819,Akt2: a role in breast cancer metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr739
3820,"Models of breast cancer: quo vadis, animal modeling?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr723
3821,Microarrays bring new insights into understanding of breast cancer metastasis to bone,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr736
3822,"8th Nottingham International Breast Cancer Conference, Nottingham, UK, 16–19 September 2003",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr735
3823,Wnt signalling via the epidermal growth factor receptor: a role in breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr737
3824,A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr658
3825,"Interleukin-2 and its receptor complex (α, β and γ chains) in in situand infiltrative human breast cancer: an immunohistochemical comparative study",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr730
3826,Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr722
3827,Radiotherapeutic use of 2-deoxy-2-[18F]fluoro-D-glucose – a comment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr728
3828,Positron emitting 18F-2-deoxy-2-fluoro-D-glucose: potential 'hot' new therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr725
3829,Breast Cancer Therapy Annual – today's drug treatment of cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr727
3830,The diagnosis and management of pre-invasive breast disease: Promise of new technologies in understanding pre-invasive breast lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr655
3831,The diagnosis and management of pre-invasive breast disease Genetic alterations in pre-invasive lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr650
3832,The diagnosis and management of pre-invasive breast disease Problems associated with management of pre-invasive lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr649
3833,The diagnosis and management of pre-invasive breast disease: The role of new diagnostic techniques,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr721
3834,Microarray technology and its effect on breast cancer (re)classification and prediction of outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr732
3835,"Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr657
3836,Are herbal remedies and dietary supplements safe and effective for breast cancer patients?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr724
3837,"Cytoplasmic p21
WAF1/CIP1
 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr654
3838,Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr653
3839,CTLA-4 based therapy (MDX-010),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr731
3840,From gene expression patterns to antibody diagnostics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr719
3841,Target discovery in the postgenomic era,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr717
3842,Hormonal interactions during mammary gland development,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr693
3843,Genetic determinants of susceptibility to estrogen-induced mammary cancer in the rat,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr691
3844,Genetically engineered mouse models of human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr689
3845,Transgenic models are predictive: the herceptin and flavopiridol experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr687
3846,Synergy between the erbB and transforming growth factor beta signaling networks: implications for molecular therapeutics in human neoplasia,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr685
3847,The comparative genetics and genomics of cancer: of mice and men,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr683
3848,Clinical breast cancer and estrogen,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr677
3849,Articles selected from Faculty of 1000 in July 2003,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr630
3850,Mouse models of human breast cancer: evolution or convolution?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr660
3851,Combined hormonal therapy for advanced breast cancer in postmenopausal patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr729
3852,Clinical applications of Affymetrix Genechip arrays for RNA and DNA analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr720
3853,Rational engineering of Fc/Fc receptor interactions to improve antibody potency,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr718
3854,Genomic approaches to drug target discovery using mouse models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr716
3855,Meta-analyses of transcriptional information: impact of data integration in understanding human breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr714
3856,Mouse models for pretesting of immunotherapeutic strategies for cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr713
3857,Immunotherapy of cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr712
3858,Prevention of breast tumor angiogenesis and metastasis by cytostatic molecules in relevant mouse models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr711
3859,Functional characterization of mammary stem cells in development and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr710
3860,Stem cells in normal breast development and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr709
3861,"Characterization, isolation and cultivation of distinctive human breast cell populations",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr708
3862,Regulation of human mammary stem cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr707
3863,In situ to invasive carcinoma transition: escape or release,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr706
3864,"Premalignancy in the human breast: how is it defined, is morphology good enough?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr705
3865,Mammary intraepithelial neoplasia outgrowths (MINO): MINO and human ductal carcinoma in situ,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr704
3866,Preneoplasia in mouse models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr703
3867,Advanced imaging and detection R&D in the Center for Biophotonics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr702
3868,Ultrasound imaging of tumor perfusion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr701
3869,Imaging angiogenesis in early stages of breast cancer using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr700
3870,Imaging mouse models of breast cancer with positron emission tomography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr699
3871,A hybrid functional/anatomical imaging system for high-throughput planar projection mouse imaging,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr698
3872,Using genomic similarities and differences to interpret mouse models of human development and cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr697
3873,Germline mutations in DNA repair and cell cycle checkpoint genes: consequential somatic gene alterations and genome instability,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr696
3874,"Expression profiling of breast cancer, influence of tumor genotype and patient genotype",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr695
3875,Function of LEF1 in early mammary development,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr694
3876,Transforming growth factor β's role in mammary gland development and carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr692
3877,Role of differentiation in carcinogenesis and cancer prevention,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr690
3878,Modeling breast cancer in the rat: a method to produce knockout rats,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr688
3879,"The mouse in preclinical trials: transgenic, carcinogen-induced, or xenograph models – which to use?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr686
3880,Proof-of-concept in vivo evaluation of targeted therapeutics: lessons from immunoliposomes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr684
3881,The molecular biology of mammary intraepithelial neoplasia outgrowths,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr682
3882,The ErbB receptor tyrosine kinases and their roles in cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr680
3883,Pregnancy levels of estrogen prevents breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr678
3884,Development of a transgenic mouse line for the evaluation of the androgen receptor activity in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr676
3885,Use of mouse models to validate and therapeutically target transforming growth factor beta as an important player in breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr675
3886,Role of animal models in oncology drug discovery,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr674
3887,Herceptin-sensitivity of HER2-transgenic mouse mammary tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr673
3888,Genetically modified cancer models: the value of luciferase-tagged tumors and in vivo luciferase-based reporter assays in oncology drug discovery,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr672
3889,Positron emission tomography and X-ray computed tomography: tools for mouse phenotyping?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr671
3890,Articles selected from Faculty of 1000 in September 2003,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr659
3891,Mammary pathology of the genetically engineered mouse,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr670
3892,Whole Slide Imaging and telepathology,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr669
3893,Advanced immunophenotyping: more is better!,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr668
3894,Genetically altered mice and cancer research: effects of the other 99.999% of the genome and other variables upon phenotype,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr667
3895,The Mutant Mouse Regional Resource Center Program,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr666
3896,Genetic manipulation of the mammary gland by transplantation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr665
3897,Reversibility and progression in conditional transgenic mouse models of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr664
3898,Integrin-mediated signal transduction in transgenic mouse models of human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr663
3899,Mouse models for BRCA1-associated breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr662
3900,Estrogen receptor alpha-positive and negative mouse mammary tumors through somatic mutations of p53 in mammary carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr661
3901,Should all adjuvant breast cancer patients receive a bisphosphonate?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr648
3902,"5th Milan Breast Cancer Conference, Milan, Italy, 11–13 June 2003",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr639
3903,The diagnosis and management of pre-invasive breast disease: Pathological diagnosis – problems with existing classifications,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr629
3904,"The diagnosis and management of pre-invasive breast disease: Flat epithelial atypia – classification, pathologic features and clinical significance",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr625
3905,The diagnosis and management of pre-invasive breast disease: Pathology of atypical lobular hyperplasia and lobular carcinoma in situ,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr624
3906,The diagnosis and management of pre-invasive breast disease: Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) – current definitions and classification,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr623
3907,The diagnosis and management of pre-invasive breast disease: Radiological diagnosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr621
3908,"The diagnosis and management of pre-invasive breast disease – current challenges, future hopes",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr641
3909,Oestrogen exposure and breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr628
3910,"The thyroid, iodine and breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr638
3911,Breast cancer in Marin County,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr633
3912,Advances in breast cancer treatment and prevention: preclinical studies on aromatase inhibitors and new selective estrogen receptor modulators (SERMs),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr626
3913,Can the stroma provide the clue to the cellular basis for mammographic density?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr642
3914,ADAM metalloproteases and EGFR signalling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr637
3915,β class II tubulin predominates in normal and tumor breast tissues,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr631
3916,A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr635
3917,Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr627
3918,Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr620
3919,Mammographic density is related to stroma and stromal proteoglycan expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr622
3920,"BRCA2mutation carriers, reproductive factors and breast cancer risk",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr619
3921,First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr618
3922,Breast cancer in association with thyroid disorders,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr609
3923,VelociGene: a high-throughput approach for functionizing the genome via custom gene mutation and high-resolution expression analysis in mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr715
3924,Predicting breast cancer behavior by microarray analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr681
3925,Steroid regulation of breast cancer cell proliferation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr679
3926,aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr652
3927,E-cadherin expression in primary carcinomas of the breast and its distant metastases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr651
3928,"Robertson JFR, Nicholson RI, Hayes DF:Endocrine Therapy of Breast Cancer. London, UK: Martin Dunitz; 2002. 296pp.",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr656
3929,"American Society for Clinical Oncology 39thAnnual Meeting, Chicago, Illinois, USA, 31 May to 3 June 2003: Breast cancer neoadjuvant and adjuvant chemotherapy – prognostic and predictive markers",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr647
3930,Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr644
3931,Inflammatory breast cancer: Clinical progress and the main problems that must be addressed,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr608
3932,Introducing a new section to Breast Cancer Research: Endocrinology and hormone therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr646
3933,Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr643
3934,Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr640
3935,Models of breast cancer: is merging human and animal models the future?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr645
3936,Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr634
3937,Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2mutation status,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr632
3938,Health food store recommendations: implications for breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr636
3939,Breast Cancer Research: the move to introduce article-processing charges,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr617
3940,"Expert Group: IARC Handbooks of Cancer Prevention. Vol.7: Breast Cancer Screening. Lyon, France: IARC; 2002. 248pp.",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr616
3941,Host microenvironment in breast cancer development: Epithelial-cell–stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr615
3942,Structure of HER receptors and intracellular localisation of downstream effector elements gives insight into mechanism of tumour growth promotion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr613
3943,Conditional mouse models demonstrate oncogene-dependent differences in tumor maintenance and recurrence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr614
3944,"8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr611
3945,"c-myc, not her-2/neu, can predict the prognosis of breast cancer patients: how novel, how accurate, and how significant?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr606
3946,Breast cancer patients with bone metastases are characterised by increased levels of nonisomerised type I collagen fragments,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr607
3947,"Correlation of expression of BP1, a homeobox gene, with estrogen receptor status in breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr602
3948,Submitting articles online to Breast Cancer Research,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr612
3949,Lack of evidence for an association of Epstein–Barr virus infection with breast carcinoma – authors' response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr604
3950,Lack of evidence for an association of Epstein–Barr virus infection with breast carcinoma – another point of view,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr599
3951,Pregnancy-induced changes in cell-fate in the mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr603
3952,Nuclear localization and function of polypeptide ligands and their receptors: a new paradigm for hormone specificity within the mammary gland?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr601
3953,Risk factors for breast cancer in a population with high incidence rates,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr605
3954,Inflammatory breast cancer: Relationship between growth factor signaling and motility in aggressive cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr598
3955,The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr593
3956,p27KIP1phosphorylation by PKB/Akt leads to poor breast cancer prognosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr596
3957,Introducing Viewpoints – Breast Cancer Research'snew style literature appraisal service,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr600
3958,The future of cytotoxic therapy: selective cytotoxicity based on biology is the key,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr597
3959,"42nd Annual Meeting of the American Society for Cell Biology, San Francisco, California, USA, 14–18 December 2002",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr590
3960,Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr589
3961,Inflammatory breast cancer: Vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr585
3962,Host microenvironment in breast cancer development: Extracellular matrix–stromal cell contribution to neoplastic phenotype of epithelial cells in the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr580
3963,Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr584
3964,Familial breast cancer and the hCHK2 1100delC mutation: assessing cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr582
3965,C766T low-density lipoprotein receptor-related protein 1 (LRP1) gene polymorphism and susceptibility to breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr591
3966,Detection of hepatocyte growth factor/scatter factor receptor (c-Met) in axillary drainage after operations for breast cancer using reverse transcriptase–polymerase chain reaction,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr588
3967,Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr587
3968,Adolescent diet and risk of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr583
3969,"Polarity determination in breast tissue: desmosomal adhesion, myoepithelial cells, and laminin 1",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr579
3970,"25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10–14 December 2002 Update on clinical research",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr576
3971,"25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10–14 December 2002 Update on preclinical and translational research",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr575
3972,New insights into the biological function of BRCA2 from its structural interactions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr581
3973,Host microenvironment in breast cancer development: Epithelial–mesenchymal transition in breast cancer development,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr578
3974,"Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr574
3975,Breast cancer cell lines: friend or foe?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr577
3976,Host microenvironment in breast cancer development Inflammatory and immune cells in tumour angiogenesis and arteriogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr573
3977,The prolyl isomerase Pin1 in breast development and cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr572
3978,Is there a role for Notch signalling in human breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr559
3979,A candidate metastasis-associated DNA marker for ductal mammary carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr571
3980,"CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr570
3981,Akt kinases in breast cancer and the results of adjuvant therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr569
3982,"C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr568
3983,Id-1 is not expressed in the luminal epithelial cells of mammary glands,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr560
3984,Articles selected from Faculty of 1000 in May 2003,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr610
3985,Articles selected from Faculty of 1000 in March 2003,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr595
3986,Articles selected from Faculty of 1000 in January 2003,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr594
3987,Articles selected from Faculty of 1000 in October 2002,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr565
3988,Six SPORE PIs have joined Breast Cancer Research's Editorial Board,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr586
3989,β-Catenin: a transforming actor on many stages,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr566
3990,Waist–hip ratio and breast cancer risk in urbanized Nigerian women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr567
3991,Centrosome cycle studies reveal promising candidates for anti-cancer drug design,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr564
3992,Expression profiling predicts outcome in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr562
3993,"Department of Defense Era of Hope Meeting, Orlando, Florida, USA, 25–28 September 2002",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr558
3994,"Intrauterine environment, mammary gland mass and breast cancer risk",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr555
3995,"Host microenvironment in breast cancer development: Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor–microenvironment interactions",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr554
3996,BAD: a good therapeutic target?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr552
3997,Expression profiling to predict outcome in breast cancer: the influence of sample selection,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr548
3998,The role of the ubiquitination-proteasome pathway in breast cancer: Use of mouse models for analyzing ubiquitination processes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr542
3999,Expression of glucocorticoid and progesterone nuclear receptor genes in archival breast cancer tissue,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr556
4000,Erratum to: Functional and molecular characterisation of mammary side population cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr563
4001,Regulation of BRCA1 expression and its relationship to sporadic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr557
4002,Complex roles for telomeres and telomerase in breast carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr553
4003,Lack of evidence for an association of Epstein–Barr virus infection with breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr561
4004,The role of the ubiquitination-proteasome pathway in breast cancer: Ubiquitin mediated degradation of growth factor receptors in the pathogenesis and treatment of cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr541
4005,Functional and molecular characterisation of mammary side population cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr547
4006,The role of the ubiquitination-proteasome pathway in breast cancer: Applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr460
4007,What centrosomes can teach us about tumor progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2002-76551
4008,Quality control of immunohistochemical assay of HER-2/neu expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2002-76400
4009,AKT signalling implicated in failure of endocrine therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2002-76350
4010,The problem of trastuzumab (Herceptin) resistance: a role for IGF-1R?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2002-75500
4011,Gene expression profiling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2002-75351
4012,Gene expression signatures may predict clinical outcome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2002-75350
4013,bcl-2: a convergence point for multiple signal transduction pathways that influence cell survival?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2002-74403
4014,Primary chemotherapy with CEF-infu,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2002-74150
4015,Sequential tumour biopsies in phase I trials,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2002-74100
4016,Mutations in DNA damage response genes and breast cancer susceptibility,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr549
4017,"Workshop on The Epidemiology of the ATMGene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr551
4018,Progesterone receptors - animal models and cell signaling in breast cancer: Implications for breast cancer of inclusion of progestins in hormone replacement therapies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr540
4019,Progesterone receptors - animal models and cell signaling in breast cancer Diverse activation pathways for the progesterone receptor - possible implications for breast biology and cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr539
4020,Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr535
4021,The importance of being a myoepithelial cell,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr459
4022,Estrogen–progestin replacement therapy: regulatory action needed,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr550
4023,A new day dawns: women without oestrogen or is a balance best?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr538
4024,Has tamoxifen had its day?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr536
4025,Prolactin signaling and Stat5: going their own separate ways?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr543
4026,Expression and prognostic significance of lysozyme in male breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr537
4027,No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr534
4028,Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr457
4029,"Breast cancer incidence and mortality trends in an affluent population: Marin County, California, USA, 1990–1999",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr458
4030,Inhibition of E2-induced expression of BRCA1 by persistent organochlorines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr461
4031,Chaperone-mediated destruction of erbB2: relevance to tyrosine kinase inhibitors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr546
4032,"British Cancer Research Meeting, 30 June-3 July 2002, Glasgow",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr453
4033,Progesterone receptors - animal models and cell signaling in breast cancer: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr452
4034,Progesterone receptors - animal models and cell signaling in breast cancer: Progesterone's role in mammary gland development and tumorigenesis as disclosed by experimental mouse genetics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr451
4035,Progesterone receptors - animal models and cell signaling in breast cancer: Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr450
4036,Progesterone receptors - animal models and cell signaling in breast cancer: Role of steroid receptor coactivators and corepressors of progesterone receptors in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr449
4037,Familial risks of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr448
4038,A new model for ductal carcinoma in situ suggests strategies for treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr447
4039,IkB kinase alpha: a link in the chain of the mammary cycle,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr446
4040,Impact of false-positive mammography on subsequent screening attendance and risk of cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr455
4041,Risk factors for breast cancer in Iran: a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr454
4042,Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr456
4043,Articles selected from Faculty of 1000 in June 2002,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr545
4044,Wnt signalling in mammary carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr544
4045,"93rd Annual Meeting of the American Association for Cancer Research, San Francisco, CA, USA, 6-10 April 2002",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr442
4046,Finding the needle in the haystack: why high-throughput screening is good for your health,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr440
4047,Cyclins in breast cancer: too much of a good thing,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr439
4048,Defining the galaxy of gene expression in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr438
4049,Maspin is a tumour suppressor that inhibits breast cancer tumour metastasis in vivo,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr437
4050,Estrogen as therapy for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr436
4051,Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr441
4052,"A49T, V89L and TA repeat polymorphisms of steroid 5α-reductase type II and breast cancer risk in Japanese women",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr445
4053,Morphological types of breast cancer in family members and multiple primary tumours: is morphology genetically determined?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr444
4054,Novel mutations in the BRCA1 and BRCA2genes in Iranian women with early-onset breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr443
4055,Phylloides tumours: review of 42 cases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr531
4056,Diagnosis of dermal calcification,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr529
4057,A 10-year review of lymphoma detected by breast screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr527
4058,Analysis of results of the X-ray mammography in diagnostics on breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr525
4059,The establishment of an assessment method for radiographers to undertake mammographic image interpretation and reporting,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr523
4060,Changes in reporting practices with time when radiographers and radiologists double read screening mammograms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr521
4061,Welcome to North Wales breast screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr517
4062,Evaluation of the need for magnification views in the assessment of calcification in computerised mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr516
4063,Decubitus position for horizontal approach mammotome: is it possible?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr515
4064,Complications of breast core biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr513
4065,Extending the screening programme: how we did it and lived to tell the tale!,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr511
4066,National Vocational Qualifications (NVQs): a learning experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr510
4067,Technical recalls and technical repeats: evaluating the effect of the Occupational Standards/Skill Mix project,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr509
4068,"Great, I've been let off the hook (the impact of advanced practice within the breast screening department)",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr507
4069,An extended role for ultrasonographers in the evaluation of breast disease: initial experiences,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr505
4070,Can ultrasound reliably localise radial scars (RS)/complex sclerosing lesions (CSL) prior to excision biopsy?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr504
4071,Is pre-operative ultrasound assessment useful in the diagnosis of radial scars (RS)/complex sclerosing lesions (CSL)?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr503
4072,"It ain't what you do, it's the way that you do it – that's what gets results",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr502
4073,Quality management in the 21st century,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr501
4074,Roadworks ahead: a collaborative approach to process redesign,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr500
4075,Breast magnetic resonance imaging (MRI) – common pitfalls: a pictorial representation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr499
4076,Image features of true positive and false negative cancers in screening mammograms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr495
4077,Extent and stage of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr493
4078,Progress report on integrating skill mix: the college perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr492
4079,Progress report on integrating skill mix: the radiographer's perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr491
4080,Progress report on integrating skill mix: the radiologist's perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr490
4081,The effect of screening across the age spectrum,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr489
4082,Therapeutic applications of vacuum biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr487
4083,Vacuum biopsy in the UK,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr485
4084,Invasive cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr483
4085,Evaluation of three different resolution workstations for reporting computerised radiography mammographic images,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr481
4086,Predicting breast cancer response to chemotherapy using quantitative magnetic resonance (MR) imaging,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr479
4087,Assessment of full field digital mammography (FFDM) detected microcalcification is not hindered by low spatial resolution,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr477
4088,The mammographic appearances of benign mammary mucocele-like lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr473
4089,Plastic surgery for patients with postmastectomy syndrome,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr472
4090,Diagnosis of lymph node metastases by axillary node core biopsy in patients presenting with primary operable breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr471
4091,UK National Health Service Breast Screening Programme (NHSBSP) multicentre image guided biopsy trial: an update,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr470
4092,The accuracy of imprint cytology of breast core biopsy under ultrasound guidance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr469
4093,A review of screen detected breast cancers among aboriginal women in Western Australia,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr468
4094,Mammography and women over 65,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr467
4095,A customer satisfaction measuring instrument for women using the breast screening service: preliminary development and testing,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr466
4096,Imaging implants,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr533
4097,Computer aided detection,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr519
4098,Hormone replacement therapy (HRT) and its effect on mammographic specificity and sensitivity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr497
4099,Hormone replacement therapy (HRT): indications and side effects,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr475
4100,Molecular pathology of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr464
4101,An audit of benign biopsies performed in patients assessed by the Leeds/Wakefield Breast Screening Unit,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr528
4102,Is it safe to allow general practitioners open access to breast imaging?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr526
4103,Assessing performance of screen readers in the National Health Service Breast Screening Programme (NHSBSP),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr524
4104,Are there demographic differences in film reading skill?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr522
4105,An evaluation of the current role of radiographer film readers in breast screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr520
4106,To mag or not mag: that was the question?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr518
4107,Pre-operative fine-needle aspiration cytology (FNAC) and core biopsy (CB) of radial scars (RS) and complex sclerosing lesions (CSL),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr514
4108,Assistant practitioners: a success story,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr512
4109,Comparison of image quality between mammograms performed by an assistant practitioner and by screening radiographers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr506
4110,Magnetic resonance imaging (MRI) in the assessment of patients with breast carcinoma: an audit of accuracy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr498
4111,Comparative effectiveness of magnetic resonance imaging in breast cancer (COMICE trial),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr496
4112,Recording breast screening decisions: human factors and new technology,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr494
4113,Multicentre evaluation of stereotactic vacuum biopsies of mammographically indeterminate or suspicious lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr488
4114,The epidemiologist's perspective,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr484
4115,Ductal carcinoma in situ (DCIS),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr482
4116,Our experience in using magnetic resonance imaging (MRI) as an adjunct to mammography and ultrasound in assessing response to neoadjuvant chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr480
4117,Computed radiography systems for mammography: an evaluation of image quality and dose,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr478
4118,Electrical impedance scanning: a new imaging technique for evaluating microcalcification in the breast?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr476
4119,Sloane Project: a prospective audit of screen detected ductal carcinoma in situ,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr474
4120,When do women really want to attend screening?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr465
4121,Reconstruction,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr532
4122,Review of clinical trials,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr530
4123,Technology update,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr508
4124,"Breast cancer and hormone replacement therapy (HRT): collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr486
4125,"Nass SJ, Henderson IC, Lashof JC (eds): Mammography and Beyond: Developing Technologies for Early Detection of Breast Cancer. Washington, DC: National Academy Press, 2001. 316 pp.",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr429
4126,CCAAT/enhancer binding proteins in normal mammary development and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr428
4127,Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr427
4128,Liposome-based drug delivery in breast cancer treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr432
4129,Hormonal control of p53 and chemoprevention,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr431
4130,The contribution of inherited genotype to breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr430
4131,Breast Cancer Research: the move to publish research articles in full online only,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr462
4132,Genetic determinants of mammographic density,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr434
4133,Mutation analysis of the CHK2 gene in breast carcinoma and other cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr435
4134,Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr433
4135,The p53 pathway in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr426
4136,The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr425
4137,How does the estrogen receptor work?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr424
4138,The contribution of the environment (especially diet) to breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr423
4139,Are Trp53 rescue of Brca1 embryonic lethality and Trp53/Brca1breast cancer association related?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr422
4140,The utility of ductal lavage in breast cancer detection and risk assessment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr421
4141,Mammary cancer and epithelial stem cells: a problem or a solution?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr420
4142,Lysosomal Enzyme-Induced Cell Death in MCF7 and Mammary Gland Cells.,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr463
4143,The role of bisphosphonates in breast cancer: Actions of bisphosphonates in animal models of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr415
4144,The role of bisphosphonates in breast cancer: Development of bisphosphonates,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr414
4145,The role of bisphosphonates in breast cancer: The present and future role of bisphosphonates in the management of patients with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr413
4146,The role of bisphosphonates in breast cancer: Direct effects of bisphosphonates on breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr412
4147,Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr411
4148,Distinct functions of BRCA1 and BRCA2 in double-strand break repair,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr417
4149,E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr416
4150,Mammographic breast density as a biomarker of effects of isoflavones on the female breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr410
4151,Comparison of various characteristics of women who do and do not attend for breast cancer screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr418
4152,Breast cancer protection: hormonal priming via p53?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-73000
4153,Dual HER-2/EGFR tyrosine kinase inhibitors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-72700
4154,Iressa inhibits growth of HER-2-overexpressing cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-72400
4155,EGF receptor: new trick for an old dog?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-72202
4156,Membrane oestrogen receptor,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-71600
4157,Her-2/neu and topoisomerase IIaexpression in primary and metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68486
4158,Her-2/neu expression in primary breast cancer and its lymph node metastases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68485
4159,GW5638: a new antiestrogen,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68484
4160,Activin can activate p38 MAPK,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68468
4161,Multigene expression patterns predict metastatic behavior,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68467
4162,Cyclin D1in breast cancer is not associated with Ki67 but with ER,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68466
4163,Breast cell interactions within a 3D model culture system,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68465
4164,Is E-cadherin/catenin axis important in grade III ductal carcinomas?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68463
4165,Tamoxifen and angiogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68462
4166,Duration of adjuvant tamoxifen treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68461
4167,ER? expression seems important in preinvasive cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68460
4168,Carbonic anhydrase expression in DCIS,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68455
4169,What do Dictyosteliumand mammary gland have in common?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68454
4170,An in vitrobreast cell immortalisation assay,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68453
4171,Endocrine response: Is CGAthe key?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68452
4172,Nuclear-cytoplasmic shuttling of p21Cip1/WAF1is regulated by Akt,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68451
4173,Comparison of DCIS and post-surgical local recurrence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68449
4174,Phase III trial of chemotherapy ? HerceptinR in metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68448
4175,Liposome-encapsulated doxorubicin in metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68447
4176,Comparison of different methods of HER-2 analysis in archival tissue,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68446
4177,Response to CMF according to HER-2 overexpression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68445
4178,Normal mammary epithelial cells escape of senescence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68444
4179,Tissue microarray validation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68443
4180,Prognosis and treatment of small breast carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-68442
4181,The effect of BRK on EGF signalling via erbB3 in mammary epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-66722
4182,"Tamoxifen, angiogenesis, oestrogens and animal models",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2001-66721
4183,Investigation of glutathione S-transferase zeta and the development of sporadic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr332
4184,"Reasons for Hope: Canadian Breast Cancer Research Conference, Le Concorde Hotel, Quebec City, Quebec, Canada, 3–5 May 2001",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr331
4185,Update on HER-2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr330
4186,Update on HER-2 as a target for cancer therapy: The ERBB2 promoter and its exploitation for cancer treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr329
4187,Update on HER-2 as a target for cancer therapy: Alternative strategies for targeting the epidermal growth factor system in cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr328
4188,Intracellular signaling pathways of ErbB2/HER-2 and family members,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr327
4189,Update on HER-2 as a target for cancer therapy: Herceptin in the clinical setting,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr326
4190,Tumour-stroma interactions: Phenotypic and genetic alterations in mammary stroma: implications for tumour progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr325
4191,Tumour-stromal interactions Reciprocal regulation of extracellular matrix proteins and ovarian steroid activity in the mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr324
4192,Predictive factor for the response to adjuvant therapy with emphasis in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr323
4193,PTEN deficiency: a role in mammary carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr322
4194,Wnt signaling in breast cancer: have we come full circle?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr321
4195,Mammary Gland Cell Death Also Involves Lysosomal Autophagy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr307
4196,BRCA1 and BRCA2 mutations in a population-based study of male breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr419
4197,"Highlights from the 37th Annual Meeting of the American Society of Clinical Oncology, San Francisco, USA, 12-15 May 2001",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr320
4198,Hypoxia and oxidative stress in breast cancer Tumour hypoxia – therapeutic considerations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr316
4199,Mutations in normal breast tissue and breast tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr311
4200,"Hypoxia and oxidative stress in breast cancer Oxidative stress - its effects on the growth, metastatic potential and response to therapy of breast cancer",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr315
4201,The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr319
4202,Hypoxia and oxidative stress in breast cancer Hypoxia and tumourigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr314
4203,Hormone replacement therapy use dramatically increases breast oestrogen receptor expression in obese postmenopausal women,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr318
4204,Hypoxia and oxidative stress in breast cancer Hypoxia signalling pathways,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr313
4205,Characterization of adjacent breast tumors using oligonucleotide microarrays,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr317
4206,BRCA2 and homologous recombination,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr310
4207,Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr312
4208,The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr309
4209,Recent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr308
4210,Tumour-stromal interactions: Transforming growth factor-β isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr301
4211,Tumour-stromal interactions: Integrins and cell adhesions as modulators of mammary cell survival and transformation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr300
4212,The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr298
4213,In vivo cell kinetics in breast carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr306
4214,Low frequency of E-cadherinalterations in familial breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr295
4215,Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr294
4216,Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr293
4217,"Update on endocrine aspects of breast cancer: Report from the 23rd San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 6-9 December 2000",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr292
4218,Applications of microarray technology in breast cancer research,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr291
4219,More breast cancer genes?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr290
4220,Modulating sensitivity to drug-induced apoptosis: the future for chemotherapy?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr289
4221,Telomerase and breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr288
4222,The complexities of breast cancer desmoplasia,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr287
4223,Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr407
4224,CD95 ligand expression in dedifferentiated breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr405
4225,Design and profile of low-molecular-weight receptor tyrosine kinase inhibitors for antiangiogenic therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr403
4226,Diminished milk fat secretion and premature mammary gland involution in episialin/MUC1 transgenic mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr401
4227,Haplotype analysis in German families with recurrent BRCA1 and BRCA2 mutations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr398
4228,Radioprotective and tumor antiangiogenic effect of the novel synthetic superoxide dismutase (SOD) mimetic compounds,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr396
4229,CD31 expression by cells of extensive ductal in situ and invasive carcinomas of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr385
4230,Novel liposomal vectors for an enhanced gene transfer in vitro,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr383
4231,Role of stromelysin-3 in mammary tumor progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr381
4232,Whole-body hyperthermia in the treatment of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr379
4233,Effect of interferon-γ (IFN-γ) on transforming growth factor-β (TGF-β) regulation of sialomucin complex/Muc4,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr375
4234,MMP-9 production by T cells from mammary tumor bearers is upregulated by tumor-derived VEGF,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr373
4235,High-dose chemotherapy with peripheral blood progenitor cell support in breast cancer: WSG AM01 and MM01,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr371
4236,High-risk breast cancer patients: comparison of lymphocyte phenotypes and function in vitro,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr369
4237,Structural features for peptides binding the class I molecules,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr367
4238,A novel phenylacetate-dextran derivative (NaPaC) inhibits breast cancer cell proliferation and modifies their interactions with endothelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr365
4239,The association between cyclo-oxygenase-2 expression and cell proliferation and angiogenesis in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr363
4240,Fhit loss in familial breast cancer: is loss of DNA repair function linked to alterations at chromosome fragile sites?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr359
4241,Protection against growth of MUC1/sec transfected mammary tumor cells is mediated by an effector cell with perforin-dependent cytotoxicity,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr350
4242,A novel sodium phenylacetate-dextran derivative ester inhibits the growth and angiogenesis of MCF-7ras breast cancer xenografts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr346
4243,Immunotoxins: experimental design,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr342
4244,Identification of HER2-positive breast carcinomas as a particular subset with peculiar clinical behaviours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr340
4245,Bovine leukemia virus in human breast tissues,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr338
4246,Transcriptional regulation of apoptosis in mouse mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr336
4247,Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr334
4248,Mutation detection in familial and sporadic breast cancers by denaturing high-performance liquid chromatography (DHPLC),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr409
4249,The CC chemokine RANTES as a potential contributor to breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr377
4250,Rescue of HER-2-positive breast carcinoma cells from dormancy by growth factors produced during wound healing,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr344
4251,CD95 ligand expression mediates immune escape in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr406
4252,The mechanism of tamoxifen in breast cancer prevention,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr404
4253,Patterns of cytokines and lymphocyte subsets in patients with breast and prostate cancer treated with a standardized mistletoe extract preparation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr402
4254,On-site audits of the two clinical trials reported from South Africa involving high-dose chemotherapy (HDC) therapy for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr400
4255,Ultrasound-guided pO2 measurement in breast cancer patients before and after hyperthermia treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr397
4256,"Herceptin clinical trials: past, present and future",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr395
4257,Chromosomal instability and cancer predisposition: insights from studies on the breast cancer susceptibility gene BRCA2,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr394
4258,Downregulation of macrophage IL-12 production by tumor-derived IL-11,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr393
4259,Serological Her2/neu-determination in patients receiving Herceptin®,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr392
4260,Normo- and hyperbaric oxygenation of tumors: from bench to bedside,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr391
4261,Control of apoptosis in breast by growth factors and extracellular matrix: targets for therapeutic intervention,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr390
4262,Heterocyclic amines (HCAS) and risk of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr389
4263,Constitutional genomic instability of 9p23-24 in BRCA2 mutation carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr387
4264,Neuroendocrine breast carcinomas of aged women may express apocrine differentiation markers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr386
4265,Pathway pathology: the wnt and erbB mammary tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr384
4266,High-dose chemotherapy in breast cancer: Dutch randomized studies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr382
4267,Identification and refinement of two regions on chromosomal arm 15q involved in breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr380
4268,C-erbB-2 overexpression in primary breast cancer: relationship to clinical and histopathological parameters of patients with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr378
4269,Apoptosis-related factors in nonpalpable breast tumors: an immunohistochemical study. Correlation with the mammographic image,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr376
4270,A retrovirus similar to MMTV associated with human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr374
4271,Human estrogen receptor-α (ER-α) transactivation by selective estrogen receptor modulators (SERMs) on VIT regulatory region in ER-α-negative breast cancer cell line Evsa-T transiently transfected by ER-α,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr372
4272,The role of subareolar methylene blue in identifying the sentinel node in patients with invasive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr370
4273,The standardized mistletoe preparation Lektinol has antitumoral potencies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr368
4274,Acidification-induced sensitization to thermoradiotherapy in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr364
4275,Cloning of novel mammary tumor progression and metastasis genes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr362
4276,Effect of anthracyclin-based neoadjuvant chemotherapy on disseminated tumor cells in breast cancer patients: an immunocytologic and molecular approach,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr361
4277,Estrogen receptor transcription and transactivation: ErbB family of receptors in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr360
4278,Organochlorines and breast cancer: effect of exposure to dieldrin on risk and survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr358
4279,Sentinel lymph node biopsies in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr357
4280,Late radiation sequelae in women after breast-conserving cancer therapy: effects of hyperbaric oxygen therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr356
4281,Transcriptional regulation through the estrogen receptor (ER)-α and splice variants of ER-β via classical and nonclassical signal transduction pathways,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr354
4282,Estrogen receptor transcription and transactivation: Antitumor potential of bisphosphonates,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr353
4283,Characterization of a hormonally induced reverse transcriptase (RT) from the human breast cancer cell line T47D: a possible involvement in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr352
4284,Regulation of episialin/MUC1 expression in breast carcinomas: a complex interplay between stimulatory and inhibitory factors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr351
4285,Telomerase activity and bcl2 expression in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr349
4286,Prognosis and treatment of locally recurrent breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr348
4287,Nongenomic effects of estrogens on signal transduction pathways in estrogen-sensitive carcinoma cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr347
4288,Estrogen receptor transcription and transactivation: Genetic modifiers of cancer risks conferred by BRCA1 and BRCA2,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr345
4289,Three-dimensional ultrasound-guided biopsy of breast lesion: a new diagnostic support in the preoperative diagnosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr343
4290,Prevention of thymic atrophy in mammary tumor bearers by IFN-gamma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr341
4291,Restored expression of Fhit protein in Fhit-minus breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr339
4292,Association of the Epstein-Barr virus with breast cancer: in vivo and in vitro studies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr337
4293,Estrogen receptor transcription and transactivation: Novel morphoregulatory functions for the adhesion receptor Ep-CAM in the mammary epithelium,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr335
4294,Spontaneous apoptosis of circulating T-lymphocytes and its correlation to their prolactin receptor expression and prolactin plasma levels in patients with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr408
4295,Monocyte phagocytic function in patients with breast cancer during therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr399
4296,The relevance of translational research for radiotherapy in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr388
4297,Phagocytic activity of monocytes in patients with breast cancer at different clinical stages,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr366
4298,Asynchronous LOH analysis of ductal carcinoma in situ from patients who subsequently developed invasive ductal carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr355
4299,The in vivo cell kinetics in breast carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr333
4300,Inducible transgenics. New lessons on events governing the induction and commitment in mammary tumorigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr297
4301,Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr302
4302,"Breast cancer mortality among Ashkenazi Jewish women in São Paulo and Porto Alegre, Brazil",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr305
4303,Possible association of β2- and β3-adrenergic receptor gene polymorphisms with susceptibility to breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr304
4304,Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr303
4305,An investigation of soy intake and mammographic characteristics in Hawaii,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr285
4306,Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr282
4307,History of sentinel node and validation of the technique,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr281
4308,Clinical aspects of sentinel node biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr280
4309,Breast cancer chemoprevention: beyond tamoxifen,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr279
4310,Challenges to the development of antigen-specific breast cancer vaccines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr278
4311,Acid Phosphatase Activity in Human Breast Tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr296
4312,Overconfident Physician Opinion on the Effectiveness of BRCA1 Risk Reduction Measures,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr286
4313,Tumour-stromal interactions: Role of the stroma in mammary development,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr299
4314,Mechanisms of suberoylanilide hydroxamic acid inhibition of mammary cell growth,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr284
4315,Hormones and Cancer 2000,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr283
4316,The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr277
4317,Monoclonal antibodies targeting cancer: 'magic bullets' or just the trigger?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr276
4318,"From Bittner to Barr: a viral, diet and hormone breast cancer aetiology hypothesis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr275
4319,Molecular profiling of breast cancer: portraits but not physiognomy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr274
4320,Ang1 in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66719
4321,c-erbB2 homodimerisation in mammary epithelial cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66715
4322,ER variants in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66713
4323,HOXA5 regulation of p53 in breast tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66711
4324,Chromosome 6 alterations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66709
4325,Microdissection and microarrays,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66707
4326,Amplification at 17q23 in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66704
4327,Clusterin in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66699
4328,Loss of heterozygosity in fibrocystic change,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66693
4329,Com-1 in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66691
4330,Mammaglobin as a marker in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66689
4331,14-3-3σ down-modulation: a ubiquitous marker for breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66683
4332,Genetic alterations in breast stroma may influence epithelial neoplasia,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66681
4333,Tamoxifen-resistant breast carcinoma xenograft,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66679
4334,BRCA1 complex contains multiple DNA repair proteins,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66677
4335,CpG island methylation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66675
4336,ErbB2 and cell cycle control,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66670
4337,Mammary pathology of genetically engineered mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66666
4338,C/EBPβ and mammary epithelial cell fate,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66664
4339,SUM-159PT: an ER-independent breast cancer model,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66660
4340,Mammographic prediction of early breast cancer survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66658
4341,ErbB-receptors in antiestrogen resistance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66654
4342,ERBB2detection and associated chromosomal alterations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66652
4343,Racial differences in breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66650
4344,Molecular cytogenetic analysis of breast cancer cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66648
4345,Breast Cancer Menu,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-2-webreport0016
4346,metaRegister of Controlled Trials,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-2-webreport0014
4347,Biology of the Mammary Gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-2-webreport0011
4348,Free access to pathology images and expert opinion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-2-webreport0007
4349,A comprehensive patient information resource,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-2-webreport0005
4350,Breast Cancer on CancerNet,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-2-webreport0001
4351,Enhanced activity of anti-Lewisyhumanised 3S193 when combined with Taxol,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66718
4352,Tailored versus high-dose chemotherapy as adjuvant breast cancer treatment,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66717
4353,Nuclear cytometric changes in breast carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66716
4354,Pathologic features associated with nonsentinel lymph node metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66714
4355,APCgene mutations in human breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66710
4356,Estrogen receptor β in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66708
4357,Marker of increased cancer risk in benign breast disease,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66706
4358,Amplification at 17q23 in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66705
4359,Matrix metalloproteinases and angiogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66702
4360,Mammographic screening does not result in a reduction in breast cancer mortality when added to annual clinical breast examinations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66701
4361,A role for PDGF in breast tumor desmoplasia,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66700
4362,The composition of mammary gland stroma regulates tumour cell invasion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66698
4363,Temporal prognostic value of ER,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66697
4364,Cognition effects of chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66696
4365,Bisphosphonates inhibit breast and prostate cancer cell invasion,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66695
4366,Breast conserving therapy vs mastectomy for larger tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66690
4367,Gemcitabine and vinorelbine in advanced breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66688
4368,Neoadjuvant hormonal therapy with anastrozole,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66687
4369,TALL-104 adoptive immunotherapy in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66685
4370,A progesterone receptor polymorphism (PROGINS) and breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66682
4371,High dose raloxifene in patients with advanced breast carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66680
4372,Comparative rat and human mammary histopathology,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66678
4373,Tamoxifen and response,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66676
4374,Beta-catenin in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66674
4375,neu/erbB-2oncogene in mouse mammary tumorigenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66673
4376,Stromal-epithelial interactions lead to tumour formation in irradiated mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66671
4377,p27Kip1 and p18INK4cin T-47D cell cycle arrest,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66669
4378,Molecular profiling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66668
4379,hCds1 phosphorylates BRCA1 after DNA damage,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66667
4380,RAFTK/Pyk2-mediated signaling in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66665
4381,Chromosome 1 in breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66663
4382,High dose therapy in metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66662
4383,"p53, genetic instability and ras overexpression",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66659
4384,High-dose chemotherapy in high-risk breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66656
4385,Aromatase polymorphisms and breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66655
4386,HRT and the efficacy of mammographic screening for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66651
4387,Assessment of breast screening programme effectiveness,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66649
4388,Truncated BRCA2 is cytoplasmic,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66647
4389,Computer-assisted mammographic imaging,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr84
4390,Freedom of information,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-2-webreport0015
4391,Breast Cancer On-line,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-2-webreport0013
4392,The Jackson Laboratory,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-2-webreport0012
4393,BRCA1 function in T lymphocytes: a cellular specificity of a different kind,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr263
4394,"Australian Breast Cancer Information, Support and Advocacy",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-2-webreport0010
4395,Breast cancer gene linkage research network,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-2-webreport0009
4396,Breast Cancer News,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-2-webreport0008
4397,Database of breast cancer biospecimens and familial data,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-2-webreport0006
4398,Syk: a new player in the field of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr261
4399,TeleSCAN,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-2-webreport0004
4400,Digital Breast Clinic,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-2-webreport0002
4401,An anti-oncogenic role for decorin,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66720
4402,Vaccination of breast cancer patients with MUC1 keyhole limpet hemocyanin conjugate plus QS-21,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66712
4403,RhoC oncogene and inflammatory breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66703
4404,A randomised trial of buserelin and tamoxifen in metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66694
4405,Thalidomide in patients with metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66692
4406,Liposome-delivered angiostatin inhibits breast cancer growth and metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66686
4407,Exemestane as third and fourth line hormonal therapy for metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66684
4408,"Id-1, invasion and steroid response",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66672
4409,Effects of flavopiridol on apoptosis and c-erbB2 in breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66661
4410,p53 mutations as predictors for response to neoadjuvant chemotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66657
4411,Risk of breast cancer in users of combined oestrogen-progestogen HRT compared with users of oestrogen alone,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-2000-66653
4412,Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr92
4413,P53 autoantibodies in 1006 patients followed up for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr91
4414,Molecular biology of breast metastasis The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr90
4415,Molecular biology of breast cancer metastasis Inflammatory breast cancer: clinical syndrome and molecular determinants,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr89
4416,Molecular biology of breast cancer metastasis Molecular expression of vascular markers by aggressive breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr88
4417,Molecular biology of breast cancer metastasis Genetic regulation of human breast carcinoma metastasis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr87
4418,Molecular biology of breast cancer metastasis Clinical implications of experimental studies on metastatic inefficiency,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr86
4419,Molecular biology of breast cancer metastasis ‘Has it spread?’: Disarming one of the most terrifying questions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr85
4420,Breast cancer risk perception: what do we know and understand?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr83
4421,Transforming growth factors-β are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr273
4422,"BRCA1 and BRCA2 protein expressions in an ovotestis of a 46, XX true hermaphrodite",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr272
4423,"Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr271
4424,VIII International Congress of the Metastasis Research Society,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr270
4425,Breast imaging technology: Probing physiology and molecular function using optical imaging - applications to breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr269
4426,Imaging biochemistry: applications to breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr268
4427,Gene therapy for carcinoma of the breast: Pro-apoptotic gene therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr27
4428,Breast imaging technology: Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects: applications to breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr267
4429,Breast imaging technology Application of magnetic resonance imaging to angiogenesis in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr266
4430,Breast imaging technology Application of magnetic resonance imaging to early detection of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr265
4431,Breast imaging technology: Current and future technologies for breast cancer imaging,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr264
4432,"The International BRCA1 /2Carrier Cohort Study: Purpose, Rationale, and Study Design",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr93
4433,Whither high-dose chemotherapy in breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr262
4434,The mammary myoepithelial cell - Cinderella or ugly sister?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr260
4435,Radial scars and stellate lesions as imaging abnormalities: a comparative study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr255
4436,Investigation into possible causes of blurring in mammograms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr253
4437,Scenic screening sites of Sussex,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr252
4438,Routine mammography for women aged 40-49 years: should mammography screening guidelines be changed in view of current research?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr249
4439,Pictorial essay of fat necrosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr247
4440,Image blur: back to basics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr237
4441,An overview of workforce issues,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1303
4442,Minimally invasive treatment of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1302
4443,Upright digital stereotaxis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1301
4444,Are too many breast cancers missed at assessment?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr220
4445,The lateral arm for stereotactic biopsy: how good is it?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr218
4446,The long term follow up of a cohort of women invited to NHS breast screening,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr216
4447,Oncology,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1300
4448,Introducing MRI into clinical breast practice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr199
4449,Future of breast cancer services,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1299
4450,Future of breast cancer services,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1298
4451,Responsibility versus residence: how will this change in Department of Health policy affect you and your breast screening service?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr259
4452,Quality management systems: the benefits of achieving ISO 9002,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr258
4453,"'To failsafe' or 'not to failsafe', that is the question?",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr257
4454,Comparison of four methods of presentation of breast specimens,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr256
4455,"An evaluation of the relationship between compressed breast thickness and glandular dose, within the breast screening service",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr254
4456,A radiographer's perspective of sentinel lymph node biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr250
4457,Galactoductography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr248
4458,Audit rules OK! The benefits of an internal quality audit programme in the breast screening service,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr246
4459,Imaging methods to screen women with breast implants,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr245
4460,Decubitus positioning for stereotactic core biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr244
4461,Flexible screening clinics: future options,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr243
4462,Galactocele in a postmenopausal woman: a case report,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr242
4463,Latent image fade and Kodak MinR2000 film,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr241
4464,A trial of duplicating film for mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr240
4465,Technical recalls (TC): a lesser service?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr239
4466,Between four walls: what level of privacy do women want?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr238
4467,Techniques and equipment in mammography - an aid to diagnosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr236
4468,Up the creek without a paddle,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr235
4469,Implanted markers prior to neoadjuvant chemotherapy: preliminary report,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr234
4470,Prediction of the underlying histology from the mammogram: mammographic-large section histologic correlation of >1000 open surgical biopsies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr233
4471,Characterising breast tissue for the development of a tissue-equivalent phantom,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr232
4472,Assessing an individual's film reading ability,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr231
4473,Comments from radiologists,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr230
4474,Comments from a breast clinician,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr229
4475,Who does what? Comments from radiographers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr228
4476,Computer aided detection,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr227
4477,Full-field digital mammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr226
4478,Using new technology to achieve the ideal mammogram,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr225
4479,UK NHSBSP multicentre image guided biopsy trial: an interim analysis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr224
4480,The technical aspects of adapting add-on digital stereotactic equipment for use with patient lying horizontally,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr223
4481,Does preoperative diagnosis reduce the number of operations required for treatment of screen-detected breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr222
4482,"Breast ultrasound in a ""moderate risk"" population",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr221
4483,Sclerosing lymphocytic lobulitis (SLL): a diagnostic challenge,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr219
4484,Can radiographers reliably read screening mammograms?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr217
4485,The early impact of the breast cancer screening programme in the city of Florence: methods of evaluation and first results (1990-1996),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr215
4486,Stages of screen-detected breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr213
4487,Extending routine invitation to breast screening to the 65-69 year age group: report of the Scottish pilot study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr211
4488,Radiological review of interval cancers in an Australian mammographic screening programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr210
4489,A comparison of prone breast biopsy procedures using a digital imaging system with a conventional upright technique,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr209
4490,Preoperative detection of multicentric breast cancer using tetrafosmin mammoscintigraphy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr208
4491,A comparative evaluation of two full-field digital mammography units,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr207
4492,The evaluation of four small-field digital mammography systems,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr206
4493,Preliminary results of a pilot study into the diagnostic value of T scan in detecting breast malignancies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr205
4494,Pre-operative diagnosis and staging of symptomatic breast disease using 99mtechnitium scintimammography,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr204
4495,Electrical impedance imaging of the breast (TranScan TS 2000): initial UK experience,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr203
4496,Surgical management,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr202
4497,Lymph node diagnosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr201
4498,MR-guided breast biopsy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr200
4499,Screening and its effect on breast cancer mortality rates,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr198
4500,The Swedish Two-County Trial 20-years on: updated mortality results and new insights from long-term follow-up,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr197
4501,Polymorphic repeat in AIB1 does not alter breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr82
4502,Estrogen receptor transcription and transactivation Basic aspects of estrogen action,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr81
4503,Estrogen receptor transcription and transactivation Structure-function relationship in DNA- and ligand-binding domains of estrogen receptors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr80
4504,Estrogen receptor transcription and transactivation Estrogen receptor knockout mice: what their phenotypes reveal about mechanisms of estrogen action,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr79
4505,Estrogen receptor transcription and transactivation Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr78
4506,Nontransgenic models of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr77
4507,Role of BRCAgene dysfunction in breast and ovarian cancer predisposition,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr76
4508,Metastases: the glycan connection,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr75
4509,What is the predictive value for malignancy of radiological classification for indeterminate microcalcification seen on mammography?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr251
4510,How long does it take to become a competent mammographer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr214
4511,How do radiographers compare to radiologists when double reading screening mammograms,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr212
4512,Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr73
4513,BRCA1 and BRCA2 mutations in central and southern Italian patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr72
4514,91st Annual Meeting of the American Association for Cancer Research,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr71
4515,Future possibilities in the prevention of breast cancer: Intervention strategies in BRCA1 and BRCA2 mutation carriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr70
4516,Future possibilities in the prevention of breast cancer: Role of genetic variation in breast cancer prevention,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr69
4517,Future possibilities in the prevention of breast cancer: Fat and fiber and breast cancer research,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr68
4518,Future possibilities in the prevention of breast cancer: Luteinizing hormone-releasing hormone agonists,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr67
4519,Future possibilities in the prevention of breast cancer: Breast cancer prevention trials,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr66
4520,"Metalloproteinases: role in breast carcinogenesis, invasion and metastasis",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr65
4521,Mammographic screening and mammographic patterns,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr64
4522,Acetyltransferases and tumour suppression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr63
4523,New hurdles for translational research,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr62
4524,Utilization of human tissue in breast cancer research,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr61
4525,Differential Expression of Mammastatin in Normal and Breast Cancer Cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr74
4526,A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr57
4527,Tyrosine kinase signalling in breast cancer: Tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr56
4528,Tyrosine kinase signalling in breast cancer: Epidermal growth factor receptor and c-Src interactions in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr55
4529,Tyrosine kinase signalling in breast cancer: Modulation of tyrosine kinase signalling in human breast cancer through altered expression of signalling intermediates,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr54
4530,Tyrosine kinase signalling in breast cancer: Fibroblast growth factors and their receptors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr53
4531,Tyrosine kinase signalling in breast cancer: Epidermal growth factor receptor - convergence point for signal integration and diversification,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr52
4532,Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr51
4533,Tyrosine kinase signalling in breast cancer: Insulin-like growth factors and their receptors in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr50
4534,Homeobox genes in mammary gland development and neoplasia,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr49
4535,Tyrosine kinase signalling in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr48
4536,Linear and cooperative signaling: roles for Stat proteins in the regulation of cell survival and apoptosis in the mammary epithelium,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr47
4537,Type V collagen induces apoptosis of 8701-BC breast cancer cells and enhances m-calpain expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr60
4538,"Second International Symposium on the Molecular Biology of Breast Cancer, March 12-16, 2000, Lillehammer, Norway",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr59
4539,"13thGeneral Meeting of The Breast Cancer Linkage Consortium, November 29-December 1, 1999, Amsterdam, The Netherlands",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr58
4540,Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-β,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr44
4541,Transforming growth factor-β and breast cancer: Cell cycle arrest by transforming growth factor-β and its disruption in cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr43
4542,Transforming growth factor-β and breast cancer: Transforming growth factor-β/SMAD signaling defects and cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr42
4543,Transforming growth factor-β and breast cancer: Lessons learned from genetically altered mouse models,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr41
4544,Transforming growth factor-β and breast cancer: Mammary gland development,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr40
4545,Transforming growth factor-β and breast cancer: Introduction,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr39
4546,"Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr38
4547,Caretaker Brca1: keeping the genome in the straight and narrow,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr37
4548,Founder populations and their uses for breast cancer genetics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr36
4549,Breast cancer research: where we are and where we should go,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr35
4550,"22nd Annual San Antonio Breast Cancer Symposium, 8-11 December 1999, San Antonio, Texas, USA",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr46
4551,Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr45
4552,Studying breast cancer on a genomic scale using DNA microarrays,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr196
4553,Tissue microarrays for high-throughput profiling in molecular oncology,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr194
4554,Predictive factors in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr192
4555,Telomerase: a breast cancer chemopreventive and therapeutic target,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr190
4556,Molecular control of apoptosis in the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr188
4557,Tumour-selective transcriptional targeting for breast cancer gene therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr186
4558,Cancer susceptibility in ATM heterozygotes: do two distinct carrier populations exist?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr142
4559,Lessons from TP53mutations in breast cancers: from carcinogen fingerprints to clinical correlates,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr140
4560,Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr138
4561,Animal models of human tumor suppressor genes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr136
4562,Herceptin in clinical use - early 2000,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr184
4563,Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr134
4564,Growth regulation and steroid hormone resistance in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr132
4565,"Hypervariable area in the 5' flanking region of GSTP1, previously reported as a minisatellite repeat",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr177
4566,Exact quantification of gene amplification in archival tissue sections by laser-assisted microdissection and real-time PCR,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr175
4567,Promising method for DNA extraction from paraffin embedded archive material,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr173
4568,Expression profiling of BRCA1 associated breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr126
4569,Genetic alterations in ductal carcinoma in situ and invasive carcinoma of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr124
4570,Does a polymorphism in the CYP17 gene predict mammographic density?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr171
4571,Other cancers in BRCA1 and BRCA2 mutation carriers: implications for counselling and follow up,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr130
4572,Molecular analyses of human breast cancer metastasis: genetic markers of progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr122
4573,Molecular characteristics of inherited breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr181
4574,Angiogenesis in breast cancer: establishing a link between angiogenesis and hormone regulation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr169
4575,"Development of a high throughput, molecular diagnostic assay for predicting telomerase activity in breast cancer cell lines and tissues",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr120
4576,"Negative regulation of p53 expression is an essential, rate-limiting function of Jun in the control of cell cycle progression",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr167
4577,"Low frequency of p16

INK4a
 promoter methylation in mammary carcinomas as revealed by positive display of methylated sites",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr118
4578,Genetic testing for BRCA1 and BRCA2 mutations - ready for implementation?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr128
4579,A detailed physical map of a region within human chromosome 16q22.1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr165
4580,Screening breast cancer patients for Norwegian ATM mutations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr163
4581,Role of the breast cancer susceptibility gene BRCA1 in radio-resistance,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr159
4582,Embryonic lethality in the Brca1-1700T mouse model suggests inhibition of p53-dependent pathways,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr161
4583,Excluding TTC4 as a target for loss on chromosome 1p31 in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr116
4584,"Loss of heterozygosity on chromosome arm 16q in breast cancer: clinical, molecular and statistical approaches",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr114
4585,Constitutional alterations of the ATM gene in early-onset sporadic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr112
4586,The expression of the EGFR family members in breast carcinomas,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr105
4587,Factors modulating integrin Beta I expression on the breast cancer cell lines MCF-7 and MDA-MB-231,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr157
4588,IGFBP-7 expression in human breast cancer and association with proliferation and cell cycle aberrations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr155
4589,Herceptin™ (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr108
4590,Relative expression of progesterone receptors A and B in premalignant and invasive breast lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr103
4591,Genetic variants of CYP19 (aromatase) and breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr153
4592,Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr151
4593,Clinical and pathological characteristics in patients with BRCA1/2-mutation associated with breast cancer (BC) with a long clinical follow-up,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr144
4594,kConFab: a unique Australasian research initiative for familial breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr101
4595,Germline BRCA2 and somatic P53alterations in male breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr99
4596,BRCA1mutation analysis in breast and ovarian cancer families from Greece,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr97
4597,"A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr95
4598,HRAS1 minisatellite alleles and breast cancer in Spanish women under age forty years,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr149
4599,One test to identify 50% of all Norwegian BRCA1 mutations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr147
4600,"BRCA1, BRCA2 and pedigree genetic analysis to determine genetic risk in the UK Royal Marsden Hospital tamoxifen prevention trial",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr145
4601,Two molecular cytogenetic views of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr195
4602,Clinical trials in breast cancer; do we have the right approaches?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr193
4603,Blood assays for earlier detection of cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr191
4604,Hypoxia and tumour angiogenesis involved in breast cancer progression and targets for therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr189
4605,G1/S control and its deregulation in cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr187
4606,"Role of the ATM gene in radiation sensitivity, relevance to breast cancer treatment",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr185
4607,p53 action in apoptosis and senescence,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr141
4608,p53-mediated apoptosis and genomic instability syndromes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr139
4609,Drug discovery in the p53 pathway,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr137
4610,Characterisation of micrometastatic tumor cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr135
4611,The EGF receptor family as targets for breast cancer therapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr183
4612,Clinical translation of progress in molecular endocrinology,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr133
4613,Comparative genomic hybridisation analysis of myoepithelial carcinoma of the breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr178
4614,Relation of gene expression-based tumor subclasses to clinical phenotypes,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr180
4615,Screening for BRCA1 gene mutations by capillary electrophoretic REF-SSCP,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr176
4616,REAL Real-Time!,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr174
4617,The role of coactivators in oestrogen action,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr131
4618,Identification of two novel breast cancer associated genes by the differential display method,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr125
4619,Transcript profiles and genotyping of cancer tissue,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr179
4620,Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr172
4621,AKT-1 and BCL-2 co-expression in breast cancer patients correlates with better survival,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr170
4622,Ribozymes targeting the tumor suppressor BRCA1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in HBL100 breast cancer cell line,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr123
4623,Mammary epithelial cells immortalized by over-expression of the catalytic subunit of human telomerase may represent a model for mammary epithelial differentiation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr121
4624,Setting up an efficient and reliable screening method for novel c-Jun N-terminal kinase substrates,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr168
4625,The pathology of inherited breast tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr129
4626,p16INK4A as a predictive factor in patients with locally advanced breast cancer treated with neoadjuvant doxorubicin monotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr166
4627,Estrogen-dependent c-jun upregulation may control cyclin D1 expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr119
4628,Analysis of Fhit expression in stages of breast cancer progression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr164
4629,The GSTT1 genotype is associated with p53 mutation status of breast cancer tumours,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr162
4630,BRCA2 interacting proteins,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr160
4631,Expression of variant forms of the MUC1 gene correlates with the invasiveness of breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr117
4632,Analysis of chromosome alterations and the E-cadherin and FHIT genes in lobular breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr115
4633,Modulation of ATM gene expression in a murine mammary epithelial cell line,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr113
4634,Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr109
4635,P53 mutations in breast and ovarian carcinomas from BRCA1 and 2 mutation carriers and noncarriers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr111
4636,HER-2 activation and TP53 inactivation as predictors of survival in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr158
4637,"Activation of the Her2/neu receptor leads to antiestrogen resistance, but acquired resistance is not caused by altered ErbB expression and activation",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr156
4638,Anti-HER2 mAb plus calicheamicin immunoconjugate linked on liposomal vinorelbine induces ADCC and apoptosis in HER2-positive high grade DCIS,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr107
4639,Phosphorylation of human progesterone receptors by MAPKs mediates transcriptional synergy between progestins and MEKK1 in human breast cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr104
4640,The involvement of the MAPK signalling pathway in the adaptation of MCF-7 cells to long-term oestrogen deprivation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr154
4641,Hairy and enhancer of split homolog-1 (HES-1) mediates the proliferative effect of Beta-estradiol on breast cancer cell lines,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr152
4642,Germline mutations of BRCA1-associated RING domain (BARD1) gene in breast and/or ovarian families negative for BRCA1 and 2 alterations,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr102
4643,Constitutional alterations of 9p23-24 in independent BRCA2 breast cancer families,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr100
4644,The importance of breast cancer research from a patient's view: the voices and visions of advocates,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr127
4645,Germline TP53mutations in Finnish breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr98
4646,"Breast cancer in young women: prevalence of LOH at p53, BRCA1 and BRCA2",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr96
4647,Denaturing high-performance liquid chromatography (DHPLC) as a fast tool to screen a control population for the occurrence of unclassified variants (UV) in the BRCA1 gene,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr94
4648,X chromosome inactivation pattern in female patients with breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr148
4649,Mammary-specific targeting of the murine BRCA2 breast cancer susceptibility gene in mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr150
4650,Mutational analysis of BRCA1 and BRCA2 genes in Spanish women with early-onset breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr146
4651,Estrogen receptors α and β in the rodent mammary gland,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr182
4652,Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr110
4653,Expression of Akt kinases related to ErbB2 and results of adjuvant therapy of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr106
4654,Altered expression of estrogen receptor-α variant messenger RNAs between adjacent normal breast and breast tumor tissues,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr30
4655,Smoking and high-risk mammographic parenchymal patterns: a case-control study,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr29
4656,Gene therapy for carcinoma of the breast: Genetic ablation strategies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr28
4657,Gene therapy for carcinoma of the breast: Therapeutic genetic correction strategies,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr26
4658,Gene therapy for carcinoma of the breast: Genetic toxins,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr25
4659,Gene therapy for carcinoma of the breast: Genetic immunotherapy,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr24
4660,Beyond the genome to tissue proteomics,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr23
4661,Breast cancer prevention,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr22
4662,Microarray foray,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr21
4663,Proteome analysis of breast cancer cells (8701-BC) cultured from primary ductal infiltrating carcinoma: relation to correspondent breast tissues,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr31
4664,"Modeling Mammary Cancer in Mice Conference, Jackson Laboratory, Bar Harbor, Maine, 5-8 October, 1999",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr34
4665,Mouse models for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr20
4666,6th Nottingham International Breast Cancer Conference (22-24 September 1999),http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr33
4667,"International Conference on the Biology of the Mammary Gland. Tours, France (16-18 September 1999)",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr32
4668,Breast Cancer Research non-peer-review research depository,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr19
4669,Down-regulation of type I collagen by breast tumour cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66646
4670,CGH of invasive breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66645
4671,Genetic alterations in normal breast tissue,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66644
4672,The importance of AP-1 activity in human breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66643
4673,HER2 expression during the menstrual cycle,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66642
4674,ATM phosphorylates BRCA1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66641
4675,VEGF and radiotherapy in node-negative breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66639
4676,Benzo[a]pyrene downregulation of BRCA1,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66638
4677,Progostic LOH markers for breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66637
4678,Progesterone in mouse mammary gland carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66635
4679,Peptide-based vaccination against the HER-2/neu oncogenic protein,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66631
4680,bcl-2 and tamoxifen-induced apoptosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66627
4681,Heregulin signalling through HER-2 leads to increased epithelial cell growth,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66625
4682,Soya foods and breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66623
4683,Protein expression mapping of normal human breast epithelium,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66621
4684,PTEN Immunohistochemistry in Breast Carcinoma,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66619
4685,High dose chemotherapy in inflammatory breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66617
4686,BRCA2overexpression in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66615
4687,Diet and survival following a diagnosis of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66613
4688,Epstein-Barr virus in breast cancers,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66607
4689,Stromelysin-1 promotes mammary carcinogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66605
4690,Liposome-plasmid complexes encoding angiostatin and endostatin inhibit breast cancer in nude mice,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66602
4691,Generation of human tumors in vitro,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66600
4692,Mutations of the TGF-β RI gene are uncommon,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66599
4693,Proliferation markers in preinvasive breast lesions,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66597
4694,LOH in a transgenic model of breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66589
4695,Impact of mammographic screening in New South Wales,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66587
4696,Interaction of BRCA1 and AR genes in breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66583
4697,Margin width influencing local recurrence in ductal carcinoma in situ,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66581
4698,Risk of breast cancer in women with palpable breast cysts,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66579
4699,Break IT - The Breast Cancer Pathology Information Kit,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-1-webreport0003
4700,Breast Cancer Research: a meeting point as well as a journal,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1
4701,A phase II trial of a histamine antagonist (DPPE) and doxorubicin in metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66640
4702,BRCA1 and Rb?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66636
4703,Telomerase inhibition reduces cell growth,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66634
4704,Mutual interaction between breast epithelial and fibroblast cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66633
4705,Organochlorine pesticides: an effect on estrogen activity?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66632
4706,Radiological review of interval cancers in Stockholm,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66630
4707,Liposomal doxorubicin in metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66629
4708,ErbB-4 dependent proliferation of ER+ breast cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66628
4709,17q aberrations in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66626
4710,ER and control of cyclin D1 expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66624
4711,Brca1 and homologous recombination,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66622
4712,Apoptosis and caspases in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66620
4713,Adenoviral topoisomerase II αgene transfer increases sensitivity of resistant cancer cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66618
4714,Tpl-2overexpression in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66616
4715,Connexin gap junctions in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66614
4716,Extracellular matrix modulates mammary gland growth factor signalling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66612
4717,Use of cDNA microarrays in breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66611
4718,The effects of HER2 monoclonal antibody in women with HER2-overexpressing metastatic breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66610
4719,Idoxifene antagonises E2-dependent breast cancer xenograft growth through apoptosis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66609
4720,Visibility of cancer on earlier mammograms in the Finnish breast screening programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66608
4721,Role of the mitotic checkpoint in transformation of Brca2 null cells,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66606
4722,Autologous stem-cell transplantation of hematopoietic cells containing the MDR1 cDNA,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66604
4723,ZACdownregulation in breast tumors,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66603
4724,Pathologic findings from the NSABP B-17 protocol: 8 year update,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66601
4725,BRCA1-associated DNA repair,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66598
4726,Interval cancers in the Scottish screening programme,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66596
4727,MMTV-c-erbB-2 and MMTV-TGF alpha transgenic rats,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66595
4728,Micrometastases and survival in women with primary breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66594
4729,ER in normal and pre-cancerous breast,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66593
4730,Missing cancers at prevalence screen affects their size at incidence screen,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66592
4731,Genetic prodrug activation in erbB-2 overexpressing breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66591
4732,Whole-genome scan for common breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66590
4733,Raloxifene and breast cancer risk,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66588
4734,"Edinburgh breast screening trial, 14 year follow up",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66586
4735,Tamoxifen treatment for DCIS - NSABP B-24 trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66585
4736,Report from 16 year UK breast screening trial,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66584
4737,Mammary gland cell proliferation and steroid receptor expression,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66582
4738,BRCA1 and estrogen receptor signaling,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66580
4739,VEGFR-3 and VEGF-C in angiogenesis,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr-1999-66578
4740,Glutathione S-transferase M1 null genotype: lack of association with tumour characteristics and survival in advanced breast cancer,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr17
4741,Late-breaking breast cancer research: from genomics to new drugs,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr15
4742,"Second International Workshop on the function of BRCA1 and BRCA2, Cambridge, UK, 9 to 10 September 1999",http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr14
4743,The pathology of familial breast cancer: Morphological aspects,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr10
4744,The pathology of familial breast cancer: The pre-BRCA1/BRCA2 era - historical perspectives,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr9
4745,Opinion: why the variation in breast cancer survival in Europe?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr8
4746,How many more breast cancer predisposition genes are there?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr6
4747,Epithelial stem cells in the mammary gland: casting light into dark corners,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr5
4748,Killing the umpire: cooperative defects in mitotic checkpoint and BRCA2 genes on the road to transformation,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr4
4749,Bringing estrogen receptors under control,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3
4750,Do we now have a relevant animal model for breast cancer?,http://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2
